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Abstract 
The development of new biocatalytic processes is hindered by the number of factors that 
must be investigated and optimised in order to create a robust and reproducible process, 
particularly where a novel enzyme is involved. It is therefore advantageous to perform process 
development experiments at micro scale, in order to reduce the material requirement for 
experimentation and increase experimental throughput by parallelisation.  
The initial focus of the thesis is on the design of a microfluidic tangential flow filter to 
test downstream processing conditions. The device was designed for reversible clamp sealing, 
allowing the simple integration of different filtration membranes, and the seal achieved with 
the device was shown to be robust up to internal pressures of 100 psi. The filtration device 
was applied to the recovery of L-erythrulose (ERY) from a synthesis reaction performed using 
transketolase (TK), where it was demonstrated that the enzyme could be fully retained using 
a commercially-available membrane, while ERY was able to permeate the membrane freely. 
The filtration device was joined in-line to the output of a T-junction reactor with a staggered 
herringbone mixer, used to perform the synthesis reaction. The filter was capable of 
continuously separating the ERY from the lysate mixture exiting the reactor over the course 
of several hours, producing 3.6 mg h-1 of pure ERY.  
A novel multi-input reactor (MIR) is also demonstrated for the purpose of intensifying 
ERY output, designed to overcome the effect of substrate inhibition on the TK enzyme by 
mimicking a fed-batch reactor. Feeding strategies were designed for the conversion of various 
concentrations of the less inhibiting substrate hydroxypyruvate (HPA) and tested in the MIR. 
A 4.5-fold increase in output concentration and a 5-fold increase in throughput were achieved 
compared with the single input reactor used in previous experiments. However, conversion in 
the MIR was reduced at higher concentrations, suggesting that the reaction in the MIR was 
being inhibited by the evolution of carbon dioxide. 
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Glossary 
The descriptions of acronyms and shortenings that are frequently used in this thesis can 
be found below. 
ERY Erythrulose 
FBS Fetal bovine serum 
GA Glycolaldehyde 
GFP Green fluorescent protein 
HPA Lithium-hydroxypyruvate 
HPLC High-pressure liquid chromatography 
MEF Murine embryonic fibroblast 
mES Murine embryonic stem cell 
MIR Multi-input reactor 
MWCO Molecular weight cut-off 
PBS Phosphate-buffered saline 
PC Polycarbonate 
PDMS Poly(dimethyl)siloxane 
PMMA Poly(methyl)methacrylate 
PVDF Polyvinylidene fluoride 
SHM Staggered herringbone mixer 
TFA Trifluoroacetic acid 
TK Transketolase 
TMP Transmembrane pressure 
Tris Trisaminomethane 
VI Virtual instrument (LabVIEW subroutine) 
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1.1 Bioprocessing 
1.1.1 Challenges in Bioprocess Development 
Bioprocessing refers to the use of cells or cellular components in the manufacture of a 
desired product (Doran, 2004). Bioprocessing has its origins in the production of beer through 
yeast fermentation, a process that is more than two thousand years old, but the advent of DNA 
sequencing, proteomics and genetic engineering techniques has vastly increased the number 
of potential applications. Where early bioprocessing involved the exploitation of a naturally-
occurring pathway to produce a useful chemical, for example in the use of plant extract to 
synthesise (R)-mandelonitrile, modern bioprocesses use cells or enzymes that have been 
manipulated specifically to produce a desired product (Bornscheuer et al., 2012). With this 
understanding it has become possible to use cells and enzymes to produce not only useful 
small molecules, but also larger macromolecular products including therapeutic proteins such 
as insulin, creating a huge range of opportunities for novel therapies (Ladisch and Kohlmann, 
1992). 
Bioprocessing now encompasses a wide range of products including biopharmaceuticals 
(therapeutic proteins, antibiotics and vaccines), industrial chemicals (food and agricultural 
products, fuels, fibres and sustainable chemicals) and waste management tools (including 
sewage processing and waste clean-up; Ladisch et al. 1992). In the last decade, bioprocessing 
of human cells for regenerative medical treatments has also become a concern, (Yang et al., 
2010), marking a change from the use of cells for the manufacture of products to the 
manufacture of cells as a product in of themselves (Placzek et al., 2009). 
Aside from their use to produce novel products, bioprocesses also have advantages over 
equivalent chemical processes in terms of sustainability. In the synthesis of small molecules 
in particular, the use of enzymes rather than chemical catalysts allows reactions to be 
performed at lower temperatures and pressures, and the high selectivity and specificity of 
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enzymes can reduce the number of side reactions, reducing waste (see section 1.2 on 
Biocatalysis). 
The primary disadvantage of bioprocesses is the amount of time and resources that must 
expended on up-front development in order to characterise the process. The added complexity 
of biological systems in the process makes it difficult to predict how the system as a whole 
will behave and adds to the number of process conditions that must be investigated to 
determine the optimum conditions for the best quality of product. The conditions chosen for 
each stage of the process will also have a knock-on effect on other stages of the process, adding 
to the complexity of the whole and the amount of experimental work that must be done in 
order to characterise each stage.  
This is a particular issue where the target product is a pharmaceutical, where the design 
and operational tolerances of the process must be fixed before clinical trials begin. In this case 
the whole process of development, from drug discovery through the clinical trials process to 
marketing, is put under time pressure by the length of the patent on the drug – usually 20 years 
– which limits the amount of time available to recoup the investment in the product.  In 
addition, the large number of potential pharmaceutical products which fail to pass through the 
regulatory procedures adds an additional burden of cost, with products that fail later in the 
regulatory process incurring higher costs. Given that around one in 10,000 potential drugs 
make it from the drug discovery phase through the regulatory process and onto the market, it 
becomes increasingly important to minimise the cost and time involved in process 
development, to reduce the losses from the drugs which fail to make it to market. 
1.1.2 Scale-Down Bioprocess Development 
The use of small-scale processing technologies as analogues to industrial-scale processes 
offers a way to increase the speed of bioprocess development and reduce the upfront cost 
involved. These technologies historically aimed to mimic different large-scale unit operations 
such as fermentation, centrifugation, filtration and chromatography at the bench-top scale, 
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using volumes in the range of millilitres to litres. Using such small-scale devices allows 
experiments to be parallelised so that multiple condition sets can be evaluated simultaneously, 
for example by running several fermentations of E. coli in parallel and testing the effect of 
different media compositions on the rate of cell growth. This increases the throughput of 
experimentation and reduces the time required to characterise unit operations. Furthermore, 
the reduction in scale decreases the materials requirement for each experiment, cutting the 
overall cost of the development. Once a process has been characterised with bench-scale 
equipment and key scaling parameters have been established (such as the oxygen mass transfer 
coefficient, kLa, in the case of fermentations), the process can be scaled up as required. 
In recent years, the size of scale-down tools has been reduced further by the introduction 
of microwell plate technology. These are of increasing importance for bioprocess development 
because of the very small volumes that they operate with, typically in the range of microliters 
to millilitres (Micheletti and Lye, 2006). The reduced volume means that between 6 and 3456 
wells can be incorporated onto a single plate with a footprint of 110 cm², allowing the 
simultaneous testing of as many different condition sets in one plate. Using such plates, 
screening of up to 105 – 106 condition sets per day has been reported in pharmaceutical process 
development (Lye et al., 2003; Zhao and Ran, 2007). Again, the reduction in operating volume 
and multiplexing of experiments means that the materials and time required for process 
development can be significantly reduced. 
The plates themselves are available in a range of materials and can be adapted to mimic 
different unit operations by the use of inserts, including membranes, specialist coatings and 
miniature impellers and baffles (Puskeiler et al., 2005; Weuster-Botz et al., 2005). In addition, 
a range of tools has been developed to automate numerous aspects of fluid handling, 
preparation and data acquisition. A single automated platform might now include robotics for 
fluid handling, a centrifuge, a plate reader for spectrographic analysis of individual wells and 
a chromatography unit. These platforms can further increase the speed of process development 
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and optimisation, as well as increasing the range of industrial-scale unit operations that can be 
mimicked at the microliter scale using microwells.  
Using automation tools, the optimisation of a biotransformation and subsequent extraction 
of the synthesised product has been performed, with the fermentation of the cells, 
biotransformation, liquid extraction and analysis of the final product concentration all being 
performed on an Tecan robotic platform (Baboo, 2012). The fermentation data has also been 
shown to be comparable to that collected in a pilot-scale unit. The same platform has also been 
used to rapidly screen conditions for denaturation and refolding of lysozyme inclusion bodies, 
performing wash, mixing and incubation steps as well as enzymatic activity assays 
automatically (Ordidge et al., 2012). 
The drawback of microwell plate systems is that they are suitable only for the evaluation 
of batch process; they cannot be used as analogues for continuous-flow processes which are 
common in bioprocessing and which are becoming increasingly popular for chemical and 
biochemical synthesis in particular. Microfluidic systems, however, can be used as small-scale 
analogues as they are almost exclusively run with continuous fluid flow.  
1.1.3 Microfluidics for Bioprocess Development 
Microfluidics has been generally defined as the study of fluids and particles within 
artificially created systems of micron-sized channels (Tabeling, 2006). It has originated from 
research into multiple fields, with roots in microanalytical technologies, biodefense 
(particularly the detection of chemical and biological warfare agents) and microelectronics 
(Whitesides, 2006). Microfluidic devices typically use fluid volumes in the range of millilitres 
to nanolitres and, more recently, picolitres. 
Flow in microfluidic channels is characterised by the lack of convective mixing that is 
seen at larger scales. This is caused by the small scale of the channels, in which the viscous 
forces of the fluid become more influential than the inertial forces (Squires and Quake, 2005). 
In this type of fluid flow regime, known as laminar flow, two streams of fluid can be flowed 
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together without any intermingling aside from diffusion, and a number of different types of 
devices have been developed that exploit this effect to perform operations that would not be 
possible at larger scales. An example of this the is ability to generate stable gradients of a 
solubilised molecule, by co-flowing two streams with different concentrations of the molecule 
for long enough that a concentration gradient can form by diffusion. These gradients have a 
number of applications, but are of particular significance because of their use to create 
gradients of chemical signalling molecules for the purposes of pharmacokinetic studies or the 
mimicking of in vivo conditions for investigation of cancer metastasis and stem cell biology 
(Pihl et al., 2005; Kim et al., 2010). 
The small scale of microfluidic devices offers advantages in terms of reagent usage and 
precise control of the microenvironment on the chip, with devices being reported for the 
investigation of individual cells and their response to chemical stimuli (Umehara et al., 2003; 
Mahoney et al., 2005). The integration of online sensing, in particular through optics, is also 
a reported advantage. The materials commonly used in microfluidic devices are optically 
transparent, allowing fluids to be interrogated by optical fibres for the purpose of measuring 
cell optical density, UV absorbance and, through the use of sensor patches or particles, pH 
and oxygen concentration (Chang-Yen and Gale, 2003; Kuswandi et al., 2007; Funfak et al., 
2008). Where observation of whole cell cultures is useful, chips can be fixed under a 
microscope and monitored in real-time, with automated image analysis providing cell 
counting and confluency measurement for adherent cultures (Jaccard et al., 2014). 
Measurements of relevant chemical concentrations, such as concentrations of glucose and 
lactate, can also be made with the use of specialised microelectrodes (Kurita et al., 2002). 
Online sensing allows the response of systems to environmental changes to be monitored in 
real-time, meaning that the response to multiple condition sets can be evaluated in a shorter 
time frame than offline methods, increasing the throughput of data for development.  
Parallelisation has also been reported in microfluidic devices as a way of increasing data 
throughput. Several devices have been reported for the purpose of performing multiple cell 
1 - INTRODUCTION 
19 
 
culture or biotransformation experiments simultaneously, using compartmentalised reactors 
with common fluidic connections, all fabricated into a single device (Barbulovic-Nad et al., 
2010; Wu et al., 2010). Advances in droplet microfluidics, where individual fluid droplets 
containing nanolitres or picolitres of fluid are created to perform thousands to millions or 
individual experiments on a single device, offer the potential for massive parallelisation, 
though these devices rely on the addition of a reporter molecule or cell to each droplet and it 
can be difficult to quantify data from the droplets (Theberge et al., 2010).  
Furthermore, there are now examples of automated microfluidic systems being used to 
perform experimentation and analysis without human supervision, resulting in further time 
saving and a reduction in the manpower required (Gómez-Sjöberg et al., 2007). One such 
example uses microstructures built onto CD-based platforms to create ‘micro-laboratories’ 
with multiple functions. A custom built workstation with a robotic pipetting system is used to 
add reagents and samples to the CDs before they are spun, as well as performing analysis 
afterwards (Ducrée et al., 2007). 
A combination of these approaches to microfluidic devices could provide very powerful 
tools for bioprocess development. This thesis will therefore focus on development of new 
tools for investigation and intensification of bioprocesses, as applied to cell processing for cell 
therapy products and biocatalysis for small molecular products. The following sections of the 
chapter will discuss bioprocessing with mammalian cells and biocatalysis, their applications 
and examples of microfluidic technology that has been reported to aid process development 
and intensification. 
1.2 Biocatalysis 
1.2.1 Features of Biocatalysis 
Biocatalysis is the use of a biological catalyst, i.e. an enzyme, to catalyse a synthetic 
reaction. The enzyme may be used by itself, having been separated from the cell it was 
produced by, or in situ inside the cell. The latter may be useful where multiple enzymatic 
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pathways are required, or where the enzyme requires a co-factor that can also be produced by 
the cell. However, using a biocatalyst in place inside a cell can add complications to the 
production process, especially in terms of mass transfer and ensuring that the cells remain 
viable, though it can be beneficial in terms of the stability of the enzyme and the replenishment 
of cofactors. 
 Both enzymatic and cellular catalysts can be used in free solution or immobilised to aid 
retention, reuse and stability. Immobilisation can simplify the downstream purification 
requirements of a process by reducing the amount of crude purification that would be needed 
to remove a solution-phase biocatalyst. However, it adds to the cost and complexity of the 
upstream process of producing the biocatalyst itself and, in the case of enzymatic catalysts, 
can reduce the activity through steric inhibition; however the beneficial effect on stability and 
reuse can outweigh these considerations.  
Biocatalysis is gaining popularity as a method of producing small molecular products or 
intermediates, and increasingly for large molecular weight polymers. An estimated 150 large 
scale (over 100 kg product per annum) biocatalytic processes have been implemented in the 
chemical synthesis industry, the majority of which are pharmaceuticals or fine chemicals 
(Straathof, 2006). A number of technological advances in DNA sequencing, bioinformatics 
and genetic engineering have contributed to the viability of biocatalysis for industrial 
synthesis. The discovery of restriction enzymes and their subsequent use to produce 
recombinant plasmids by S. Cohen and H. Boyer in 1973 allowed enzymes with specific 
functions to be introduced into rapidly-growing microorganisms such as E. coli (Bornscheuer 
and Buchholz, 2005). 
Recombinant technologies also allow enzymes to be modified to act on non-natural 
substrates, tolerate a different range of temperature or pH extremes, or remain active for longer 
periods of time. Advances in sequencing, analysis and bioinformatics have been particularly 
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advantageous in this regard, allowing insights into the relationship between genomics and 
proteomics, and therefore likely candidates for mutagenesis. 
More recently, directed evolution techniques have been used to modify the properties of 
enzymes, using random mutagenesis and high throughput evaluation of their activity to select 
mutants that are more effective in terms of substrate specificity, activity in organic solvents or 
stability at extremes of temperature (Bornscheuer and Pohl, 2001). You and Arnold used error-
prone PCR to increase the activity of 13M subtilisin E 16-fold over the previous mutant 10M, 
and 470-fold in 60% DMF over the wild-type enzyme (You and Arnold, 1996). A similar 
technique was used to improve the specificity of Cytochrome c peroxidase from S. cerevisiae 
towards guaiacol, a non-natural substrate, by 300 times over the wild-type enzyme  (Iffland et 
al., 2000). 
1.2.2 Biocatalysis for Chemical Synthesis 
Biocatalysis has a number of advantages by comparison with more common chemical 
catalysis methods. Biocatalysts typically do not require the high temperatures and pressures 
that chemical catalysts do, usually being able to operate a little above room temperature and 
at atmospheric pressure (Woodley, 2008). Biocatalysts also tend to have high specificity for 
particular substrates arising from the particular configuration of their active sites, as well as 
selectivity in terms of the product formed (Saibi et al., 2012). This limits the number of side 
reactions that occur, improving molecular efficiency and avoiding the need for numerous 
protection and deprotection steps that might be required when using a chemical catalyst, and 
may even render production using a chemical catalyst impossible, or at least impractical 
(Wohlgemuth, 2010).  
Furthermore most biocatalysts exhibit stereoselectivity, favouring conversion to a single 
stereoisomer of a product while some enzymes – dehydrogenases or lyases in particular – can 
catalyse asymmetrical reactions, creating new chiral centres with a single stereoisomer. This 
is of particular benefit to the synthesis of pharmaceutical products, where enantiomeric purity 
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is required and would be quite costly to achieve by using multiple chemical protection and 
deprotection steps or purification alone (Pollard and Woodley, 2007). A number of enzymes 
have been identified that are capable of asymmetrical reactions that would useful to the 
synthesis of high-value chemicals, including hydroxylation, transamination and Baeyer-
Villiger oxidation. Use of these enzymes at an industrial scale tends to be limited by their 
supply, though Merck and Co. Inc. have established a process using alcohol dehydrogenase 
from Rhodococcus erythropolis to perform an asymmetric ketone reduction to form an 
intermediate for the product of NK-1 receptor antagonists (Pollard et al., 2006; Woodley, 
2008). 
Aside from molecular efficiency, biocatalysts also have advantages in terms of the 
sustainability of synthesis. Biocatalysts conventionally operate in aqueous solution, avoiding 
the use of organic solvents that are commonly required for chemical synthesis. They also have 
the potential to avoid the use of toxic substrates. For example it has been demonstrated that 
the production of ketones, an essential active pharmaceutical ingredient (API), can be 
performed in aqueous solution with alcohol dehydrogenase from Rhodococcus erythropolis 
using non-toxic co-factors (Pollard et al., 2006). 
Naturally-occurring biocatalysts can also be adapted to perform industrially useful 
operations, most commonly by modifying them to accept non-natural substrates or tolerate 
different conditions of pH or temperature. For example, the L-arabinose isomerase enzyme is 
a potentially useful catalyst for the industrial production of D-tagatose, but has a high optimal 
operating pH and temperature, which accelerate the formation side products when the reaction 
is run at an industrial scale (Rhimi et al., 2009). However, mutation of the enzyme to introduce 
a sequence associated with a greater tolerance of acidic conditions, and combination with an 
existing mutant that was stable at lower temperatures, resulted in a mutant enzyme with a 
relatively lower optimum pH of 6.5 and temperature of 65°C. Directed evolution 
methodologies are also particularly useful for the purpose of adapting enzymes, allowing large 
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libraries of mutant recombinant enzymes to be screened for the desired trait, with the best-
performing mutants selected for further rounds of recombination and selection. 
1.2.3 Biocatalysis in Microfluidics 
A number of applications have arisen that utilise the strengths of biocatalysts and of 
microfluidic platforms. One of the advantages of using microfluidics is the reduction in the 
use of reagent and biocatalyst required to perform reactions, from the millilitre scale used in 
typical bench-top technologies down to micro- or nanolitre volumes (Wang, 2002). This is 
particularly beneficial when attempting to evaluate the properties of a biocatalyst as it is often 
expensive and time-consuming to produce large volumes of purified enzyme, but it is useful 
to be able to study its sensitivity to a range of conditions such as pH, temperature, substrate 
concentration and inhibitory factors. In such cases, use of microfluidic platforms can reduce 
the amount of enzyme and consumables required by a hundred to a million-fold. 
Devices have been developed which take advantage of this feature to determine the kinetic 
parameters of enzymes such as β-galactosidase and acetylcholinesterase (Hadd et al., 1997, 
1999). In both instances the chip design relied on electrokinetics to perform the fluid transport 
and mixing, combining enzyme and substrate. In the case of β-galactosidase catalysed 
reaction, a fluorescent product was formed which allowed the direct online measurement of 
the product concentration by laser-induced fluorescence. The thiocholine product catalysed 
by acetylcholinesterase was not itself fluorescent, but the chip design in this instance featured 
an additional junction which allowed the derivitisation of the product with 
coumarinylphenylmaleimide and subsequent detection in a similar fashion.  
Both chips were used to determine the substrate dissociation constant (KM) and turnover 
number (kcat) of the respective enzymes, which were comparable to those determined by 
standard experimental methods. However, the enzyme and reagent consumed by the chips was 
much reduced, down to 120 pg of enzyme and 7.5 ng of substrate per assay in case of 
galactosidase. Furthermore, in this case the chip could be operated in continuous-flow mode 
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and the concentration of the substrate introduced to the enzyme could be stepped up or down 
by changing the relative flow rates. By stepping the concentration of substrate up and 
measuring the resultant change in fluorescence continuously a complete kinetic profile could 
be generated in a single 30-minute assay, from which the kinetic parameters of the enzyme 
could be determined. This was also applied to varying concentrations of the inhibitor 
phenylethyl β-D-thiogalactosidein order to determine the KI value (Hadd et al., 1997). 
The scale of microfluidic devices offers further advantages beyond reduction of reagent 
usage. The scale of the channels used in reactor devices means that the flow regimes within 
them are predominantly laminar, so mixing of fluids occurs by diffusion only. The behaviour 
of fluids and dissolved species within the channels are therefore more simple to predict, 
allowing precise control of heat and mass transfer in reactions (Miyazaki and Maeda, 2006; 
Wiles and Watts, 2008; Fernandes, 2010). The scale of the channels also provides high surface 
area to volume ratios for heat exchange with the external environment and the laminar flow 
behaviour can be used to create large interfacial areas for exchange of soluble species where 
multiple fluid phases are used (Miyazaki et al., 2008; Fernandes, 2010). 
Microreactors designed to exploit these properties have become increasingly popular in 
the chemical synthesis industry. Here additional advantages are offered in terms of 
temperature control, where the efficiency of heat-exchange means that isothermal operation 
is easier to achieve, preventing runaway reactions and the formation of side products (Jähnisch 
et al., 2004; Roberge et al., 2008 a). The size of the reactors also limits the hazard created by 
use of high pressures, temperatures or toxic reagents (Murphy et al., 2007; Roberge et al., 
2008 b). Furthermore, the continuous flow operation of microfluidic reactors can serve to 
reduce reaction time and increase throughput, increasing volumetric efficiency and offering a 
way to avoid the use of large batch reactors (Anderson, 2001). Continuous flow can also be 
used to overcome problems with unstable or hazardous reaction intermediates by ensuring 
they are consumed in the next reaction step as soon as they have been synthesised (Zhang et 
al., 2004). 
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For these reasons the adoption of microreactors is steadily increasing in the chemical 
synthesis industry, either by scaling up or scaling out the reactor designs that have been 
established at the bench scale. Examples of this approach range from the production of 
ethylacetoacetate at a throughput of 150 g d-1, using 30 reaction channels operated in parallel, 
to the use of a single scaled-up microreactor to produce 2 tons of a lithiated product over the 
course of a year, to the use of 100 parallel microreactors to produce 100 kilotonnes of 
monoammonium phosphate per year (Chambers et al., 2005; Chen et al., 2011 a; Kockmann 
et al., 2011). 
There is increasing interest in biocatalytic microreactors for chemical synthesis, given that 
they can provide shorter synthesis routes and can be used to perform asymmetrical synthesis 
of chiral metabolites (see Section 1.2.1). Relevant examples of reactions performed include 
the production of pharmaceutical compounds such as L-DOPA as well as synthesis of 
optically-pure cyanohydrins, important precursors for the synthesis of fine chemicals and 
pharmaceuticals (Koch et al., 2008; Tišma et al., 2009). Biocatalytic reactors have been 
developed to use biocatalysts in various forms; in free solution, in the form of cell lysates or 
purified catalyst, or immobilised, entrapped or covalently bound within microchannels. Where 
the water solubility of the desired substrate is problematic, reactors have also been developed 
for multi-phasic systems, primarily using solubilised free enzyme in the aqueous phase 
(Fernandes, 2010; Marques and Fernandes, 2011).  
Biocatalytic microreactors can offer similar advantages to synthesis reactions as those 
noted for chemical microreactors above. However, they have not yet been shown to be capable 
of the high throughputs of chemical microreactors, not is their adoption as wide-spread in 
industry. Chemical microreactors have also been demonstrated for perform multi-step 
synthesis reactions to work up to complex molecules, something that is lacking for biocatalytic 
processes to date, despite the potential advantages in terms of the products that could be 
synthesised (Bolivar et al., 2011). Furthermore, there has been a lot of focus on the upstream 
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reaction, but little on downstream steps such as purification that would help to bring about 
multi-step synthesis in a compartmentalised manner (Marques and Fernandes, 2011).  
1.3 Microfluidic Downstream Processing 
Numerous applications of microfluidic devices have been developed for the analysis of 
multi-component fluids, including a variety of different chemical species, biological samples 
such as DNA and proteins and analysis of cell concentration and population. Generally these 
components must be individually extracted in order to effect an efficient analysis of their 
properties, or the samples need to be prepared in some way (such as concentration or removal 
of particular components), which has led to the development of a number of different ‘on-
chip’ separation techniques suitable for the processing of biological samples (Pamme, 2007 
b). These techniques rely on microscale fluid phenomena, in particular laminar flow, as well 
as the enhanced effects of electrical, thermal and magnetic fields in order to differentiate 
particles and molecules based upon size, charge:size ratio, polarizability, magnetisation, 
density and, in the case of peptides or polypeptides, isoelectric point (see Table 1). This section 
will discuss these techniques and their applicability to downstream processing of biological 
material. 
Technique Separation by Separation of Flow rate Reference 
Acoustophoresis Size, density, 
compressibility 
Polyamide 
spheres, red 
blood cells 
0.1 – 0.4 ml 
min-1 
(Nilsson et al., 
2004; Petersson 
et al., 2005) 
Obstacle-based 
(including 
membranes) 
Size Polystyrene 
beads (0.6 – 1.0 
µm), DNA (100 
bp – 158 kbp), 
blood 
components 
10 – 100 pg 
h-1 (DNA) 
5 – 12 µl 
min-1 
(blood) 
(Duke and 
Austin, 1998; 
Huang et al., 
2004; Sethu et 
al., 2006) 
Obstacles and 
electric field 
Size DNA (50 bp – 
209 kbp) 
10 pg h-1 – 
10 ng h-1 
(Huang et al., 
2002; Fu et al., 
2007) 
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Technique Separation by Separation of Flow rate Reference 
Hydrophoretic 
separation 
Size Polystyrene 
beads (8 – 20 
µm), white 
from red blood 
cells 
Not 
specified 
(Choi and Park, 
2007; Bernate et 
al., 2013) 
Free-flow 
isoelectric 
focusing 
Isoelectric point Proteins 42 nl s-1 (Macounová et 
al., 2001; Xu et 
al., 2003) 
Dielectrophoresis Size, 
polarisability 
Yeast (viable 
from non-
viable), E. coli 
(labelled from 
unlabelled) 
40 – 300 µl 
h-1 
(Doh and Cho, 
2005; Hu et al., 
2005; Li et al., 
2007) 
Optical lattice Size, refractive 
index 
Protein 
microcapsules 
(2 – 4 µm) 
1,200 
particles s-1 
(MacDonald et 
al., 2003) 
Free-flow 
magnetophoresis 
Size, magnetic 
labelling, 
inherent 
magnetic 
properties 
Magnetic 
particles, E. 
coli, HeLa cells, 
red/white 
blood cells 
5 – 40 µl h-1 (Han and Frazier, 
2006; Pamme 
and Wilhelm, 
2006; Xia et al., 
2006) 
Thermal fluid-
flow 
fractionation 
Size, thermal 
capacity 
Small 
molecules, 
polystyrene 
beads (nm) 
0.01 – 7 ml 
h-1 
(Edwards et al., 
2002) 
Sedimentation Size, density Polystyrene 
beads (1 – 20 
µm) 
1 ml h-1 (Huh et al., 
2007) 
Table 1: Types of microfluidic separation techniques and applications to biological materials. 
1.3.1 Diffusion Based Separation 
The simplest device allowing the separation of species based on diffusion is the H-filter 
or ‘membraneless’ filter (Squires and Quake, 2005). This design makes use of the lack of 
convective mixing at micro-scale to combine two streams of fluid in a single channel. The 
relationship between mass transfer due to advection and transfer due to diffusion is represented 
by the Péclet number, which is the product of the Reynolds number (Re) and the Schmidt 
number (Sc), defined as: 
 𝑃𝑒 = 𝑅𝑒 ∙ 𝑆𝑐 (1) 
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𝑃𝑒 =
𝜌𝑢𝐿
𝜇
∙
𝜇
𝜌𝐷
 (2) 
   
 
𝑃𝑒 =
𝑢𝐿
𝐷
 (3) 
   
Where ρ and μ are the density and viscosity of the fluid, u is the velocity of the fluid, L is 
the characteristic length of the surrounding channel (perpendicular to the flow of fluid) and D 
is the diffusivity of the molecule concerned. A high Pé value indicates the dominance of mass 
transfer by advection within system, whilst a low Pé value indicates the dominance of diffusive 
transfer. The Péclet number is typically very low in microfluidic channels, so mixing between 
two solutions is poor and mass transfer occurs only by diffusion. 
In an H-filter two fluid streams are able to flow in parallel without mixing, but particles 
are able to diffuse across the liquid-liquid boundary. Smaller particles with lower Péclet 
numbers (i.e. higher diffusivity) can diffuse across the boundary into the clear stream more 
quickly, and were separated out when the two streams were split at the other end of the device 
(see Figure 1). By selecting appropriate channel lengths and fluid velocities a variety of 
particles with different diffusivities could be separated (Brody et al., 1996). This device was 
limited in its separation resolution and selectivity, but more sophisticated designs have been 
presented utilising multiple H-filters or so called ‘flat’ filters (where the streams are brought 
together in the vertical plane) to improve both of these properties (Yager and Brody, 2004). 
This device was proposed for use as a tool for extracting urea from blood and was theoretically 
capable of reducing the level of urea to 0.01% of its original level in 1.1 hours.  
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Figure 1: Illustration of an H-filter device.  
Smaller particles with lower Péclet numbers (blue) are able to diffuse more quickly and cross the fluid 
boundary, whilst larger particles (red) cannot.  
Microscale diffusional separation methods are governed by the characteristic diffusional 
length, l: 
 𝑙 = √𝐷𝑡 (4) 
   
Where D is the diffusion coefficient of a spherical particle and t is the time over which 
diffusion takes place. D is given by: 
 
𝐷 =
𝑘𝐵𝑇
6𝜋𝜂𝑟
 (5) 
   
Where kB is the Boltzmann constant, T is temperature, η is viscosity and r is the particle 
radius. Assuming a particle radius of 8μm, the diffusion coefficient of a stem cell in water at 
room temperature would be 6.13×10-14 m²s-1, which in turn gives a characteristic diffusion 
time of 1630 seconds for a distance of 10 μm. This may be useful for separating stem cells 
from proteins, which generally have diffusion times a factor of 10 smaller over the same 
distance. Having said this, the maximal separation efficiency that could be achieved from a 
single H-filter would be 0.5, as the concentrations of proteins in the two streams would 
eventually equilibrate. Multiple H-filters arranged in series would be required to achieve 
higher efficiencies, making the design more complex. 
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1.3.2 Flow Based Separation 
Pinched flow fractionation also allows the sized-based separation of particles, but does 
not rely on their relative diffusivities. Two streams are brought together, one containing 
particulates and moving at a lower flow rate, the other clear and moving at a higher flow rate, 
which are then focused through a narrow aperture (47-82μm) into a wider channel. This 
focusing causes the path of the particles to deflect when they enter the wide channel, with 
smaller particles being deflected to a greater degree than larger particles. The focussing causes 
the smaller particles to become trapped in the slower moving fluid due to their closer proximity 
to the channel wall, while larger particles are accelerated due to their greater exposure to the 
faster flow (see Figure 2A). The particulate mixtures can be fractionated by dividing the wider 
channel into a series of parallel channels of smaller width, such that particular sizes are 
deflected into specific outlets. This method has been used to separate polystyrene beads based 
on size and red blood cells from serum (Yamada et al., 2004; Takagi et al., 2005).  
 
Figure 2: Illustration of pinched-flow fractionation (A) and hydrodynamic filtration (B) devices. 
Hydrodynamic filtration utilises a similar effect to purify and concentrate streams of 
particulates. A main central channel is used with sets of smaller channels branching off at right 
angles. The flow rate is set so that fluid exits from both the main channel and the branched 
channels, creating a ‘slipstream’ of fluid that runs along the walls of the main channel and is 
drawn into the branches. When particles flow through the main channel, the slipstream draws 
them towards the wall of the main channel and, if the particles are small enough, they will be 
drawn out of the main channel altogether (see Figure 2B). This effect can be used to purify 
particles by size or to concentrate a suspension (Yamada and Seki, 2005).  
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This has been applied specifically in the extraction of plasma from whole blood, adjusting 
the branch channel such that red blood cells remain in the centre of fluid flow and allowing 
high throughputs of near-pure plasma to be achieved (Jaggi et al., 2007). A more recent design 
has used a gradually decreasing branch channel length to incrementally reduce the hydraulic 
resistance of each successive channel, allowing the gradually fractionation of smaller 
particulates. This was used to separate fungal spore populations from larger cellular debris 
(Inglis and Herman, 2013). 
A system with a very similar design was used to separate white blood cells from red blood 
cells, but a buffer solution was perfused through the side channels and across the main channel, 
perpendicular to the main flow of fluid. This secondary fluid flow pushed the red blood cells 
into the side channels and out of the device whilst retaining white blood cells, which were too 
large to fit through the narrow (~3µm) apertures and were driven along the main channel 
(VanDelinder and Groisman, 2007). 
Hydrophoretic separation employs a similar phenomenon to hydrodynamic filtration, but 
in this case the boundary flow effect is used to differentiate particulate sizes within a single 
channel rather than using additional side channels. Angled grooves are fabricated into the floor 
of a wide channel, sized such that the smaller particles to be separated will be able to fit into 
them wholly but the larger particles will not. The grooves create stagnant zones where fluid 
flow slowed and aligned towards the direction of the groove. Two or more fluid streams are 
used to focus the mixed population of particles to one side of the channel. Larger particles, 
unable to fit completely into the grooves, will be driven over them by main fluid flow and will 
not deviate across the channel from the point at which they were entered it. Smaller particles, 
slowed by the boundary flow at the channel floor, will be able to drop into the stagnant zones 
and will be drawn towards the opposite side of the channel. This principle has been 
demonstrated for the separation of polystyrene beads by size as well as for the separation of 
red and white blood cells, where the discoid shape of the former allowed them to be drawn 
into the grooves more easily (Choi and Park, 2007; Bernate et al., 2013). 
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1.3.3 Obstacle Based Separation 
Devices that operate in a manner analogous to filters have been developed from scratch, 
as demonstrated by Chen et al. Their device was designed to allow the integrated isolation, 
lysis and DNA purification of white blood cells from whole blood. The separation system 
consisted of a tortuous channel lined with 20µm pillars, which were spaced out to leave 6.5µm 
gaps. This allowed red blood cells and other contaminants to move into the two waste streams 
alongside the main channel, whilst retaining the white blood cells (Chen et al., 2007 b). Having 
the fluid flow perpendicular to the mass transfer across the bordering pillars in this way 
prevented the device from becoming clogged. 
Other, more conventional, filtration systems have also been developed. PDMS lends itself 
to the incorporation of membrane materials such as polysulphone due to its compressibilty 
and the relative ease with which it can be sealed (Duffy et al., 1998). A polyvinylidene fluoride 
(PVDF) membrane was sandwiched into a PDMS system and pre-treated with BSA to 
enantioselectively separate a racemic mixture of L- and D-tryptophan (Wang et al., 2002). 
Another device developed by Ismagliov et al. incorporated two polycarbonate membranes into 
two sets PDMS channels aligned perpendicularly to one another, forming a grid of 
microreactors. Gradients of chemical inputs could be applied along the two sets of channels, 
allowing reactions to be performed under a variety of input conditions simultaneously 
(Ismagilov et al., 2001). Although not strictly a separation technology, it demonstrates the 
ability to incorporate prefabricated membranes into microfluidic devices. 
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Figure 3: Illustration of a lateral displacement device.  
Smaller particles (blue) are able to remain with a single streamline and follow the most direct route 
through the obstacles. Large particles (red) cannot remain within the streamlines and are displaced 
towards the side of the device. 
Several methods of sized-based particle separation have been developed to work without 
the need for physical retention. One such method, lateral displacement, uses a wide channel 
containing rows of micron-sized posts, each row being slightly out of line with the other. 
When fluid is passed through the channel from one corner to the opposing corner it creates 
streamlines which follow the most direct path through the posts (see Figure 3). Smaller 
particles are able to remain within these streamlines and pass through the device quickly, 
whilst larger particles are displaced towards the side of the channel (Duke and Austin, 1998). 
This technique has been applied to separate DNA by size and individual components of whole 
blood (Huang et al., 2004; Sethu et al., 2006). Importantly, the effectiveness of the separation 
depends more on the lateral displacement between the successive rows of posts than it does 
on the gap between individual posts. This means that particles can be effectively separated 
without the risk of them becoming trapped within the device, unlike more conventional 
physical trapping techniques which rely on the particles or molecules being directly retained 
by the obstacles (Pamme, 2007 a).  
1.3.4 Homogenous Electrical Field Separation 
Homogenous electrical field separations use a combination of flow-driven and 
electrophoretically-driven movement to separate molecular mixtures. Typically, the solution 
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is passed through a shallow chamber with an electrical field applied across is, perpendicular 
to the direction of flow. The molecules are deflected from their flow path by the field 
depending on their charge and can be collected in separate outlets (see Figure 4). 
 
Figure 4: Illustration of a device using free-flow electrophoresis.  
A particle mixture is passed through a homogenous electrical field; particles with a positive charge (red) 
move towards the negative electrode, whilst particles with a negative charge (orange) move towards the 
positive electrode. Particles with no net charge (green) do not move towards either electrode. 
One of the first examples of homogenous electrical field separation was free-flow 
electrophoresis (FFE), originally developed at larger scale to carry out rapid separations in 
chemistry and biochemistry. Devices designed to perform such separations at micro-scale 
were found to have distinct advantages over their larger-scale counterparts as their greater 
surface area:volume ratio allowed better heat dissipation. This meant that stronger fields could 
be used without the adverse effect of heating and thermal convection currents on separation 
performance (Krivánková and Bocek, 1998; Pamme, 2007 a). 
There are numerous examples of free-flow electrophoresis available, based around 
molecular separations of molecules with different charge:size ratios. One particular example 
allowed the very rapid, high-resolution separation of amino acid mixtures, where the average 
residence time of a molecule on the chip was only two seconds (Krivánková and Bocek, 1998; 
Zhang and Manz, 2003; Pamme, 2007 a).  
A large proportion of the systems developed attempt to address the problem posed by 
generating high voltage fields without exposing the solution being separated to the electrodes. 
The original devices fabricated from silicon without electrodes which directly contacted the 
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solution were only able to generate fields up to 100 V cm-1 whilst later revisions in other 
materials such as PDMS and glass were able to reach 200-300 V cm-1 (Raymond et al., 1994). 
This was better than the devices with electrodes which directly contacted the solution, where 
field strengths could only reach a few tens of V cm-1 (Macounová et al., 2001). More elaborate 
solutions have since been developed by exploiting the laminar flow conditions at microscale 
to introduce trenches of fast-flowing fluid between the electrodes and the sample solution, 
allowing the field strengths of up to 580 V cm-1 (Fonslow et al., 2006). 
A slight enhancement of this separation method has been made to efficiently separated 
proteins or polypeptides according to their isoelectric point (pI), known as free-flow 
isoelectric focusing. The device design is essentially the same as those described above, but a 
pH gradient is created across the width of the channel by flowing an acidic and an alkali 
solution through troughs at either side. When the sample of polypeptides is passed through the 
channel, they migrate according to their charge towards the area of channel where the pH is 
equivalent to their pI. At this point their overall charge becomes zero and migration ceases. A 
device of this kind was developed by Kohlheyer et al. which was capable of generating a pH 
gradient from 3 to 10, as well as efficiently transmitting the majority of the electric potential 
to the separation channel (Kohlheyer et al., 2006). Devices have been used to separate 
mixtures of amino acids, peptides and whole proteins by their pI, in some cases resolving the 
individual components is sub-second residence times (Macounová et al., 2001; Xu et al., 
2003). 
Electrophoresis has also been combined with obstacle-based separations to resolve DNA 
chains based on their length. The devices consist of several channels joined by weirs which 
are a significantly shallower than the channels themselves. By flowing a sample of mixed 
lengths of DNA into one of the channels and applying an electric field, the different lengths 
of DNA could be separated into separate channels, with shorter chains being able to travel 
through the weirs more easily and therefore travelling further across the chip from the starting 
point (Huang et al., 2002; Fu et al., 2007). 
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1.3.5 Inhomogeneous Electrical Field Separation 
Inhomogeneous electrical field separation (also known as dielectrophoresis or DEP) 
utilises a non-uniform electric field to generate dipoles on particles within a solution and has 
an advantage over FFE methods since the particles do not need to have an inherent charge to 
be separated. Instead, the field exerts a force on the particles, the strength of which is 
dependent on the polarizability of the particles. More polarisable particles move towards the 
highest field strength area, whilst less polarisable particles move towards the field minimum 
(see Figure 5). DEP is a widely adopted separation technique at microfluidic scale, but is 
difficult to scale up as the force generated by the electrical field decays exponentially from 
the electrode surface (Hughes, 2002). 
 
Figure 5: Illustration of a device using dielectrophoresis.  
A particle mixture is passed through an inhomogenous electrical field; particles with greater polarizability 
than the surrounding fluid (orange) move towards the area of stronger electrical field, whilst particles with 
a lesser polarizability than the surrounding fluid (red) move towards the area of weaker electrical field. 
Inhomogeneous electrical fields can be generated by applying a fixed voltage across a 
microfluidic channel containing obstacles. A uniform voltage can be applied across the entire 
length of the channel, generating non-uniform fields where the depth of the channel changes. 
This can be used to effect a separation in a number of ways, depending upon the channel 
design. Barrett et al. designed a chip which was able to separate Bacillus subtilis cells from 
polystyrene beads by placing ridges at either side of a central channel. When an electrical field 
was applied to the chip, the shallow areas over the ridges became charged, preventing the cells 
from passing into side channels but leaving the polystyrene beads unaffected (Barrett et al., 
2005). 
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A more complex system was designed by Fu et al. to separate DNA molecules, consisting 
of a series of trenches separated by arrays of alternating pillars and shallows. Two electrical 
fields were applied, one parallel to the trenches and another perpendicular to them. The 
parallel field drove the negatively charged DNA molecules along the length of the channel, 
whilst the perpendicular field drove the molecules to cross from one channel to the next. The 
molecules could be separated in three different ways, depending upon the electrical fields 
applied and the ionic properties of the fluid, either on the basis of size (favouring small or 
large molecules) or of charge (Fu et al., 2007). 
DEP may prove to be particularly useful for label-free cell separations. The current 
methods for separating and counting stem cells from populations of differentiated cells revolve 
around antibody labelling either with fluorescent particles (for FACS) or magnetic particles 
(for MACS). Antibody labelling has previously been used to modify the polarizability of cells 
with specific surface markers (Hu et al., 2005), but a newer method allows separation on the 
basis of the surface markers themselves, without the need for antibodies. This was used to 
separate populations of yeast into live and dead cells (Li et al. 2007). The resolution was 
relatively low, as was the efficiency (around 25% of the cells were trapped in the chip), but 
with further development this method could potentially be used to separate stem cells on the 
basis of pluripotency markers, without antibody labelling. 
1.3.6 Other Flow Fractionation Techniques 
A multi-functional rotating platform known as Bio-Disk has been developed which can 
be used to carry out centrifugal separations at the microfluidic scale. By equipping a Bio-Disk 
with an appropriate channel design, the rotary force generated by a CD player (or the 
proprietary Bio-Disk rotor) can be used to carry out single or multi-step separations on the 
basis of density. A simple single channel design has been used to separate hematocrit from 
pure blood to determine its concentration, whilst a more complex design featuring two 
separation chambers connected by a channel was used to isolate pure plasma. A battery-
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powered DEP device was also integrated to allow two-dimensional separation by density and 
polarizability, used to separate dead from viable cells (Ducrée et al., 2007). 
A high-throughput technique for clarifying particulate suspensions, the ‘microfluidic 
equivalent of centrifugation,’ was developed using high-frequency acoustic standing waves to 
isolate the particles from the fluid. A piezoelectric transducer was used to generate the 
standing waves within a silicon cavity which the fluid was then passed through. The particles 
were drawn to and held in the pressure node created by the standing waves, allowing clear 
fluid to be drawn out (Harris et al., 2003). 
1.3.7 Separation Technique to be Investigated 
There are a number of criteria to be fulfilled in the selection of a suitable microfluidic 
downstream processing platform. The platform must of course be capable of performing the 
separations required without causing damage to the desired product. It must also be scalable 
if the platform is to be used to evaluate conditions for potential large-scale processes. The 
flexibility to test different separation conditions is also important. The ease of design, 
fabrication and use are not as critical to the selection, but must still be considered.  
A simple dead-end filtration chip is likely to be the best option for an initial design. Filter 
membranes can be bonded into PDMS, one of the more popular material choices for 
microfluidic chips, relatively easily (Ng et al., 2002). Also, the fabrication of a membrane 
filtration chip would potentially be much easier and quicker to perform than that of other chip 
designs, such as the more complicated hydrodynamic filtration chip developed by Yamada 
and Seki or the lateral displacement channel described by Duke and Austin, due to the lack of 
small feature sizes. Additionally, the simpler membrane filtration chip would have fewer 
internal surfaces which could entrap cellular material, an effect noted in hydrodynamic 
filtration chips with large internal surface areas (Carlson et al., 1997).  
Whilst a dead-end membrane filtration chip could be used to concentrate cell suspensions 
or to remove reagents, a more complex chip designed for tangential or ‘cross-flow’ filtration 
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might have more versatility. The tangential flow regime is advantageous as it tends to prevent 
an excessive build-up of solid material on the membrane, a problem which would be observed 
in the dead-end flow configuration. This fouling effect would reduce the efficiency of the 
dead-end filter and may also damage the cells. 
A tangential flow filter could allow a greater degree of control over the separation process 
by the fine tuning of the feed flow rate, cross flow rate and transmembrane pressure (TMP) to 
alter the rate of diffusion across the membrane. Such a device might be used to exchange 
growth media where necessary (e.g. during directed differentiation processes) and would 
allow the cells to be recirculated more easily.  
1.4 Membrane Filtration in Bioprocessing 
Membrane filtration has historically played a major role in bioprocessing, including some 
of the earliest examples of modern bioprocesses, and is still commonly used for a variety of 
purposes due to its versatility and the range of filtration technologies, membrane types and 
pore sizes available (Ladisch and Kohlmann, 1992; van Reis and Zydney, 2007). Filtration 
processes are susceptible to fouling, accumulation of particles on the surface or inside the 
pores of the membrane, reducing its permeability. This in turn reduces its capacity, the amount 
of material that the membrane can be used to process before it must be cleaned or replaced, 
adding to the cost of the process. Determining the best conditions for product yield and 
membrane lifetime is therefore a high priority for the development of a bioprocess involving 
membrane filtration. 
This section will discuss the types of membrane available, applications to bioprocessing, 
the equations that have been developed to describe the behaviour of membrane separations 
(particularly with regards to fouling) and finally the developments that have been made in 
microfluidic filtration. 
1.4.1 Filtration Technology, Membrane Types and Applications 
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Types of membrane filtration operation can be broadly categorised by the size of particle 
or molecule that is retained by the membrane, with the membranes being classified by their 
average pore size or molecular weight cut-off (the largest size of molecule that is able to pass 
through the membrane). Different membrane filtration operations can be used at various stages 
in a bioprocess, though the operations typically directly involved are microfiltration, 
ultrafiltration and virus filtration. Nanofiltration and reverse osmosis are also used, but usually 
in preparative steps such as water purification, rather than the process itself. 
Microfiltration uses pore sizes in the region of 0.1 – 10 µm and is therefore used for the 
purpose of retaining cells, particularly for performing initial separations of cells from smaller 
solutes or for removing excess liquid. Virus filtration uses smaller pore sizes on the order of 
hundreds of nanometers to retain virus particles, a function which is particularly important in 
bioprocessing for ensuring the sterility of thermolabile products such as proteins, which could 
not be sterilised by heat treatment. Ultrafiltration has pore sizes on the order of tens of 
nanometers, which are typically defined by a MWCO in Daltons (Da, equivalent to one twelfth 
of the weight of a carbon atom), and is typically used at the latter stages of the process where 
retention of macromolecular components is required. It is commonly used in diafiltration 
operations, used to exchange buffer solutions between different chromatography steps 
(Kalyanpur, 2002).  
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Figure 6: Typical separations in different membrane technologies (adapted from van Reis and Zydney, 
2007). 
Membrane filtration is operated in one of two flow modes; normal flow, where the feed 
solution is applied perpendicularly to the membrane surface, and tangential flow, where the 
feed solution is applied in parallel to the surface (see Figure 7). In the case of tangential flow 
a fluid stream may also be applied in parallel to the permeate side of the membrane, either in 
the same direction as the feed solution (co-current) or in the opposite direction (counter-
current). 
 
Figure 7: Illustration of two main modes of filtration; normal flow (A) and tangential flow (B). 
Normal flow filtration is typically only used with microfiltration membranes in situations 
where the feed solution contains a low concentration of particulates, as rapid fouling can occur 
otherwise. In particular, normal-flow microfiltration has been used in place of centrifugation 
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for the industrial-scale harvesting of mammalian cells immediately following their growth, in 
order to avoid exposing the cells to the high shear forces generated by centrifuges at this scale. 
Higher cell concentrations can also be recovered using tangential flow microfiltration in order 
to overcome the fouling effects observed in normal flow mode (van Reis et al., 1991; 
Kalyanpur, 2002). 
Ultrafiltration membranes are used almost exclusively in tangential flow mode and usually 
utilised in the later stages of downstream processing. Ultrafiltration unit operations tend to 
involve the concentration of protein solutions or the exchange of solutes with much smaller 
molecular weights (at least 5 – 10 times smaller) than the protein being retained. In the case 
of concentration operations the filter would be operated without any permeate fluid stream, 
just recycling the retentate stream until the proteins were at the desired concentration. Where 
exchange of solutes is required, a permeate stream could be run in counter-current mode, 
creating a constant concentration gradient across the length membrane. 
1.4.2 Governing Equations 
In membrane filtration the key metric of filtration performance is the membrane flux, the 
volumetric flow rate of fluid through the membrane normalised to the membrane area, with 
units of L·m-2·s-1. The pressure applied to the retentate (P) and the flux through the membrane 
(J) can be related by Darcy’s law: 
 
𝐽 =
𝑃
𝑅𝜇
 (6) 
   
Where µ is the viscosity of the solution and R is the resistance of the membrane to fluid flow, 
a property which increases as the filtration process proceeds and the membrane becomes 
fouled by particulates.  
There are several models of pore blocking in membrane filtration which can be used to 
relate the changing resistance of the membrane to the volume of fluid that has been processed 
or the length of time that the process has been running for. The standard model describes the 
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membrane as a series of cylindrical pores with a defined initial radius that decreases as 
particulates build up on the inner surface (Bolton et al., 2006). In this case, the changing 
resistance caused by fouling (R) can be related to the initial resistance of the membrane itself 
(R0) as a function of the volume of liquid processed by the following equation: 
 
𝑅 = 𝑅0√1 −
𝐾𝑆𝑉
2
 (7) 
   
Where KS is the standard blocking constant, which can be determined experimentally for 
particular combinations of membrane and liquid by measuring the change in flux as the 
volume of liquid processed increases and fitting the model to the data. 
Fouling can also be modelled as the complete blockage of pores by particulates, reducing 
the overall area of membrane available for fluid to flow through rather than increasing the 
resistance of the membrane. The ratio of available membrane area (A) to the initial area (A0) 
can be related to the volume of liquid processed by the following equation: 
 𝐴
𝐴0
= 1 −
𝐾𝑏
𝐽0
𝑉 (8) 
   
Where J0 is the initial flux of fluid through the unfouled membrane and Kb is the pore blocking 
constant, which again can be determined for a particular combination of membrane and 
process fluid by fitting the model to experimental data. 
Finally, fouling can be modelled as the build up of a cake layer on the surface of the 
membrane, causing additional resistance to fluid flow on top of the resistance of the membrane 
itself. This increase in resistance is related to the volume of fluid processed by: 
 𝑅
𝑅0
= (1 + 𝐾𝑐𝐽0𝑉) (9) 
   
Where Kc is the cake filtration constant, determined as above for Ki and Kb. In reality the 
fouling of a filtration membrane will involve a combination of the above models, such as cake 
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formation and standard fouling models. Where the pressure or volumetric flow rate is kept 
constant throughout the process, the combined effect of the different models on the change in 
flux can be related through Darcy’s law, essentially becoming a summation of the different 
resistances. For example, relating the cake formation and standard fouling model for a constant 
pressure filtration operation, Darcy’s law becomes: 
 𝐽0𝑅0𝜇 = 𝑃 = 𝐽𝑅 (10) 
   
 𝐽
𝐽0
=
𝑅0
𝑅
=
1
√1 −
𝐾𝑆𝑉
2 + (1 + 𝐾𝑐𝐽0𝑉)
 
(11) 
   
The equation can then be integrated to determine the change in flux as a function of time 
and, with Ks and Kc determined experimentally, can be used to predict the rate of flux decline 
and determine the point at which the membrane would need to be changed. Other models of 
fouling can be combined in same manner (Bolton et al., 2006). 
1.4.3 Microfluidic Devices for Membrane Filtration 
The number of reported microfluidic devices featuring integrated filtration membranes 
has increased significantly over the past decade, primarily for the purposes of on-chip sample 
preparation (de Jong et al., 2006). A large number of microfluidic chips have been developed 
for investigation of complex biological samples, particularly for the purposes of medical 
diagnostic tests, where the size of the devices and the ability to incorporate multiple sample 
preparation and analysis steps onto a single chip is especially attractive for point-of-care 
diagnostics (Rivet et al., 2011). Where membranes have been integrated into these chips, they 
have been used to remove unwanted components from test samples, for example isolating 
plasma or white blood cells from whole blood, or to isolate bacterial cells or spores for the 
purposes of detection (Crowley and Pizziconi, 2005; Floriano et al., 2005; VanDelinder and 
Groisman, 2006, 2007). 
Microfluidic chip designs have also been reported for the non-invasive analysis of fouling 
of membranes when used for the filtration of particulate streams, including biological samples, 
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which may be of particular interest for bioprocessing applications. These devices tend to 
consist of a membrane fabricated or sealed in place into a set of channels, with a clear window 
over a part of the membrane to allow the cake formation to be observed under a microscope 
(see Figure 8A). Other methods such as laser triangulometry or refractometry have also been 
used to observe the rate of cake formation (see Figure 8B), where respectively the distance 
that an angled laser beam is deflected by the surface of the cake or the degree of refraction of 
the laser through the cake layer was used to estimate the cake thickness (Chen et al., 2004). 
 
Figure 8: Illustration of devices reported in literature for in-situ analysis of fouling in membrane filtration. 
(A) and (B) respectively show measurement of the fouling by transmission of light through the fouling 
layer and by laser refractometry. (C) and (D) show a top view and side view of a device designed to allow 
the direct observation of fouling layer formation during filtration. 
Mores and Davis demonstrated the direct observation of membrane fouling in the 
microfiltration of yeast, carried out using cellulose acetate and anodised alumina membranes 
sealed into an acrylic support with glass plates on either side providing transparent windows 
for the observation the membrane. This setup was used to evaluate the rate of cake formation 
and the distribution of yeast cell deposits in the two membrane types by continuously 
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recording the build-up of dyed cells on the surface. Significantly, from a bioprocess evaluation 
perspective, it was also used to determine the effect of different lengths of back-washing steps 
on the removal of the deposited cells from the membrane surface, using the images generated 
to estimate the clearance of the surface (Mores and Davis, 2001).  
The main disadvantage of this system was that the thickness of the cake layer could not 
be determined in situ, but had to be measured after the filtration experiment had been 
completed by SEM. Ngene et al. reported the use of a microfluidic chip that overcame this 
problem, which consisted of two parallel channels fabricated in membrane material 
(polyetherimide/polyvinylpyrrolidone/N-methylpyrrolidone), separated by a small strip of 
membrane and sealed on one side with a glass slide (see Figure 8C & D). A solution of 6 µm 
polystyrene particles in water was flowed through one channel, the retentate, and were 
retained, while the water was able to flow through the divide and into the permeate channel. 
By continuously observing the process under a light microscope, the build-up of particulates 
on the membrane surface could be recorded, allowing the change in cake thickness to be 
measured in real time (Ngene et al., 2010). This demonstrates the potential power of 
microfluidic membrane devices for bioprocess evaluation, although relatively few devices 
have been reported specifically for this purpose, nor for the purpose of evaluating whole 
bioprocesses at the microfluidic scale. 
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1.5 Aims of the Thesis 
The overall aim of this thesis is to demonstrate the use of microfluidics for scale-down 
studies of bioprocessing, in particular for the investigation of upstream and downstream steps 
and their interaction when combined, an aspect that has not been extensively explored in the 
literature to date. An additional aim is to investigate how microfluidics might be used to 
intensify the output of established scale-down bioprocesses. There are examples in literature 
of the intensification and subsequent scale-up of chemical synthesis reactions and it may be 
beneficial to investigate whether the same might be possible for biocatalytic synthesis 
reactions. 
Chapter 3 of this thesis shows the development and initial characterisation of a device for 
the investigation of filtration processes at the microfluidic scale. Chapter 4 demonstrates how 
the filtration device could be combined with a biocatalytic reaction performed in a continuous-
flow microfluidic reactor and, in particular, how the operation of the two devices could be 
investigated separately before they were brought together into a single network. 
 Chapter 5 presents the development of a novel microfluidic reactor for the intensification 
of the biocatalytic reaction performed in Chapter 4, creating an analogue of a fed-batch 
operation in a continuous-flow device. Finally, Chapter 6 outlines a conclusion of the 
presented work and suggests what further work might be performed to make the devices more 
suitable for bioprocess development and for intensive production of chiral metabolites at 
microfluidic scale. 
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2.1 Fabrication 
2.1.1 Micromachining 
Rigid parts of the filter and SHM reactor were designed with 3D modelling software 
Solidworks (Dassault Systѐmes, Vélizy-Villacoublay, France) and translated into G-code 
instructions using Mastercam (CNC Software Inc, Tolland, USA). Parts were fabricated in 
poly(methylmethacrylate) (PMMA) or polycarbonate (PC; RS Components Ltd, Corby, UK)  
with a CNC milling machine (Folken IND, Glendale, USA), using various gauges of micromill 
tools from 0.1 to 2 mm (Kyocera, Kyoto, Japan). Areas were cut in a spiral pattern with a 70% 
overlap and maximum depth cut of 0.5 mm.  
2.1.2 Laser Ablation 
The parts of the multi-input reactor were designed in Adobe Illustrator (Adobe, San Jose, 
USA) and fabricated in 1.5 mm PMMA using a CO2 laser marking head (Laserlines, Banbury, 
UK) with a maximum power of 25 W. The features were ablated with a power of 50% and a 
mark speed (laser tracking speed) of 200 mm s-1 and 10 mm s-1 for channels and cut-outs, 
respectively.  
2.1.3 Polymer Casting 
Gaskets for the filtration devices were made from poly(dimethylsiloxane) (PDMS, 
Sylgard 184, Dow Corning, Midland, USA). The liquid polymer was prepared in a ratio of 
10:1 monomer to curing agent, degassed and then cast in PMMA moulds which had been 
fabricated on a milling machine (as described above). The PDMS was degassed in the mould 
and then cured at 90°C for 2 hours. 
2.1.4 Assembly of Filter by Clamping 
Membranes for the filtration unit were cut to size from commercially available regenerated 
cellulose or polysulphone sheets (Durapore, Millipore, Cork, Ireland) using a CO2 laser 
marking head (Synrad Inc., Mukilteo, WA, USA). Polyvinyldifluoride (PVDF) membranes 
(Durapore) were cut to size with a scalpel. 
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Interconnect ports were milled from 5 mm PMMA, with two holes tapped with an M3 
thread for attachment to the device, and an M6 threaded hole to allow standard connection 
fittings to be used (P-221, Upchurch Scientific, Oak Harbor, USA).  
The interconnect ports were attached to each half of the device, before the PDMS gasket 
and appropriate filter membrane were placed into the retentate side of the device. The two 
halves of the device were aligned and clamped together using screws, applying a specific 
torsion to each using a torque driver in order to generate an even seal around the membrane.  
2.1.5 Assembly of Microreactors by Thermal Bonding 
Microreactor PMMA components were thoroughly cleaned after milling or ablation and 
then sealed by thermal bonding (1.5 h, 105°C). Interconnect ports (made as described above) 
were attached with screws to allow the connection of tubing. 
2.2 Cell Filtration for Trypsin Removal 
2.2.1 Reagents and Analysis 
Unless otherwise stated, all chemicals and reagents (Invitrogen, Paisley, UK) involved in 
the cell filtration experiments were used without further purification. 
A colourimetric assay was used to determine the concentration of trypsin present in the 
output and compare to concentration of the original solution. 100 μL of output sample was 
added to 100 μL of 1 mM of L-BAPNA in 2.5% v/v dimethylformamide in 20 mM CaCl2 and 
40 mM Tris (Sigma-Aldrich, Gillingham, UK). The change in absorbance at 405nm was 
recorded every 20 seconds for 25 cycles, a total of 10 minutes. 
A ViCell™ XR (Beckman Coulter, High Wycombe, UK) automated counting device was 
used to acquire viability and cell count data, using Trypan Blue as a stain for non-viable cells. 
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2.2.2 Cell Culture 
Oct4-GFP mouse embryonic stem cells (mESCs) were grown in T25 adherent culture 
flasks (Nunc, Langenselbold, Germany) pre-treated with 0.1% v/v gelatine in water. The 
culture media used was Knock-Out Dulbecco Modified Eagle Medium (KO-DMEM), 
supplemented with 50 mL fetal calf serum, 5 mL l-glutamine, 5ml non-essential amino acid 
solution, 3.5 μL β-mercaptoethanol and 200 μL leukaemia inhibitory factor. 
The cells were passaged every three days. They were removed from the culture surface 
by incubation with 0.5 mL of 0.025% v/v trypsin in chick serum for three minutes, which was 
then inactivated with a further 0.5 mL of media. The cell colonies were broken up into a 
suspension of single cells by repeated aspiration with a Pasteur pipette before being diluted 
and seeded into ten separate T25 flasks. 
2.2.3 Cell Exposure to Trypsin 
To determine the effect that longer trypsin exposure might have on cell viability, four 6-
well plates were seeded with Oct4-GfP cells at a density of 3×105 cells cm-2 and left to grow 
for 3 days. They were then exposed to ES trypsin for 5, 10, 20 and 30 minutes before being 
quenched with media as per the standard passaging protocol. 
2.2.4 Cell Exposure to Filtration Device 
The filtration rig was assembled with a PVDF membrane (0.45μm pore size) which had 
been wetted in a solution of 1x D-PBS. The clamp screws were tightened to a torsion of 15cN-
m and the inlet and outlet ports on one size of the device were sealed.  
Single T25 flasks of Oct4-GFP mESCs were incubated with 0.025% v/v trypsin in chick 
serum to detach the cells (as per the standard passage method described above). After three 
minutes the trypsin was quenched with 2 mL culture media. 0.5 mL of the cell suspension was 
drawn off for prefiltration cell counts. The remaining 2 mL of suspension was drawn up into 
a 5ml syringe, which was connected to the device via a leur-lock fitting and placed on a syringe 
pump (KD Scientific, Holliston, USA). The cells were passed through the device at a flow 
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rate of 0.5 mL min-1 and collected from the outlet port in an Eppendorf tube. 0.5 mL of this 
suspension was taken for postfiltration cell counts.  
2.2.5 Crystal Violet Stain 
After passing the cells through the device as per the method described above, the PVDF 
membrane was removed from the device and placed into a Petri dish. A layer of methanol was 
added to the dish to fix any retained cells onto the membrane surface. The methanol was 
removed and replaced with 1 mL crystal violet. After incubating briefly, the crystal violet was 
removed and the membrane was rinsed thoroughly with 1x D-PBS before being placed on a 
microscope slide for imaging with an inverted microscope (Nikon, Kingston upon Thames, 
UK).  
2.2.6 Centrifugation/Filtration Exposure 
T25 flasks of Oct4-GFP mES cells were incubated with trypsin as per the standard 
passaging protocol. As in the filtration protocol, the trypsin was quenched with 2ml culture 
media and 0.5ml of suspension was withdrawn for cell number and viability analysis. The 
remaining suspension was transferred to a Falcon tube and centrifuged at 1200 rpm for 3 
minutes. The supernatant was removed and the cell pellet was resuspended in a further 2 mL 
of culture media. 0.5 mL of this suspension was taken for a post-centrifugation cell count. As 
before, all cell counts were conducted with a ViCell™ cell viability analyser. The count data 
was compared to that of the filtration exposure results. 
2.2.7 Trypsin Filtration 
The filtration rig was assembled with a PDVF membrane (0.45 μm pore size) as described 
above. A milliGAT™ pump was used to circulate 1xD-PBS (Sigma-Aldrich) along one side 
of the membrane. A 5 mL leur-lock syringe was loaded with a 0.025% v/v solution of trypsin 
in chick serum, connected to the opposing side of the membrane and placed in a syringe pump 
(KD Scientific). The two pumps were then operated at a variety of flow rates and the output 
trypsin solution was collected. 
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A set of standard solutions were made up to form a calibration curve. A solution of 0.025% 
v/v trypsin in chick serum was diluted to 1 in 2, 5, 10, 20, 50, 100, 200 and 500 and the 
absorbance rates were measured as above. 
2.3 Biocatalytic Synthesis and Filtration 
2.3.1 Reagents and Analysis 
Unless otherwise stated, all chemicals and reagents (Sigma-Aldrich) for the biocatalytic 
synthesis and filtration experiments were used without further purification. Pure L-erythrulose 
(ERY) for HPLC standards was produced by flash silica chromatography of commercially-
available ERY as per the method of Smith et al (Smith et al., 2008).  
Protein concentrations were measured by SDS-PAGE electrophoresis with 12% Tris-
glycine resolving gel, using purified transketolase (TK) standards. 20 μg of total protein was 
applied to each lane and the samples were stained with Comassie Blue R-250. 
HPLC analysis of products from TK-catalysed reactions was performed on an Aminex 
(Biorad, Hemel Hempstead, UK) ion-exchange column (HPX-87H, 300  7.8 mm), mobile 
phase: 0.1% v/v aqueous trifluoroacetic acid (TFA) at 0.6 mL min-1. HPA and ERY were 
detected by UV absorption at 210 nm. 
Enantiomeric excess data for the formation of ERY were calculated from chiral HPLC 
analysis of the derivatised ketodiols compared to racemic standards (Smith et al., 2008, 2009). 
The enantiomeric excess for (3S)-l,3-dihydroxypentan-2-one was obtained by chiral HPLC 
(Cázares et al., 2010). 
2.3.2 Preparation of Transketolase Lysate 
Transketolase lysates were prepared according to the method of Matosevic et al. 
(Matosevic et al., 2008). For the wild type TK, overnight cultures of E. coli BL21gold(DE3) 
(with transketolase-producing plasmid pQR791) were grown in 200 mL shake-flasks from 
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inoculation of 20 mL Lysogeny Broth (LB)-glycerol with a single colony obtained by 
streaking out cells from glycerol stocks (25% v/v glycerol stored at -80 °C) on (LB)-agar  
plates. This was incubated for 12-16 hours at 37°C. The resulting cell suspension was 
transferred to a conical flask with 200 mL LB-glycerol medium, which was incubated at 37 °C 
until the bacterial growth had reached stationary phase, as confirmed by optical density 
measurements.  The contents of the flask were transferred to 50 mL falcon tubes and 
centrifuged at 5000 rpm for 10 min. The supernatant was discarded and the cell paste was 
frozen at -80 °C until needed for lysis and purification. 
For lysis, the cell paste was resuspended in 5 mL 50 mM tris buffer, cooled on ice and 
sonicated (10 cycles of 10 seconds on, 10 seconds off) with a sonication probe (Soniprep 150, 
Sanyo, Japan). The suspension was then centrifuged and filtered with a 0.2 μm filter, and 
stored at -80°C until required.  
For the mutant D469T TK, the same procedure was followed except the pQR791 plasmid 
had been specifically mutated according to the methods of Hibbert et al. (Hibbert et al., 2007, 
2008).   
2.3.3 Batch Transketolase Reaction 
For the reaction of HPA with glycolaldehyde (GA), 30 L wild type TK lysate (4.47 mg 
mL-1) was incubated with 170 L cofactor solution (23.1 mM MgCl2, 5.7 mM thiamine 
diphosphate in 50 mM Tris-HCl buffer, pH 7) for 20 minutes at room temperature. 150 L of 
this solution was added to 150 L substrate solution (100 mM HPA, 100 mM GA in 50 mM 
Tris-HCl buffer, pH 7) in a 96-well plate to initiate the reaction (final concentrations: 50 mM 
HPA, 50mM GA, 0.34 mg mL-1 wild type TK, 2.4 mM ThDP, 9.8 mM MgCl2). Aliquots 
(20 L) were removed at the required time intervals, quenched with 180 L 0.1% v/v aqueous 
TFA, centrifuged (5000 rpm, 5 minutes) and the supernatant analysed by HPLC. 
2.3.4 Continuous Flow Microfluidic Transketolase Reaction 
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TK lysate solutions and substrate solutions were prepared at the concentrations described 
above. Using a twin syringe drive, the solutions were pumped into separate inlets of the 
microfluidic reactor at the same flow rate for at least 1.5 times the residence time before 
collecting the output in pre-weighed sample vials containing 360 L 0.1% TFA. The quenched 
reaction mixture was centrifuged and analysed by HPLC as above. Residence times were 
calculated by dividing the reactor volume (60 L) by the flow rate. 
2.3.5 Filtration Back Pressure Measurements 
Constricting capillaries (internal diameter 50, 75, 100 and 200 m) were attached to the 
retentate outlet of the filtration device in cross-flow mode (Figure 2D). The resulting back 
pressure was measured with an inline pressure sensor (40PC100, Honeywell, Morristown, 
USA), and the data was logged with a LabVIEW instrument (National Instruments, Austin, 
USA). 
2.3.6 Filtration of Model Reactor Output and Integration 
The filtration unit was charged with Tris buffer (50 mM, pH 7). A model stock solution 
of TK (0.34 mg mL-1) and ERY (50 mM) in Tris buffer (50 mM, pH 7) was pumped through 
the retentate inlet with a syringe drive, while tris buffer was pumped through the permeate 
inlet. Samples were collected at the retentate and permeate outlets for analysis by HPLC and 
SDS-PAGE. 
For the integration of the microfluidic reactor and the filtration unit, a HPA/GA solution 
(both 100 mM) and a TK/cofactors solution (0.68 mg mL-1 TK) were combined and flowed 
through a microfluidic reactor at 10 μL min-1. The output was connected to a filtration unit via 
a length of tubing to give the desired residence time. A 50 μm i.d. capillary was fitted to the 
retentate outlet of the filtration unit. The reaction was run for a total of 10 hours. Samples 
taken from the retentate and permeate outlets were analysed by HPLC. 
2.4 Biocatalytic Synthesis in Microfluidic Multi-Input Reactor 
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2.4.1 Reagents and Analysis 
Unless otherwise stated, all chemicals and reagents (Sigma-Aldrich) were used without 
further purification. Concentrations of TK, HPA and GA we determined as described in 
Section 2.3.1. 
2.4.2 Continuous Flow Microfluidic Reaction of HPA to ERY (with 
multiple GA Inputs) 
Two separate solutions were used to perform the reaction. The main reaction mixture 
(solution A) consisted of 0.069 mg mL-1 clarified transketolase lysate, different HPA 
concentrations (211/316/421/526 mM HPA, depending on experiment), 2.53 mM thiamine 
diphosphate (ThDP) and 10.3 mM MgCl2 in 50 mM Tris-HCl buffer, pH 7. The concentrations 
of the solutes were chosen such that they would be diluted to the following concentrations 
once combined with the first GA input: 0.066 mg/mL clarified transketolase lysate, 
200/300/400/500 mM HPA, 2.4 mM thiamine diphosphate (TDP) and 9.8 mM MgCl2. The 
supplementary GA solution (solution B) consisted of 1 M GA in 50 mM Tris-HCl buffer, pH 
7. 
The MIR was primed with Tris-HCl buffer (50 mM, pH 7).  Solution A was pumped into 
the first primary input of the reactor with a single-drive syringe pump. Solution B was pumped 
into the second primary input, along with a number of auxiliary inputs, using a dual-drive 
syringe pump adapted to fit ten 1 mL syringes. The flow rates and the number of auxiliary 
inputs used were dependent upon the desired residence time and input HPA concentration (see 
Table 5, Section 5.3). 
The reactor was allowed to equilibrate for 2.5 residence times before sampling began. 
Samples were collected in pre-weighed vials containing 270 μL 0.1% (v/v) aqueous 
trifluoroacetic acid (TFA). The quenched samples were weighed, centrifuged and the 
supernatant was diluted 1:1 with 0.1% TFA before being analysed by HPLC as described in 
section 2.1.  
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2.4.3 Fed-Batch Reactions in Microwell Plates 
Fed-batch reactions were performed in 96-microwell plates. 200 µL of solution A was 
made up in each well. 10 µL of solution B was manually added to each well to start the 
reactions. Further 10 µL doses of solution B were then manually added to the reaction mixtures 
at specific time points, corresponding with the feeding strategy used in the continuous-flow 
reactions. Endpoint samples were taken after the reactions had run for the equivalent residence 
times, diluting 30 µL of reaction mixture in 270 μL 0.1% TFA. Samples were centrifuged 
before being analysed by HPLC. 
2.4.4 12-Hour Continuous Production of ERY 
The experiment was run at the conditions of the 500 mM HPA conversion (Table 5), using 
the same solutions and reactor setup as described in section 2.4.2. The output tubing from the 
MIR was connected to a RotAXYS auto-sampling system (cetoni GmbH, Korbussen, 
Germany), programmed to take 30 µL samples every hour from the start of the reaction. 12 
wells of a 96-microwell plate were each filled with 270 µL of 0.1% TFA to quench the 
samples. Samples were centrifuged before being analysed by HPLC. 
2.5 Confocal Imaging of Mixing in Microreactors 
2.5.1 Confocal Imaging of Mixing in SHM Microreactor 
Two solutions (phosphate buffered saline and fluorescein-conjugated bovine serum 
albumin in phosphate buffered saline, pH 7) were flowed through separate inlet ports of the 
microreactor. Confocal microscopy images were taken before and after the SHM structures 
(at 1 cm and 6 cm from the T-junction, respectively) with a Leica TCS SP2 (Leica 
Microsystems UK Ltd, Milton Keynes, UK). A 10× objective was used with 12% laser power, 
taking 5 µm sections from the top to the bottom of the channels. The sections were compiled 
into composite images using with Leica Confocal Imaging software (Leica Microsystems UK 
Ltd). 
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2.5.2 Confocal Imaging of Mixing in MIR 
Confocal imaging was used to analyse the rate of diffusion of substrate fed at the auxiliary 
inputs into the main reaction mixture. A microfluidic chip was designed specifically for this 
purpose, mimicking the structure of a single auxiliary input and channel section in the MIR, 
with some modification to accommodate confocal imaging (Figure 9). The chip was fabricated 
from two layers of PMMA using laser ablation, with an adhesive-free microwell plate sealing 
film used to seal the channels of the top layer. The cross section of the channels was identical 
to those of the MIR i.e. 1 x 0.5 mm (w x d). The two PMMA layers were bonded together as 
described in Section 2.1.5, with the sealing film being attached and smoothed to remove 
trapped air pockets after the PMMA had cooled. 
 
Figure 9: Design of chip used to mimic MIR auxiliary input for confocal imaging. 
Areas filled in red represent channels cut into the bottom layer and areas filled in blue represent channels 
in the top layer. Blue lines indicate through cuts in the top layer only, while purple lines indicate through 
cuts in both layers. 
Water and 0.1 mg ml-1 fluorescein in water were flowed through the primary and auxiliary 
inputs respectively (labelled a and b in Figure 9). Confocal microscopy images were taken 1 
and 2 cm downstream from the channel join with a Leica TCS SP2 confocal microscope (Leica 
Microsystems UK Ltd). A 10× objective was used with a 488 nm argon laser at 30% power 
and a FITC filter. The channel was imaged from the top to the floor in horizontal sections 5 
microns apart. The flow rates and location of the imaging were adjusted to visualise the 
diffusion at different residence times, between 1.4 and 60 seconds. The ratio of the water to 
fluorescein solution flow rates were maintained at 20:1, regardless of the residence time 
2 – MATERIALS AND METHODS 
59 
 
investigated. The sections were compiled into composite images using with Leica Confocal 
Imaging software to create vertical cross-sections of the channel. 
2.5.3 Confocal Imaging of Backflow at MIR Inputs 
The rate of diffusion along the auxiliary channel itself was also evaluated in order to 
ensure there was no backflow of reaction mixture out of the auxiliary ports. In this case the 
fluorescein solution was flowed through the primary input (a in Figure 9) and water was 
flowed into the auxiliary input (b in Figure 9). The join between the channels was imaged 
across both layers in horizontal sections 10 microns apart, using the same settings as above. 
Fluorescein solution and water were flowed into the chip in a 20:1 ratio, at 3.3µl min-1 and 
0.17 µl min-1 respectively. A control image was taken with static fluorescein solution in the 
main channel and the auxiliary input. 
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3  
Development of Microfluidic Tangential Flow Filter for  
Harvesting of Mammalian Cells  
This chapter illustrates the development of a microfluidic filtration device for 
bioprocessing, with the aim that it could be used to test filtration conditions for a range of 
potential applications. The application initially used as a model for development was the 
capture of mammalian cells after removal from a culture plate using the enzyme trypsin. The 
chapter shows the proof of concept experiments performed using a bench scale filter and the 
subsequent development of a modular tangential filtration device that could be used with 
commercially available membranes.  
The results in this chapter have been presented in part in several conference proceedings 
and the design and burst pressure characterisation of the final device have been published in 
the Journal of Molecular Catalysis B: Enzymatic in a contribution entitled ‘Modular 
Microfluidic Reactor and Inline Filtration System for the Biocatalytic Synthesis of Chiral 
Metabolites’ (see Appendix C). 
Some of the data in this chapter was produced as part of a Bachelor’s degree in 
collaboration with Mélissa Nafir. The data in Figure 28, Figure 29, Figure 30 and Figure 31 
was produced by Mélissa Nafir using the filtration device detailed in section 3.4.1. 
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3.1 Introduction 
Filtration is a widely-used and established technology in bioprocessing, owing to the fact 
that it can be applied to separations in variety of bioprocesses as well as at several stages 
within individual bioprocesses. It is commonly used in initial clarification and cell harvest 
steps as well as later purification and preparation steps such as protein concentration and 
buffer exchange (van Reis and Zydney, 2007). This versatility arises from the range of pore 
sizes and membrane materials available, allowing the fractionation of different components 
across many orders of magnitude in size (see Figure 6 in Section 1.4.1), therefore making it 
an attractive choice for the creation of a microfluidic downstream separation device that is 
industrially-relevant when compared with other examples discussed in Section 1.3. 
Filtration processes usually take the form either of normal flow (or dead-end) filtration, 
where the fluid flow and pressure are applied perpendicularly to the membrane, or tangential 
flow (or cross-flow) filtration, where the fluid flow runs in parallel to the surface of the 
membrane but the pressure is applied perpendicularly (see Figure 7 in section 1.4.1). Whilst 
normal flow filtration is more simple to implement, the driving of fluid flow directly into the 
membrane results in the adsorption of both soluble and suspended components, causing rapid 
fouling of the membrane (Belfort et al., 1994).  
In tangential flow filtration, however, inertial lift and shear-induced diffusion effects 
cause back-flow of particulates away from the membrane surface, reducing the rate at which 
debris can build up on the membrane. Furthermore, tangential flow filtration units possess a 
‘critical flux’,  a level of flux below which fouling is negligible, or at least minimal, and there 
is little or no measurable decline in flux over the course of operation (Field et al., 1995; Pollice 
et al., 2005). This makes tangential flow filtration particularly useful in bioprocessing, where 
the typically high concentration of biological debris can cause very high fouling rates if not 
mitigated. The widespread use of tangential flow filtration in industry and its range of 
applications therefore makes it the most relevant choice for a scale down device. 
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The foremost requirement for the proposed device was that it should be able to test a 
variety of conditions for possible separations processes, be it cell harvesting, protein recovery 
or others. The primary conditions that would need to be varied to be relevant to industrial scale 
bioprocessing were identified as the membrane material, pore size and filtration pressure. In 
order to achieve this it should ideally be possible to integrate any one of the range of 
commercial membranes available into the device for testing, and the device and the 
connections to it would also need to be robust to typical filtration pressures, in the range of 10 
– 60 psi (Zeman and Zydney, 1996; van Reis and Zydney, 2007). 
A key requirement of the device design was that it should be possible to produce the device 
without resorting to complex or costly fabrication techniques, which can be time-consuming 
and costly (Han and Frazier, 2005). Alternatively, if such fabrication techniques were 
unavoidable, the device should be readily reusable.  Designs which relied on the use of micro-
patterned features were therefore excluded, as these generally required complex fabrication 
processes and were not compatible with the integration of pre-made membranes (Pamme 
2007).  
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3.2 Proof of Principle Experiments 
The test case initially chosen for the development of the microfluidic filter was the 
separation of mammalian cells, in particular mouse embryonic stem (mES) cells grown in 
adherent culture from the trypsin enzyme used to remove them. The standard method for 
separating the cells from the trypsin is centrifugation, but both mES and human embryonic 
cells have been shown to be sensitive to excessive shear forces, which can bring about 
differentiation. The long-term aim was to be able to use the filtration device to exchange 
soluble media components within cell suspensions, retaining the cells themselves so that they 
could be cultured further and reducing the amount of shear they were exposed to. The aim of 
the test case was therefore to establish whether mammalian cells could be retained by the filter 
without suffering any adverse effects, whilst the trypsin enzyme was completely removed. 
This was tested first in a bench-scale system using commercially-available hollow fibre 
membranes, to determine whether separation could be achieved before starting the design and 
fabrication of a microfluidic filter. Oct4-GFP mES cells were selected as the test cell culture 
as they produce green fluorescent protein while they remain undifferentiated. 
3.2.1 Feasibility of Stem Cell Recovery Using Filtration 
A bench scale filter was fabricated for the purpose of running proof-of-concept 
experiments with mES cells, to determine whether the recovery of the cells using a filtration 
system was feasible.  
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Figure 10: Design of bench scale hollow fibre filtration unit for proof of concept experiments. 
(A) Dimensions of filtration unit (units in mm); (B) partially exploded view of unit showing sealing of 
hollow fibre connection with epoxy plug and o-ring; (C) longitudinal cross section through unit. 
The body of the filter unit was designed to accommodate a single polysulphone hollow 
fibre with a diameter of 1 mm and length of 100 mm, leaving a clearance of 1.6 mm between 
the fibre and the inner wall of the body (Figure 10A). The hollow fibre was cut to size and 
fitted with epoxy ‘plugs’ at either end, then threaded into the filter body. A seal was made 
around either end of the fibre by fitting o-rings around the plugs and clamping two flanged 
sections of pipe, which provided connections for tubing (Figure 10B). Two further inputs on 
either side of the filter unit provided connections for tangential flow in co-current or counter-
current mode (Figure 10C). 
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To determine the effect of filtration on the viability of the mES cells (including any 
toxicity caused by parts such as the epoxy plugs), several suspensions of Oct4-GFP cells were 
passed through the bench scale device. The cells were detached from the culture flasks as per 
the standard passage protocol, removing the cells from the culture surface with a solution of 
trypsin enzyme and inactivating with FBS after detachment to eliminate any adverse effect on 
the cells from exposure to the active enzyme. The cells were passed through the hollow fibre 
at a rate of 5 ml min-1, with a counter-current of 5 ml min-1 media in the space around the fibre.  
 
Figure 11: Viability of Oct4-GFP cells before and after filtration with bench-scale device (n = 8, error bars 
show standard deviation) 
The cell suspension recovered from the filtration device was more dilute than the input, 
suggesting either that cells were becoming entrained on the membrane surface or that the net 
flux was into the cell suspension, or a combination of these effects. However, the main purpose 
of the experiment was to determine whether filtration could be a viable method for recovering 
the cells and not, at this stage, what might determine the efficiency of the recovery. Cell counts 
performed with trypan blue on samples collected after filtration showed no significant 
difference in percentage viability compared with samples taken before filtration, confirming 
that the process had no short-term effects on cell viability (see Figure 11). 
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3.2.1 Effect of Trypsin Exposure on Cell Viability 
The standard method of removing trypsin during passage involves quenching the enzyme 
with an excess of FBS-containing media then centrifuging the cell suspension to separate the 
cells from the media. Under these conditions the cells are exposed to the trypsin for around 
five minutes after the trypsin is inactivated. Separating the cells using filtration would likely 
require exposing them to active trypsin for longer periods of time; hence it was necessary to 
determine whether this would have a detrimental effect on cell viability. Four 6-well plates of 
mES Oct4-GFP cells were trypsinized and quenched with FBS-containing media after 5, 10, 
20 and 30 minutes respectively, before the cell viability was analysed (Figure 12). 
The cell counts after exposure to trypsin showed an average overall cell viability of 95%, 
with the length of exposure to active trypsin having no significant effect on the viability of the 
cell suspension. This suggested that filtration could be a feasible method of clearing trypsin 
from suspensions of stem cells. Longer and repeated exposure to proteolytic enzymes has the 
potential to reduce the pluripotency and proliferation potential of stem cells, though this effect 
was not investigated at this point (Majd et al., 2009). 
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Figure 12: Viability of mES Oct4-GFP cells after exposure to active trypsin for different lengths of time (n 
= 6). 
3.2.3 Detection of Trypsin with Colourimetric Assay 
Detection of trypsin was achieved by a colourimetric assay with L-BAPNA, a 
chromogenic substrate for proteolytic enzymes which releases p-nitroaniline when 
hydrolysed. Several concentrations of trypsin were combined with the substrate and incubated 
while the change in absorbance was measured. An initial rate was taken to determine the 
concentration of active enzyme in each sample (see Figure 13). 
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Figure 13: Calibration curve for the determination of trypsin concentration using L-BAPNA colourimetric 
assay 
The assay was capable of providing an accurate measure of trypsin concentration between 
concentrations of 0.025 and 0.25 mg ml-1, equivalent to a 1 – 100x dilution of the enzyme 
when used in cell culture. This was suitable for determining whether the removal of trypsin 
had taken place. 
3.2.4 Separation of Trypsin from Cell Media using Bench-Scale Filter 
The bench scale filtration rig (shown in Section 3.2.1) was used to perform a series of 
preliminary experiments to test whether it was possible to remove of trypsin from mES cell 
culture media and, if so, what conditions were necessary to remove the enzyme. FBS-free 
media containing trypsin was passed through the hollow fibre of the filtration rig, with back 
pressure applied by a tubing clamp on the outlet and monitored by an in-line pressure meter. 
Trypsin- and FBS-free media was passed through the void space around the fibre in counter-
current mode. The amount of active trypsin present in the retentate and permeate was then 
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measured using the colorimetric assay described in Section 3.2.3 The percentage of trypsin 
removed for each condition set is shown in Figure 14. 
 
Figure 14: Clearance of trypsin using bench scale filter (n = 3, error bars indicate standard deviation). 
FR is flow rate through hollow fibre, CFR is counter flow rate through outer housing, P is back pressure 
applied to outlet from hollow fibre. 
The initial tests suggest that the contact time of the two fluids was more important for the 
removal of trypsin than the back pressure on the hollow fibre. The highest clearance of trypsin 
occurred while using flow rates of 1 ml min-1 for the retentate and permeate streams, meaning 
that the trypsin-containing media was in contact with trypsin-free media for approximately 15 
seconds. 
3.2.5 Feasibility of Microfluidic Filter Fabrication 
The design of a dead-end microfluidic filter was attempted in the first instance to test the 
principle of filtration at the microfluidic scale. The filter was fabricated in PMMA and PDMS, 
with a polysulphone membrane. The PMMA enclosure acted as a rigid frame for the PDMS 
assembly, providing support and fluidic connections to tubing, and was intended to be 
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reusable, whilst the PDMS and membrane assembly were intended to be disposable (see 
Figure 15). The design was adapted from that of Ismagilov, who sealed polycarbonate 
membranes into their PDMS chips by manually wetting the areas of membranes that they 
wanted to seal with liquid PDMS prepolymer before curing at 65°C, preventing any leakage 
from the chip or exchange of fluids between channels (Ismagilov et al., 2001). Ismagilov’s 
method was chosen because it presented the simplest way to integrate a range of different 
membranes into PDMS, avoiding the complication of having to identifying functionalising 
methods for each membrane type. 
The PDMS and polysulphone membrane made up the main structure of the filter. Both 
PDMS layers were 60 x 25 x 2 mm (l x w x d) with 5 x 5 x 1 mm cavities in their centre and 
7.5 x 1 x 1 channels to connect the cavities to the ports. These were inverted to make one 
continuous fluid path from one end of the chip to the other. The filter membrane was sealed 
into the PDMS layer by treating the edge with liquid polymer, then clamping and curing it in 
place. The PDMS/membrane chip was clamped into the PMMA enclosure, and commercially 
available interconnects (N-333, Upchurch Scientific, Oak Harbor, USA) were bonded onto 
the surface of the enclosure to allow the connection of tubing. 
The seal achieved by this method was reasonably reproducible provided that the 
placement of the liquid PDMS was done carefully, with a failure rate of around 1 in 5 
PDMS/membrane chips which did not form a complete seal around the edge of the membrane 
(as observed by testing with water blue solution). However, the liquid PDMS was observed to 
spread laterally through the pores of the membrane and in some chips this reached the main 
cavity such that, when cured, the area available for filtration was reduced. 
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Figure 15: Design of first generation dead-end filtration chip (not to scale) 
The filtration device was tested for the recovery of mES cells from a suspension after 
passage using standard passage protocol. The suspension, containing active trypsin, was 
passed though the device at 0.5 ml min-1. The permeate was collected from the output of the 
device. FBS-free media was then passed through the device in the opposite direction to recover 
the cells; this was the retentate. 
Analysis of the concentration of trypsin remaining in the permeate and retentate showed 
that the filter was capable of separating the cells from the trypsin, which was able to permeate 
through the membrane (see Figure 16). However the recovery of the cells from the device was 
difficult, presumably because of impaction on the membrane, and the retentate cell 
concentration was reduced by two orders of magnitude from the prefiltration concentration. 
The resulting cell suspension was too dilute to be replated without further concentration, 
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having an average viable cell count of 4.2 × 104 cells ml-1 with a standard deviation of 2.4 × 
104 cells ml-1 (see Figure 17), where a concentration of around 1.0 × 106 cells ml-1 would be 
necessary for the cells to grow to confluency.  
Cells were also observed in the suspension collected from the permeate at a concentration 
of 1.3 × 104 cells ml-1, around a quarter of the total number of cells recovered from the filtration 
process, implying that leakage occurred through or around the membrane. The cell population 
was around 40% viable, suggesting that the route taken through the filter was traumatic to the 
cells. This, combined with the low overall yield of cells from the filter and the low 
concentration at which they were recovered, indicated that normal-flow filtration would not 
be a viable method for recovery. 
 
Figure 16: Concentration of cell suspension before and after recovery using microfluidic normal flow 
filtration device (n = 3, error bars indicate standard deviation). 
Normal flow has the additional disadvantages that it is very susceptible to fouling by 
biological materials and is relatively inflexible in the range of unit operations that it can be 
applied to (it cannot, for example, be used to exchange solutes).   
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Figure 17: Cell number and viability after recovery using microfluidic normal flow filtration device (n = 3, 
error bars indicate standard deviation). 
Light grey indicates viable cell count; dark grey indicates non-viable cell count. Refer to the left axis for 
prefiltration cell counts (units are ×106 cells ml-1). Refer to the right axis for the permeate and retentate 
cell counts (units are ×104 cells ml-1). 
The initial proof of principle experiments showed that separation of the cells from the 
trypsin enzyme was possible, but several challenges had been presented. The key challenge 
was the reproducible integration of the filtration membrane, without leakage and without 
obstructing the area for fluid transmission. Secondary to this was the poor recovery observed 
in the normal flow filtration device, resulting from impaction of the cells on the membrane. 
This would likely prove problematic for processing of other biological materials, so the choice 
was made to continue development with a tangential flow design instead. 
An additional challenge identified was that mammalian cell suspensions were not the most 
suitable test system for filtration, given the amount of ancillary work required to maintain 
them and prepare samples for experimentation. For this reason the filtration of cells was made 
a lower priority, with research focussing on the technical challenges that had been identified. 
Further cell filtration experiments were carried out once these had been overcome, the results 
of which are shown in Section 3.5. 
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3.3 Development of Tangential Flow Filtration Device 
A number of designs were evaluated in the process of developing the final design from the 
initial proof of concept device shown in Figure 15. This section will consider the rationale for 
the device’s final design in the context of these. The final design of the tangential flow 
filtration device had several key features, developed over the course of a number of iterations 
of prototyping and testing. These were: 
 Straight channel with cross-sectional area of 1 x 1 mm and filter area of 45.8 mm² 
 Clamp sealing 
 Rigid hard polymer chip, robust to pressures of up to 100 psi 
 PDMS gasket to enclose membrane 
 Modularity of parts and standard interconnect fittings 
3.3.1 Straight Channel Design 
The initial normal-flow filter design featured a large cavity in the centre of the PDMS chip 
which formed the filtration area. Its relatively large geometry was chosen for ease of 
fabrication and to minimise the likelihood of clogging of the channels; however, this caused 
problems with priming, frequently resulting in large bubbles which reduced the effective 
filtration area (Figure 18).  
 
Figure 18: Water blue test of normal flow microfluidic filter design. 
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Grey arrows indicate bubble formation; white arrow indicates area of membrane inadvertently sealed 
with prepolymer. 
The next design iteration therefore aimed to improve priming by using a narrower channel 
with a 1 x 1 mm cross-section as the filtration area. This was fabricated as a meander in order 
to give the same overall filtration area as the normal-flow filtration device, 25 mm² (Figure 
19), with a fluidic connection at either end of the chip so that it could be used as a tangential 
flow filter. Use of a meander structure was intended to provide a torsional flow pattern 
secondary to the direction of flow, which might have helped to reduce the rate of membrane 
fouling. However, the meander made alignment of the two parts of the chip more crucial, as 
any slight misalignment could reduce the available filtration area. In addition, when the design 
moved to clamp sealing (see next section) it quickly became apparent that a meander would 
significantly increase the complexity of the design, as an even sealing pressure would be 
needed over the length of the channel. The meander was therefore abandoned in the final 
design, but the channel was lengthened to 50 mm in order to provide a larger filtration area. If 
a larger area were required it may be possible to widen the channel, using a flow distributor 
such as those evaluated by Vangelooven  et al. (Schoenmakers et al., 2010; Vangelooven et 
al., 2010). 
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Figure 19: Design of first generation tangential flow filtration chip (not to scale) 
3.3.2 Clamp Sealing of Filtration Membrane 
The normal-flow filter design and subsequent early tangential flow designs relied upon 
the bonding of the membrane into PDMS structures with liquid prepolymer in order to seal 
the filter. As mentioned before, the spread of the prepolymer could cause inadvertent blocking 
of parts of the membrane in the filtration chamber. In the proof of concept design this problem 
did not completely block the filtration area, although it did reduce the reproducibility of the 
design. When using smaller channel geometries however, the PDMS could spread to cover 
the majority of the filtration area if too much prepolymer was applied. Changing the filter 
design to seal the membrane in place by clamping was therefore chosen as a way to make the 
filter work more reproducibly. 
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Using clamp sealing also meant that the fabrication could be simplified. Sealing the 
membrane in place inside a PDMS chip added another step to the fabrication process which 
needed to be repeated in preparation for each filtration test, since the PDMS components could 
not easily be reused. Use of clamp sealing meant that these components were no longer 
required and the main body of the filtration device could be designed to be reusable, with only 
the membrane being disposed of between experiments, saving time and resources.  
3.3.3 Rigid Hard Polymer Chip 
In order to maintain a robust seal, the clamp sealing filtration device had to have minimal 
flex. Where earlier designs had used thinner (3mm) hard polymer PMMA and PC components 
as enclosures to facilitate fluidic connections to the PDMS and membrane component (see 
Figure 15 and Figure 19), the hard polymer components in the clamp sealed device served as 
the fluidic connection and channel. They were therefore fabricated in thicker 5 mm PMMA or 
PC to give the structure of the filtration device greater rigidity and help to ensure a robust seal. 
The use of hard polymer for the channels and fluidic interconnects meant that they could 
be joined by screws and that there was no soft/hard polymer interface to consider. This was a 
significant design advantage, as non-permanent interfaces between soft and hard polymers 
often require a significant amount of development to ensure a robust seal at high pressures 
(Reichen, 2011). The use of PC rather than PMMA also meant that the device could be used 
in applications where sterility is necessary, such as cell handling, where sterilisation is 
typically achieved by autoclaving at 121°C. The glass transition temperature of PMMA is 
105°C, meaning that any parts would likely suffer deformation during the autoclaving process. 
PC has a glass transition temperature of 147°C, reducing the risk of deformation of parts 
during autoclaving.  
 
3.3.4 PDMS Gasket to Enclose Membrane 
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Earlier filter designs used roughly-cut membranes, relying on sealing by treatment with 
liquid PDMS or pressure to prevent fluid from entering parts of the membrane outside of the 
filtration area. As discussed above, the former resulted in inadvertent sealing of parts of the 
membrane in the filtration area. A design was therefore tested which aimed to cut off the 
lateral flow through the membrane by sealing with a combination of a PC boss fabricated in 
the permeate side of the device and a recessed PDMS gasket fabricated in the retentate side of 
the device. The two sides were clamped together around the membrane with screws, using a 
specific torque. The height of the PDMS gasket recessed in the retentate side could also be 
changed to tune the quality of the seal (see Figure 20). 
 
Figure 20: Design of tangential flow filtration chip with interlocking PC and PDMS seal mechanism. 
The quality of the seal was evaluated by flowing a defined weight of water blue through 
the retentate side of the device whilst the fluidic connections of the permeate side were sealed. 
The difference between the weight of water blue flowed through the device and the amount 
collected was recorded first under varying assembly screw torsions, then with different PDMS 
gasket heights (using the screw torsion that caused the least leakage of water blue).  
The use of a PDMS gasket did reduce the amount of leakage, as did the use the of a screw 
torsion of 15 cN-m; however the combination of the two was not enough to prevent leakage 
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altogether (see Figure 21A and B), as lateral diffusion of fluid through the membrane was still 
possible. Use of a gasket height above 0.4 mm or screw torsion above 25 cN-m also caused 
shearing in the channel wall (Figure 21C).  
 
Figure 21: Effect of clamp screw torsion and PDMS gasket height on integrity of membrane seal.  
(A) Effect of clamp screw torsion on loss of water blue from device; (B) effect of PDMS boss height on loss 
of water blue; (C) shearing of the retentate channel wall by expansion of 0.4 mm PDMS gasket under 
sealing pressure. 
The final design therefore aimed to completely seal the membrane within the filtration 
area, rather than clamp over a part of the membrane. This made the preparation of the 
membranes slightly more complicated, although they could be cut to fit the device quite 
accurately using laser ablation. The combination of a hard polymer lip and recessed PDMS 
gasket was also abandoned in favour of a raised PDMS gasket, which aimed to put less stress 
on the channel walls when the two halves of the device were clamped together. The offset 
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between the channel structure and the recess in which the gasket sat was also increased for the 
same purpose. 
3.3.5 Modularity of Design 
The use of clamp sealing in the filter design meant that the individual parts could be 
exchanged or replaced as required, facilitating the reuse of the device. The interconnects were 
also designed for use with standard M6 fittings, meaning that the device could be integrated 
into a larger network of devices if desired (see Chapter 4).  
3.4 Clamp-Sealed Microfluidic Tangential Flow Filtration Device 
3.4.1 Final Design 
The final design was fabricated in 5 mm PC, with a PDMS gasket. The retentate and 
permeate sides each had a 1 x 1 x 46 mm channel milled into the centre (45.8 mm² filtration 
area), with a 1 mm diameter through-hole at either end for fluid connection. The recess for the 
gasket was offset from the channel wall by 1 mm and was 0.85 mm deep. The gasket itself 
was fabricated in a mould and was 1 mm deep, leaving a 650 µm prominence over the surface 
of the permeate plate to accommodate the membrane, and which deformed on clamping to 
seal the membrane in position. The two sides were clamped together with M3 screws placed 
at regular intervals along the length of the device. Interconnect ports were also attached with 
M3 screws; these had M6 threads for compatibility with standard fittings (Figure 22). 
The interconnects were adapted from a design by Reichen et al. and were changed to 
attach to the side of the device without interfering with the main assembly screws (Reichen et 
al., 2010). The choice to use these rather than the commercially available interconnects, used 
in earlier phases of the development and more widely across other reported designs, was made 
because of the difficulty encountered in attaching the commercially available ports in a robust 
way, particularly when the devices were exposed to filtration pressures. Such problems are 
common across microfluidic device designs and could affect their reproducibly and utility, 
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although commercial solutions such as chip holders have become available more recently from 
specialist manufacturers of microfluidic devices (Nittis et al., 2001; Mair et al., 2006). These 
products allow the rapid connection of multiple fluidic inputs through clamping, and could 
potentially have made the assembly of the filtration device easier and the clamping more 
reproducible. However, the cost of the holders is quite prohibitive and they can be quite 
restrictive in terms of the size and port layout of the chip that can be used.  
Use of clamping meant that a reversible seal could potentially be created around any 
commercial membrane that was cut to size. This made for a very simple fabrication process 
and meant that the device could be used to test a variety of process applications and conditions 
without needing to change any part of the device itself. It also meant that the device could be 
quickly repurposed to test different conditions, such as material and pore size, and that the 
device itself could be reused. This is preferable to previously demonstrated tangential flow 
filtration devices where the membrane surface was fabricated into the devices themselves, 
where changing the membrane properties would mean refabricating the entire device 
(VanDelinder and Groisman, 2007; Chen et al., 2008). 
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Figure 22: Final design of clamp-sealed tangential flow filtration chip (not to scale). 
3.4.2 Burst Pressure Characterisation 
The seal achieved in the device was dependent upon the clamping pressure applied with 
the screws. A torque driver was used to apply a specific torque to each screw in order to 
maintain an even pressure over the length of the device. The effect of the clamping pressure 
on the seal quality was characterised by measuring the burst pressure in the device under 
different assembly and interconnect port screw torsions. A pressure transducer was attached 
to the outlet of the retentate and air was flowed into the inlet with a syringe drive; the permeate 
connections were sealed (Figure 23A). 
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Figure 23: Burst pressure characterisation. 
(A) Diagram of setup used to measure burst pressure in microfluidic filtration device; (B) representative 
pressurisation profiles recorded after device was sealed with various assembly screw torques. ST refers to 
torque on screws of main assembly, PT to torque on screws used to attach interconnect ports. Torque units 
are cN-m. 
Evaluation of the burst pressure data suggests that the use of a 10 cN-m torsion for both 
sets of screws (ST and PT) creates a more effective seal than any of the other assembly 
conditions tested (Figure 23B). Using this torsion for both the main assembly screws and the 
interconnect port screws created a seal that did not burst at pressures up to 100 psi, the 
measurement limit of the pressure transducer used (40PC100, Honeywell), although a slow 
leak was observed after the maximum pressure had been reached.  
Higher torsions resulted in a lower-quality seal; a screw torsion of 10 cN-m on the main 
assembly screws and 30 cN-m on the interconnect screws caused the seal to burst at around 
55 psi, while a screw torsion of 40 cN-m on the main screws and 30 cN-m on the interconnect 
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screws prevented the device from being pressurised at all. This is presumably due to 
deformation of the plates and resulting poor contact between the PDMS gasket and the 
permeate side of the device. 
The data also suggested that the torsion applied to the interconnect screws was a greater 
factor in determining the quality of the seal than that applied to the main assembly screws. 
Increasing the interconnect screw torsion from 10 to 30 cN-m resulted in a much greater drop 
in burst pressure (40 psi) than a corresponding increase from 10 to 40 cN-m (10 psi; see Figure 
23B).  
3.5 Mammalian Cell Recovery in Microfluidic Tangential Flow Filter 
3.5.1 Separation of Trypsin from Cell Media using Microfluidic Tangential 
Flow Filter 
To validate the results of the bench scale test and to further investigate the conditions 
required for trypsin removal in the microfluidic tangential flow filter, further tests of trypsin 
clearance were performed using the filter design described in Section 3.4. FBS-free media 
solution containing trypsin enzyme at 0.25 mg ml-1 was passed through the retentate side of 
the filter whilst FBS- and trypsin-free media was passed through the permeate side of the filter. 
A polysulphone membrane with 0.45 µm pore size was used for the experiments, equivalent 
to that used in the proof of concept tests in the bench scale device. Flow rates were controlled 
with a syringe drive and MilliGAT pump (see Figure 24). 
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Figure 24: Illustration of setup used to test clearance of trypsin from solutions of FBS-free media. 
The measurement of trypsin remaining after filtration using various retentate and permeate 
flow rates suggest that a lower flow rates result in a greater trypsin clearance, particularly 
where a lower retentate flow rate and higher permeate flow rate are used (see Figure 25). The 
greatest clearance of trypsin was achieved when using permeate and retentate flow rates of 
0.1 and 0.01 ml min-1 respectively, resulting in a 50% reduction in trypsin concentration 
compared with the original media solution. This is a better clearance than was observed where 
flow rates of 0.01 ml min-1 were used on both sides of the membrane, suggesting that the 
mechanism of clearance is a combination of diffusion of trypsin from the retentate to the 
permeate side, along with dilution by the trypsin-free media flowing through the permeate 
side. 
Whilst this result demonstrated that it was possible to remove a substantial amount of 
trypsin with the microfluidic filter, it was not sufficient for the purpose of using the device for 
media exchange in cell culture, where complete removal of all undesired media components 
would be necessary. Further optimisation of the filtration conditions was therefore undertaken, 
using a combination of flow rate control and flow restriction with capillaries to affect the 
contact time of the media with the membrane and the transmembrane pressure (TMP).  
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Figure 25: Effect of retentate/permeate flow rate on trypsin clearance from cell suspensions (n = 3, error 
bars indicate standard deviation). 
3.5.2 Control of TMP with Flow Restricting Capillaries 
Initial investigation into the filtration conditions required to remove trypsin suggested that 
control over transmembrane pressure (TMP) would be necessary to make the process feasible. 
To this end, glass capillaries with defined diameters were used in combination with the input 
flow rate to control the pressure on the retentate and permeate sides, and hence the TMP. The 
selection of capillaries was made by calculating the theoretical pressure that each would 
supply at defined flow rates and hence the TMP in the filter. The calculations were based upon 
the Hagen-Poiseulle equation, using the diameter and length of the capillaries, the tubing 
connecting them to the microfluidic filter and the channels of the filter itself. The selection of 
flow rates and capillary diameters and the TMP they were used to supply is shown in Table 8. 
The spreadsheet used to calculate the pressures that each capillary would supply and select the 
condition set for the desired TMP is shown in Appendix A. 
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Retentat
e 
Permeat
e 
Retentat
e 
Permeat
e 
Retentat
e 
Permeat
e 
0.696/10.0
9 
100 100 0.32 0.32 0.1 1.0 
1.344/19.4
9 
200 100 0.32 0.32 0.1 1.0 
2.078/30.1
4 
100 200 0.5 0.32 1.0 5.0 
Table 2: Condition sets used to achieve specific TMP in cell filtration experiments. 
3.5.3 Separation of MEF Cells from Trypsin using Microfluidic Tangential 
Flow Filter 
Having established that trypsin could be at least partially removed by filtration, and that 
TMP could be controlled using glass capillaries of defined size, the recovery of mammalian 
cells was tested with the tangential flow microfluidic filter. Murine embryonic fibroblast 
(MEF) cells were used as a stand-in for mES cells due to the relative ease with which they 
could be cultured. The cells were detached from the surface of culture flasks using 0.25 mg 
ml-1 trypsin and the resulting suspensions were made up to 3 ml with FBS-free media.  
 
Figure 26: Illustration of setup used to test the separation of MEF cells from trypsin during passage. 
The suspension of dissociated cells was then divided into three samples; one to determine 
the initial concentration of trypsin and cell count, one to be passed through the filter, and a 
final sample to be centrifuged and resuspended as per the stand passage protocol. The filtration 
experiments were carried out using the condition sets defined in Table 8, with the cell 
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suspension being passed through the retentate side of the filter and FBS- and trypsin-free 
media being passed through the permeate side (see Figure 26). The performance of the 
filtration step was evaluated in terms of the amount of trypsin removed, the number of cells 
recovered and the effect on cell viability before and after filtration. 
 
Figure 27: Cell viability after filtration with tangential flow filter and centrifugation (n = 6, error bars 
indicate standard deviation) 
The effect of filtration on cell viability was determined to be negligible, regardless of the 
TMP used (see Figure 27). Cell suspensions were found to have 99-100% viability before and 
after filtration with no variation at TMPs of 10, 20 and 30 psi. Cell suspensions processed by 
the standard passage method had viabilities in the range of 98-99%, but the difference between 
this and the filtration samples was not significant. This indicated that the filtration process, in 
particular the shear that the cells would likely have been exposed to in the capillaries used for 
pressure control, was not damaging to the cells. 
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Figure 28: Percentage cell loss after filtration and centrifugation (n = 6, error bars are standard deviation) 
The cell loss, as a percentage of the number of cells in the initial samples, was in most 
cases significantly higher for filtration than it was for centrifugation (see Figure 28). At 10 psi 
almost 50% of the cells fed into the filter were not recovered, with around 30% lost at 20 psi. 
However at the highest operating TMP, 30 psi, only 8% of the cells entering the filter were 
lost.  
The loss of these cells could be attributed to their accumulation on the surface of the 
filtration membrane as the fluid passed through to the permeate side. Investigation of the 
membranes by staining with crystal violet after filtration showed large numbers of cells on the 
surface which would seem to confirm this (see Figure 29). This being the case, it might be 
expected that a higher TMP would correlate with a greater loss of cells through accumulation 
on the membrane surface, in which case the lowest cell loss encountered at 30 psi would seem 
to be counter-intuitive. However, to achieve a TMP of 30 psi the retentate had to be passed 
through the filter at a higher flow rate of 5 ml min-1 (see Table 8, Appendix A), which would 
generate a greater shear force at the membrane surface and reduce the accumulation of cells, 
thus reducing the overall cell loss. This illustrates the main drawback of using capillaries to 
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control fluid pressure; since a limited range of capillary diameters were available, higher flow 
rates had to be used to reach pressures above 20 psi, but in doing so additional variability was 
created between the condition sets, which made them less comparable. 
 
Figure 29: Analysis of the surface of two membranes after filtration of cell suspensions at 20 psi TMP. 
A, B and C and D, E and F are collections of three images taken from two different membranes. A and D 
show the area of the membrane immediately under the filter input, B and E show the area in the centre of 
the membrane and C and F show the area under the filter output. Scale bars are 100 μm in length. 
The amount of trypsin remaining in the samples was measured using the colourimetric 
method shown in Section C.1.3. Analysis of the cell suspension exiting the filter showed that 
the maximum clearance of trypsin was a 45% reduction from the original mass, achieved at a 
TMP of 10 psi (see Figure 30). At the highest TMP of 30 psi, where the transmission of trypsin 
would be expected to be highest, 85% of the original mass remained in the retentate. Again, 
this is likely due to the fact that the retentate flow rate had to be increased in order to reach a 
TMP of 30 psi, reducing the residence time of the cell suspension within the filter and therefore 
also reducing the efficiency of the transmission.  
The ability of the filtration unit to remove trypsin was very poor when compared to the 
standard centrifugation protocol; samples which had been centrifuged contained a maximum 
of 7% of the original amount of trypsin used to dissociate the cells, and in some cases the 
trypsin concentration was reduced below detectable levels. 
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Figure 30: Percentage of initial trypsin remaining after filtration and centrifugation (n = 6, error bars are 
standard deviation) 
3.5.4 Replating of MEF Cells after Filtration 
Although the filtration process tested in Section 3.5.3 was shown to have no significant 
effect on the viability of the cells, other effects such as contamination and phenotypic changes 
induced by shear stress could not be determined immediately after the recovery of the cell 
suspensions. Such effects only become apparent over several days, or weeks, through repeated 
passages. The filtered cell suspensions were therefore replated in fresh culture flasks to 
determine whether any of these effects became apparent. 
Suspensions of cells filtered at 20 psi were chosen to be replated, as these had relatively 
low concentrations of trypsin of the three condition sets tested and had high enough 
populations remaining after filtration to make confluency feasible. Two cell suspensions were 
at 20 psi as detailed in C.2.2, the retentate was collected, diluted with media containing FBS 
and then left in new culture flasks to reattach (see Figure 31C and D). These were compared 
with suspensions processed by the standard centrifugation protocol (see Figure 31A and B). 
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Cultures passaged using filtration had visibly lower concentrations of cells, and failed to 
reach confluency after 6 days of incubation with daily media exchange. The cultures did not 
show any signs of contamination, indicating that the PC components and the membrane itself 
were properly sterilised.  However, the cultures could not be sustained over more than one 
passage due to the very low cell concentration, meaning that any longer-term phenotypic 
effects of the filtration process could not be investigated. 
 
Figure 31: Culturing of cells recovered after centrifugation (A and B) and filtration (C and D).  
Cells recovered after filtration were unable to reach confluency after 5-6 days of culture. Scale bars are 20 
μm in length. 
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3.6 Summary of Findings 
This chapter has demonstrated the design of a microfluidic tangential flow filtration 
device. A microfluidic normal flow filter was developed as proof of concept device, to 
establish whether a membrane could reliably be sealed into PDMS. This design was 
abandoned after testing with the normal flow filter showed that the device became inoperable 
very quickly as a result of membrane fouling. Testing of the normal flow device for the 
recovery of mES cells from suspension after passage showed that the cells could be separated 
from the trypsin used to detach them, but not without significant cell loss due to impaction on 
the filter membrane and subsequent dilution when recovering the retentate. Tangential flow 
filtration was therefore chosen instead because of its improved resistance to fouling, as well 
as the additional flexibility it offered.  
The final device design was fabricated primarily in PC with a PDMS gasket, allowing 
filter membranes to be sealed into the device by clamping. This design was chosen over soft 
polymer designs due to the challenges involved in sealing membranes into PDMS by thermal 
compression bonding and the complexity of chemical bonding methods. The fabrication of 
the filter enclosure in 5 mm rigid polymer reduced the degree of deformity that occurred and 
facilitated clamp sealing. The seal was shown to be robust to bursting up to 100 psi for defined 
clamping screw torsions of 10 cN-m, with increasing torque causing deformation and reducing 
the ‘burst pressure’ of the device. 
The device was designed to be wholly reusable, with only the membrane being disposed 
of between applications. The use of polycarbonate as the hard polymer meant that it could be 
autoclaved for use in sterile applications if desired. It was also designed to be modular and 
intercompatible with other devices, such that single parts could be quickly redesigned or so 
that it could be integrated into a series of cascaded devices (see the application to biocatalytic 
synthesis in Chapter 4). 
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The membranes used were cut to size to fit within the PDMS gasket in order to achieve a 
good fluidic seal. This added a small amount of extra complexity to the setup of the filter, but 
was shown to be necessary after the failure of several filter devices which were designed to 
clamp over a larger piece of filter membrane. In these cases the lateral spread of fluid through 
the membrane allowed leakage out of the devices. 
Finally, the use of clamp sealing meant that the device could be used in conjunction with 
different membrane types, allowing its application to different downstream bioprocessing 
scenarios. The use of the device as part of a larger process could therefore be evaluated, 
working towards the investigation of a bioprocess at the microfluidic scale.  
The recovery of mammalian cells from a suspension containing the enzyme trypsin was 
investigated as an application of the filtration device. Although initial experiments indicated 
that trypsin could potentially be removed from cell suspensions by filtration as opposed to 
centrifugation, further investigation indicated that it would not be practical, at least not by the 
methods described in this chapter. Though filtration was shown to have no effect on the 
viability of the mES and MEF cells filtered, the loss of cells as a result of accumulation on the 
filtration membranes was generally very high, with up to half of the cells unrecovered. The 
concentrations of trypsin remaining in recovered cell suspensions were also too high, possibly 
as a result of the short residence time of the cell suspensions in the filter. 
Cell suspensions recovered from filtration at a TMP 20 psi were replated in an attempt to 
determine any adverse effects of the process on the cells that were not detectable immediately 
after sampling. Although this did show that the cells were not contaminated, the cell 
concentrations were too low for the cultures to be able to reach confluency, preventing them 
from being passaged more than once. Investigation into the use of the tangential flow filter for 
filtration of mammalian cell cultures was therefore abandoned. 
Work towards an alternative application of the filter is shown in Chapter 4, looking at the 
recovery of a small molecular product from a biocatalyst. However, since the device is clamp 
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sealed and is robust to high pressures, the use of a wider range of membranes and testing 
conditions is possible, meaning that it could be used to investigate other bioprocesses where 
membrane separation is a candidate for downstream processing. Candidate membranes would 
need to be cut to fit within the device however, and the device itself might require modification 
to accommodate different thicknesses of membrane and further burst pressure testing to 
validate the seal if higher pressures were required. 
4 – BIOCATALYTIC SYNTHESIS USING INLINE MICROFLUIDIC FILTRATION DEVICE 
96 
 
 
 
 
4  
Biocatalytic Synthesis Using Inline Microfluidic Filtration 
Device 
This chapter explores how the tangential filtration device developed in Chapter 3 could 
be used with an upstream biocatalytic reactor to produce and purify a chiral metabolite. The 
metabolite chosen as a test case for the work was L-erythrulose (ERY), a product of the 
reaction between glycolaldehyde (GA) and hydroxypyruvate (HPA) and catalysed by 
transketolase (TK) from E. coli cell lysate. 
Some of the results in this chapter were produced in collaboration with Homan Al-Bahrani 
and Dr Brian O’Sullivan. The data in Figure 32 and Figure 33 was produced in collaboration 
with Brian O’Sullivan and Homan Al-Bahrani. The reactor design (presented in Figure 34) 
was developed by Homam Al-Bahrani, based on a design by Stroock et al.; the data in Figure 
36 was produced in collaboration with Homam Al-Bahrani. 
The data in this chapter has been published in part in “Modular microfluidic reactor and 
inline filtration system for the biocatalytic synthesis of chiral metabolites”, by O’Sullivan et 
al. (2012). 
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4.1 Introduction 
There are many advantages associated with biocatalytic synthesis of chemical products, 
in particular the lower requirements in terms of temperature and pressure, and fewer protection 
or deprotection steps and side reactions as a result of the greater selectivity and specificity of 
biocatalysts. For these reasons biocatalysis is viewed as a more sustainable alternative to 
chemical catalysis, with many current and potential industrial applications, particularly in the 
production of metabolites and active pharmaceutical ingredients (Woodley, 2008; 
Wohlgemuth, 2010; Clouthier and Pelletier, 2012; Meyer et al., 2013). 
The properties of microfluidic systems have a number of useful benefits to biocatalytic 
synthesis, and especially for process development. These include improved heat and mass 
transfer for control of reaction conditions, as well as real-time monitoring and parallelisation 
for rapid optimisation of yield (Miyazaki and Maeda, 2006; Wiles and Watts, 2008; Mak et 
al., 2009). As a result, a number of microfluidic reactors have been reported for use with 
biocatalysts, including use of cellular and enzymatic catalysts; however relatively few have 
focussed on the need for downstream purification of the desired product, and particularly not 
on scalable methods of separation. 
When developing any biocatalysed synthesis process it is necessary to consider the 
purification of the product, especially the retention of the catalyst itself. In many reported 
cases the biocatalyst is immobilised inside the reactor, either by adherence to the channel walls 
or to another surface that is trapped inside the reactor (e.g. membrane, beads or monolith). 
While this eliminates the requirement for downstream separation (assuming that no leaching 
of the catalyst occurs), immobilisation can significantly reduce the activity of the biocatalyst 
through diffusional limitation or steric inhibition. It also increases the complexity of 
development, usually requiring that the biocatalyst be adapted for immobilisation, and can 
reduce the flexibility of reactors if the channel walls are used as the immobilisation surface. 
Solubilised enzymes can therefore provide more flexibility and simpler development of 
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reactor design, as well as an increased yield of active biocatalyst, though this comes at the cost 
of long-term stability. 
Solubilised enzymes require separation from the reaction product downstream of the 
reactor. Given the size difference between the biocatalyst (a cell or large molecular weight 
protein) and product (generally a small molecular weight chemical), membrane separation is 
feasible and commonly used in industry. The flexibility of the microfluidic filter design 
previously described in Chapter 3 means that it could be used in combination with a membrane 
with a suitable molecular weight cut-off, in order to retain the biocatalyst downstream of the 
reactor. In addition, the tangential flow design of the filter should reduce the rate of fouling of 
the membrane, a particular problem when dealing with solutions containing cells or cell debris. 
This could also allow the recovered biocatalyst to be recycled for further use in the reactor, 
depending on its stability. 
Similar microfluidic devices for biocatalysed reactions and membrane recovery of the 
product have been reported previously. Once such device was used for the separation of pectin 
hydrolases from pectin lyase. A microfluidic enzyme reactor was integrated with a regenerated 
cellulose membrane to create an in situ product recovery system, which was used to separate 
low molecular weight pectin hydrolysate product from higher molecular weight pectin 
fragments and the lyase enzyme (Alam et al., 2011). The configuration was suitable for this 
particular application as a relatively low residence time was required for the hydrolysis of the 
pectin, and because the unreacted substrate could be retained by the same membrane that was 
used to prevent the pectin lyase enzyme from leaching.  
Further devices have been developed which use membranes to immobilise enzymes in 
place either by chemical immobilisation on the membrane surface or physical trapping 
between two membranes with specific hydrophobicities to allow the enzyme to be retained 
without fouling (Zhang et al., 2010; Machsun et al., 2011). However, these devices either 
failed to achieve complete conversion of substrate to product or relied on relatively rapid 
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reaction rates which allowed complete conversion with a short residence time. This would not 
necessarily be applicable to biotransformations requiring longer residence times to go to 
completion or which used low molecular weight substrates, as unreacted substrate could 
potentially exit the reactor before being converted, therefore requiring further separation 
downstream. It may be possible to take the output from such a reactor and recycle it in order 
to achieve complete conversion; however this would likely require a further separation step to 
isolate the unreacted substrate from the product (Pohar et al., 2012). 
It would be therefore be advantageous to have a modular continuous reaction and filtration 
system that could be adapted to different reaction setups, allowing the reactions to go to 
completion before the catalyst is removed and thereby eliminating the need for further 
purification steps or substrate recycling. Such a system would also allow the separate testing 
and optimisation of upstream and downstream processing conditions before the two units were 
combined.  
This chapter will show the development and characterisation of such a system for the 
biocatalytic synthesis of ERY from hydroxypyruvate HPA and glycolaldehyde GA using a 
solubilized transketolase TK enzyme. This particular reaction was selected as it is a well-
characterised biotransformation which yields a single product and is driven to completion by 
the evolution of carbon dioxide as a by-product. Transketolases are attractive biocatalysts for 
asymmetric synthesis due to their wide substrate tolerance, ability to form carbon-carbon 
bonds with high enantioselectivity and high specificities (Hibbert et al., 2007, 2008; 
Charmantray et al., 2009; Liese et al., 2009; Cázares et al., 2010).  
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4.2 Synthesis of ERY in Microfluidic Reactor using Transketolase 
4.2.1 Determination of HPA and ERY concentrations by HPLC 
HPA and ERY were analysed by HPLC using an ion-exchange column and 0.1% TFA 
mobile phase. Measurement of UV absorbance at 210 nm under these conditions returned 
single peaks for HPA and ERY at 9-10 minutes and 11-12 minutes respectively. Calibration 
curves were established for the two species using pure standards (see Figure 32 and Figure 
33). The response factors for HPA and ERY were determined to be 526 mM Au-2 (R2 = 0.9935) 
and 667 mM Au-2 (R2 = 0.9797) respectively. The maximum concentration that could be 
accurately measured was 20 mM for both species. 
 
Figure 32: Calibration curve for HPA standards 
GA could not be detected with this method but, as the substrates were being used at 
equimolar concentrations, it was assumed that the concentration would be equivalent to that 
of HPA. 
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Figure 33: Calibration curve for ERY standards 
4.2.2 Design and Characterisation of SHM reactor 
The microfluidic reactor used to perform the TK-catalysed reactions was a modified 
version of Stroock’s staggered herringbone mixer (SHM), chosen to facilitate passive mixing 
of the enzyme and substrates entering the reactor through separate inlets (Stroock et al., 2002; 
Ansari and Kim, 2007). The structures were required to ensure rapid homogenisation of the 
enzyme and reactants in the absence of turbulent flow and thereby create a defined point at 
which the solution could be said to be well-mixed, for the purposes of accurately measuring 
the reaction residence time. This was necessary in order for the reactions performed in the 
SHM reactor to be comparable to those performed in the 96-well plates that are commonly 
used in batch mode for bioprocess evaluation, which are generally stirred to ensure 
homogenisation of the reaction mixtures. 
The channels of the reactor were arranged into a T-junction, each channel having a cross-
section of 500 x 250 µm (w x d), with a channel length of 89.5 mm between the junction to 
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the outlet (see Figure 34). The choice of a relatively large channel size was made to allow 
soluble enzymes to be used in the reactor without causing clogging that might occur in smaller 
geometries. The use of larger structures also meant that the reactor could be fabricated in with 
the same technology as the filter device, facilitating the potential later integration of the two 
devices. The SHM structure, consisting of 7 groups of 10 grooves with an alternating bias, 
was milled directly into the floor of the channel, starting one centimetre from the channel join. 
The sizes of the structures are shown in the inset of Figure 34. 
 
Figure 34: Design of staggered herringbone mixer (SHM) reactor. 
Given the size of the enzyme used (72 kDa), it was necessary to ensure that the SHM 
structures in the reactor were capable of homogenising a solution of small molecular weight 
substrates and large molecular weight proteins. To demonstrate the efficiency of the structures 
for this purpose, two T-channel reactors of identical size were fabricated, with and without the 
SHM structures. Two solutions were run through the inlets at various flow rates: reverse 
osmosis purified water and a 0.3 mg ml-1 solution of fluorescein-conjugated bovine serum 
albumin (BSA, 65 kDa). Confocal images were taken at 6 cm from the T-junction 
(downstream from the SHM structures, see Figure 35A) and a composite of the images was 
built to give a cross-section view of the intermingling of two solutions. 
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Figure 35: Imaging of mixing conditions in SHM using confocal microscopy. 
Setup of reactor for confocal imaging (A), vertical sections of channels (B - E). Sections taken in reactor 
with SHM (B and C) and without (D and E), at flow rates of 0.03 ml min-1 (B and D) and 3 ml min-1 (C and 
E). 
At higher flow rates (3 ml min-1, Figure 35C and E), distinct separation of the labelled and 
non-labelled fluid streams was observed in the non-SHM channel, while the streams in the 
SHM channel appeared to be well mixed. At lower flow rates (0.03 ml min-1, Figure 35B and 
D) the two streams appeared to be well mixed in both reactors, regardless of the presence or 
absence of SHM structures, presumably since the residence times at this point in the channel 
are long enough to allow diffusion of the protein across the channel width. At this flow rate 
and with a mass diffusion coefficient of 6.8 × 10-7 cm² s-1 (equivalent to that of BSA in aqueous 
solution; Wojcieszyn et al. 1981), the Péclet number is 294,000 (see below). This value is 
typical for the small channel dimensions used in microfluidic reactors. 
 
𝑃𝑒 =
𝑢𝐿
𝐷
=
0.4𝑐𝑚 ∙ 𝑠−1 × 0.05𝑐𝑚
6.8 × 10−7𝑐𝑚2 ∙ 𝑠−1
= 29,400 (12) 
   
These results suggested that the SHM structures were unnecessary where low flow rates 
were used, as diffusion was the predominant method of transport and appeared to occur at a 
sufficient rate to allow the enzyme to spread across the width of the reactor. However, ensuring 
that the input streams were well mixed regardless of the flow rate was essential in order that 
the reactor could be used for a range of residence times, for evaluation of reaction kinetics and 
for compatibility with more rapid reactions. It was also necessary to be able to define where 
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the streams would be homogenous, regardless of the flow rate used, in order to be able to 
accurately control the concentrations of each component and define the starting point of the 
reaction for the purpose of measuring the residence time of the reaction. 
4.2.3 Kinetics of Transketolase-Catalysed Synthesis of ERY 
The kinetics of the transketolase-catalysed conversion of HPA and GA to ERY were 
investigated in the SHM reactor and compared to batch reactions carried out in 96-well plates. 
The residence time of reactions performed in the SHM reactor were controlled by adjusting 
the flow rate, where the residence volume was defined by the combined volume of the reactor 
channel and the outlet tubing. The reaction endpoint was defined by the collecting samples 
from the outlet tubing in a vial containing 0.1% TFA, which inactivated the enzyme. Placing 
the end of the outlet tubing into the TFA solution ensured that the reaction was quenched 
immediately after exiting the tubing, so that the residence time could be precisely defined. 
Batch reactions were controlled in a similar manner, by diluting samples of the reaction 
mixture in defined volumes of TFA at the specified end point. Reaction residence times in the 
range of 1 to 180 minutes were evaluated and were controlled in the SHM by adjusting the 
flow rate in the range of 0.07 – 12 µl min-1.  
The reaction kinetics showed that complete conversion of 50 mM HPA and GA to ERY, 
in both the SHM reactor and 96-well plate, occurred in 120 minutes (see Figure 36). This is 
in agreement with previous work by Matosevic et al. (Matosevic et al., 2010). The evolution 
of CO2 as a by-product allows the reaction to go to completion, although no gas bubbles were 
observed in the reactor, possibly because the concentration (and therefore partial pressure) 
was too low for evaporation to occur in the sealed channels.  
The reaction profiles in both the batch-mode 96-well plate and the continuous-flow SHM 
reactor were reproducible and comparable, showing similar concentrations of HPA and ERY 
at each time point. The enantiomeric excess (e.e.) values of the ERY produced were also 
similar, measured at 90% and 87% L-ERY for the batch and SHM reactors respectively. This 
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might be expected given that the chemical interaction is the same in both systems, though it 
was necessary to rule out any variability in the reaction profiles brought about by clogging of 
the SHM reactor, which could have increased the apparent reaction rate by increasing the 
reaction residence time beyond its intended value. 
The use of clarified lysate containing biocatalyst, rather than immobilised enzymes, can 
be problematic in the small channel geometries that are common to microfluidics. However, 
the larger cross-sectional area channels used in the reactor were able to accommodate the 
lysate without clogging. The reactor could therefore be used for early process evaluation 
where testing with a number of different enzymes is necessary and therefore the requirement 
to immobilise would be a disadvantage. 
 
Figure 36: Kinetics of transketolase-catalysed synthesis of ERY, performed in microwell plates and SHM 
reactor (n = 6, error bars indicate standard deviation). 
As the reaction data was comparable, it is worthwhile examining whether the reactor could 
be considered as a viable alternative to 96-well plates, for the purpose of evaluating synthesis 
processes using biocatalysts. Multi-well plates have the advantage of being able to perform a 
large number of different reaction conditions simultaneously, something that is not possible 
in a single SHM reactor. Increased experimental throughput could of course be achieved by 
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‘numbering up,’ though running an equivalent number of reactions in parallel in SHM reactors 
would likely be impractical at this scale. Being a continuous flow reactor however, it may be 
more suitable for use in scale-down evaluations of continuous synthesis bioprocesses, as this 
is increasingly the preferred option in industry due to the advantages that continuous processes 
offer in terms of improved process efficiency and the conversion of unstable intermediates  
using multi-step synthesis processes (Yoshida et al., 2013). 
The continuous flow reactor provides the additional possibility of a step towards small-
scale industrial production. At the conditions required for 100% conversion (i.e. with a 120 
minute residence time) the reactor produced 50 mM ERY at a rate of 10 µl min-1, or 3.6 mg h-
1. This may be too low for an industrial process, but could be relatively easily increased by 
scaling or numbering up the reactor, or a combination of the two. Given the size of the channel 
geometry it may even be possible to include several parallel channels on a single chip. This 
possibility has already been explored by for industrial chemical synthesis of monoammonium 
phosphate, where 100 microreactors were combined into a single parallel reaction system with 
a process capacity of 100 kilotonnes per annum (Chen et al., 2011 b). Assuming continuous 
production, this equates to the production of 114g of monoammonium phosphate per reactor, 
per hour. This is several orders of magnitude greater than the output both of the SHM reactor 
shown above and the majority of biocatalytic reactors in current literature. Given the 
advantages of microfluidic systems for chemical reaction control, it is feasible that such 
systems could also be applied to biochemical synthesis; however the limitations on reactor 
output, imposed primarily by enzymatic inhibition at high substrate and product 
concentrations, would need to be addressed.  
4.3 Filtration of SHM Reactor Output 
The filtration device described in Chapter 3 offers a number of possibilities for the 
investigation of downstream processing conditions. The purification of the output of the 
reactor described in the previous section, in order to separate the synthesised ERY from the 
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crude lysate containing TK, was chosen as a test case for the filtration device, to determine 
whether it could be used to establish a set of operating conditions for the purification.  
One of the advantages of continuous flow synthesis is that it offers the possibility of 
performing several reaction steps in a single network of reactors, linking the output from one 
reaction to the input of the next, such as those that have been exploited for chemical synthesis 
applications (Sahoo et al., 2007). It also makes possible the use of unstable intermediates, 
which can be synthesised continuously and converted to more stable products before 
degradation occurs, something that is more difficult to achieve in batch processes (Yoshida et 
al., 2013). However, if we wish to connect reactor modules in series for a multi-step reaction, 
it is desirable to have a purification step for the product of the first reactor before it enters the 
next one, such that the reactors can operate independently of one another at their own optimal 
conditions. This provides a further potential use for the filtration device. 
4.3.1 Control of Back Pressure using Capillaries 
Control of back pressure on the retentate output of the microfluidic filter was required to 
regulate the flux of fluid across the filtration membrane and separate the ERY synthesised in 
the reactor from the TK lysate catalyst. This was achieved by the attachment of capillaries of 
specific length and diameter to the retentate outlet of the tangential-flow filter (see Figure 
37A).  
 
Figure 37: Schematic of setup of microfluidic tangential flow filter for back pressure measurement (A) and 
equivalent hydraulic resistive network (B). 
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In the schematic illustrated above, the blue line in Figure 37A indicates the hypothetical 
path of fluid through filtration device. The numbered sections correspond to the following 
resistances: 
[1]  the resistance of inlet tubing and port, 
[2]  the resistance of retentate channel up to point at which fluid crosses membrane, 
[3]  the resistance of membrane itself,  
[4]  the resistance of permeate channel from point at which fluid crosses membrane to 
permeate outlet,  
[5]  the resistance of permeate outlet port and tubing, 
[6]  the resistance of the retentate channel from point at which fluid crosses membrane to 
the retentate outlet, 
[7]  the resistance of the retentate outlet port and tubing,  
[8]  the resistance of the capillary used to apply pressure to retentate channel. 
In this context, ‘back pressure’ indicates the resistance to flow created by the capillary at 
point 8. The resistance at this point and at point 3, where the fluid crosses the membrane, will 
be the most dominant over flow through the device. As long as the resistance caused by the 
capillary at point 8 remains higher than that of the membrane at point 3, fluid will cross the 
membrane into the permeate. However, as filtration progresses, the resistance at point 3 will 
increase due to the build-up of material on the membrane. 
The Hagen-Poiseuille equation was used to identify the length and diameter of capillaries 
that would be required to generate back pressures in the range of 5 – 30 psi in the retentate 
channel at the operating flow rate of the SHM reactor. Capillaries with lengths of 30 cm and 
internal diameters of 50, 75, 100 and 200 μm (Upchurch) were identified as being able to 
generate the desired range of back pressures. These were connected to the output of the 
retentate channel and purified water was run through both the retentate and permeate channels 
at various flow rates. The back pressure on the retentate flow was measured using a pressure 
transducer (Honeywell, NJ, USA) with a LabVIEW virtual instrument (National Instruments, 
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TX, USA) that recorded the voltage output from the transducer and converted it into a pressure 
value (Figure 38A). The virtual instrument code is shown in Appendix A. 
 
Figure 38: Control of back pressure in filter with capillaries of fixed diameter. 
(A) Illustration of setup used to measure back pressure on retentate side of filter; (B) effect of capillary 
diameter and flow rate on recorded back pressure. 
The flow rates tested were in the range of 10 - 30 μl min-1, at the higher end of the range 
of flow rates used in the SHM reactor. Using the above capillary diameters the pressures 
generated were in the range of 1 - 15 psi (Figure 38B), lower than those predicted by the 
Hagen-Poiseuille equation. The calculation did not take account of capillary forces, which 
may have reduced the pressure drop across the capillaries tested.  
The path of least resistance will initially be closest to retenate inlet; however this will only 
remain so whilst membrane is unfouled. As filtration progresses and that area of membrane 
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becomes fouled, the path of least resistance will move along membrane to unfouled areas until 
the entire membrane is fouled and the resistance exceeds that of the capillary. To balance flow 
across membrane at all points would require an increase in the overall resistance to flow at 
closest point of membrane to the retentate inlet a reduction at furthest point from the inlet. 
This could be achieved by modification of permeate side channel to constrict the channel 
dimensions and increase resistance to flow closest to retentate inlet. A slope could be 
introduced to the floor of permeate side channel, with the narrowest point nearest the retentate 
inlet and the widest point near to the retentate outlet, as well as moving the permeate outlet to 
the opposite end of the channel. This would serve top increases the overall resistance to flow 
across the membrane at one end and reduce it at the other, evening out the total resistance and 
therefore the flux across membrane at all points. 
Overall, control of back pressure with capillaries was found to be more reproducible than 
with commercially available micro-metering valves, with the added advantages of being 
considerably cheaper, and having no moving parts, but at the expense of being able to adjust 
the back pressure to maintain a constant flux throughout the filtration process.  
4.3.2 Filtration Experiments with Model Reactor Output 
The ability of the tangential flow filter to purify a solution of enzyme and product was 
investigated using solutions containing ERY and lysate at the same concentrations as the 
expected output from the reactor. These solutions were flowed through the retentate of the 
filter under different flow rates and with different diameters of capillary attached to the 
retentate outlet.  
SDS-PAGE studies from a representative selection of flow conditions confirmed that a 
regenerated cellulose membrane with 10 kDa molecular weight cut-off was sufficient to 
ensure the full retention of transketolase along with all other protein in the lysate (Figure 39). 
Similar concentrations of ERY were found in the permeate and retentate solutions (as 
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measured by HPLC), indicating that the compound was able to permeate the membrane freely, 
without adsorption or other interactions. 
 
Figure 39: SDS-PAGE showing protein present in reaction mixture before filtration (Pre), and in the 
retentate (R) and permeate (P) after filtration 
The ultimate aim of the filtration step was to maximise the fluid flux across the membrane, 
and therefore the amount of ERY recovered. To investigate this, 30 cm capillaries with internal 
diameters of 100 μm, 75 μm and 50 μm were connected to the retentate outlet, allowing the 
evaluation of recovery under different back pressures, and the permeate and retentate volume 
outputs were measured under various flow conditions (Table 3).  
Flow rate \ μl min-1 10 20 30 
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50 
% Permeate 
(Pressure \ psi) 
89 
(5.3) 
56 
(14) 
67 
(20) 
75 
% Permeate 
(Pressure \ psi) 
85 
(5.3) 
41 
(10) 
36 
(15) 
100 
% Permeate 
(Pressure \ psi) 
31 
(2.7) 
24 
(4.6) 
25 
(6.9) 
Table 3: Comparison of permeate volumetric output as a percentage of the total filter output, and the back 
pressures generated, under various conditions of capillary diameter and flow rate. 
Figures in italics represent the amount of fluid recovered in the permeate as a percentage of the output 
from both outlets. Figures in brackets are the back pressures measured at the retentate outlet for each 
flow condition (n = 6). 
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As expected, the yield was increased as the internal diameter of the capillaries used was 
decreased. However, increasing the flow rate from 10 to 30 µl min-1 tended to decrease the 
permeate yield for any given capillary, despite the corresponding increase in back pressure. 
Of the condition sets investigated, the best conditions for maximum product recovery were 
found to be a capillary diameter of 50 μm and an operating flow rate of 10 µl min-1, resulting 
in a back pressure of 5.3 psi (Table 3), which gave a permeate yield of 89%. This also meant 
that the tangential flow filter could be connected directly to the output of the SHM reactor, as 
the flow rate at the outlet of the reactor was 10 µl min-1. 
With regards to the effect of increasing flow rate on the permeate yield, it is possible that, 
by further increasing the flow rate and hence the pressure on the retentate, the system was 
being pushed past the critical flux. Beyond this point the effects of inertial lift caused by the 
tangential flow would be cancelled out by the increasing concentration polarization of protein 
and cellular debris towards the membrane (Field et al., 1995). This would lead to more rapid 
fouling of the membrane and a therefore a reduced fluid flux, despite the increased pressure. 
However, further investigation of the operational space around the established optimum would 
be required in order to characterise the change in the rate of flux that would accompany the 
passing of the critical flux point. 
4.3.3 Integration of SHM Reactor with Microfluidic Tangential Flow Filter 
In order to demonstrate that the two devices could be used for continuous synthesis and 
purification of ERY, the output of the SHM reactor was connected in series with the filtration 
unit and run for 10 hours (Figure 40A). Conditions had been optimised for the complete 
conversion to ERY, with GA and HPA concentrations of 50 mM, 0.34 mg mL-1 TK and a 
residence time of 120 minutes. The conditions were also optimised for the best recovery of 
ERY from the reactor output, using a 10 μl min-1 flow rate and a 50 μm diameter capillary 
fitted to the retentate outlet to maximise the permeate yield (see Section 4.3.2). A 236 cm 
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length of tubing was used to connect the two devices in order to extend the residence time of 
the reaction to 120 minutes while operating at the higher flow rate. 
HPLC analysis showed that complete conversion of the GA and HPA to ERY occurred 
throughout the experiment – there was no loss of activity of the TK over the ten hours that the 
reactor was running. The yield of ERY recovery was therefore entirely dependent on the 
partition of fluid between the permeate and retentate. It was found  that the permeate output 
was stable at almost 100% for two hours (once the remaining tris required for the priming of 
the system had been flushed out), after which it declined sharply, presumably due to build-up 
of cell debris on surface of membrane, reducing the permeability and therefore the flux (Figure 
40B). After 7 hours, the filtration unit was back-washed with purified water in an attempt to 
remove this material, and the permeate yield was temporarily restored to 70-80%. 
 
Figure 40: Showing the setup (A) and results from (B) the continuous flow TK-catalysed reaction with 
filter separation. 
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The long-term performance of the filter could be improved in several ways. Modifying 
the reaction conditions to reduce the residence time (for example, by increasing TK 
concentration) would also reduce the amount of time required to prime (and equilibrate) the 
system, thereby reducing the material lost during this stage of the process. Further 
investigation of the optimum filtration flow rate and back pressure to reduce the rate of fouling 
would also allow the filter to operate for longer, though possibly at the cost of the rate of 
product transmission. 
The filter itself could also be modified to improve the surface area available for product 
transmission, for example by widening the filtration channel and incorporating flow splitter 
structures to ensure that the fluid is spread evenly over the surface area (Schoenmakers et al., 
2010; Vangelooven et al., 2010). Finally, the back-washing process could be incorporated into 
the system and automated with the help of electronically-actuated valves and pumps to reduce 
the build-up of cellular debris on the membrane surface. 
4.4 Summary of Findings 
This chapter has demonstrated the use of a modular microfluidic reactor in combination 
with the developed microfluidic tangential flow filtration unit for the transketolase-catalysed 
synthesis of ERY and subsequent separation of the biocatalyst from the product. The two 
devices were initially used separately to identify the optimal conditions for conversion and 
separation, which were a 120 minute residence time and filtration back pressure of 5.3 psi 
(achieved with a flow rate of 10 μL min-1 and a 50 μm capillary attached to the retentate outlet). 
Under these conditions, complete conversion of HPA and GA to ERY was achieved in the 
reactor and a maximum yield of ERY of 89% was achieved in the filtration unit. 
The reaction profiles generated in the continuous flow reactor were found to be 
comparable to those performed in batch 96-well plates, indicating that it could be used for the 
investigation and development of other continuous flow biocatalytic processes at the 
microfluidic scale. A commercially-available 10 kDa MWCO was used in the filtration unit 
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and was able to fully retain the crude lysate used to catalyse the reaction, whilst allowing the 
product to permeate freely. The successful integration and testing of different filtration 
conditions with this membrane suggests that the unit could be used in the scale-down testing 
other membranes as part of the evaluation of other bioprocesses. 
The two devices were integrated for the continuous synthesis and purification of ERY 
over a ten-hour period, achieving complete conversion of GA and HPA to ERY and full 
retention of the crude lysate biocatalyst throughout the operation. An average product yield of 
approximately 63% was achieved from the permeate outlet over this period, with a maximal 
yield of 100% for the first hour after equilibration.  
The successful integration of an initial downstream separation step into continuous flow 
synthesis at the microfluidic scale could also provide opportunities for the cascading of 
additional purification or reaction steps to generate more complex, high-value products. In the 
latter case, the ability to generate a pure stream of product from one reactor is particularly 
important to prevent any undesirable side reactions and to allow each reaction step to operate 
at with its own ideal condition set (Wohlgemuth, 2009). The additional devices could also 
include online analysis tools, to facilitate more rapid feedback on changes to operating 
conditions and therefore accelerate the optimisation of bioprocesses (DeMello, 2006; 
Whitesides, 2006), the ultimate aim being a system of devices that can be brought together for 
the rapid development of whole biocatalysed processes at the micro scale. 
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5 
Microfluidic Multi-Input Reactor for Biocatalytic Synthesis 
This chapter shows the development of a microfluidic multi-input reactor (MIR), designed 
to mimic fed-batch processes in a continuous flow reactor, in order to improve yields from a 
substrate inhibited biocatalytic reaction. The reaction chosen to as a test case for the work was 
the synthesis of L-erythrulose (ERY) from hydroxypyruvate (HPA) and glycolaldehyde (GA), 
using E. coli cell lysates containing a transketolase (TK) enzyme. 
The data in this chapter has been published in part in “Microfluidic multi-input reactor for 
biocatalytic synthesis using transketolase”, by Lawrence et al. (Lawrence et al., 2013). 
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5.1 Introduction 
Chemical synthesis using biocatalysts in microreactors has a number of advantages, as 
discussed in Section 1.2 and Chapter 4. However, unlike their chemical counterparts, 
microreactors using biocatalysts have for the most part been used to produce only very low 
concentrations of product, in the range of nM – mM. Whilst this may be suitable for the 
investigation of reaction kinetics, it would be advantageous to be able to produce higher 
concentrations of product for the purposes of chemical synthesis. 
In a typical microreactor consisting of a microchannel with two (or more) inputs at one 
end of the channel, the substrate concentration is defined at a single point (the input) and 
cannot be supplemented further. In such reactor designs, a higher concentration of product is 
obtained by increasing the concentration of substrate at the input. This poses a fundamental 
challenge for flow-based biocatalytic synthesis, as the effects of increased substrate 
concentrations, such as substrate inhibition and enzyme denaturation, set limits on the amount 
of substrate that can be added at a single point and therefore the concentration of product that 
can be synthesised.  
Fed-batch reactors are a well-established solution to this problem, having been used to 
gradually feed substrate in order to maintain reaction rate and achieve a higher yield of product 
without exposing the biocatalyst to concentrations that are inhibitive. Miniaturised versions 
of fed-batch reactors have been demonstrated for this purpose (Weuster-Botz et al., 2005; 
Funke et al., 2010) though there has been no example of a similar principle operated in 
continuous-flow mode. 
Microreactor systems that allow the injection of substrates at multiple points have been 
demonstrated for the purpose of controlling chemical reactions. These systems were designed 
for the continuous synthesis of allylcarbinol and of organometallic compounds, using multi-
point feeding to control the formation of impurities and the generation of heat respectively 
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(Barthe et al., 2008; Roberge et al., 2008 a; Cervera-Padrell et al., 2012). However, such 
systems have not been applied to the problem of substrate inhibition in biocatalytic reactions. 
Continuous-flow microreactors, designed to allow the recycling of unconverted 
substrates, have previously been demonstrated for biocatalytic synthesis (Alam et al., 2011; 
Tudorache et al., 2011). It is possible to use these reactors to gradually feed substrate and 
avoid inhibitory effects; however the continuous injection of substrate into the recycling loop 
at a single point means that complete conversion to pure product is fundamentally difficult to 
achieve. These reactors also use in situ removal to recover the product, requiring that the 
biocatalyst is either immobilised or removed by an in-line separation system, with the latter 
option necessitating a more complex reactor design. 
In the case of the TK-catalysed synthesis of ERY, an increase in reaction rate and yield 
with increased HPA and GA input has been observed up to concentrations of 300 mM GA; 
however it has previously been shown that GA concentrations of 500 mM GA cause a 
significant reduction in the activity half-life of TK, to 200 minutes as compared with 400 
minutes for a concentration of 250 mM (Chen et al., 2007 a). In addition, from observations 
when performing microfluidic reactions with GA concentrations of 500 mM, visual inspection 
of the reactor has shown that denaturation occurs at the boundary layer where the enzyme and 
substrate meet, causing a build-up of solid material and clogging the reactor channel. This is 
in spite of the use of relatively large channel geometries (w x h, 500 x 250 µm). This severely 
impaired the functionality of the reactor, halting the flow before it had time to equilibrate. 
This chapter explores whether feeding strategies such as those used in fed-batch processes 
could be mimicked in the design of a continuous-flow microfluidic reactor. The concept is 
illustrated in Figure 41. A prospective microfluidic reactor for this purpose would need a 
primary input (or inputs) for the reaction mixture containing the enzyme and non-inhibiting 
substrate, plus small amount of inhibiting substrate to start reaction (at t = 0 in Figure 41). In 
equivalent fed-batch system the non-inhibiting substrate and enzyme would be present in the 
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reactor already, and a small amount of inhibiting substrate would be added through a separate 
input to initiate the reaction. As the reaction proceeded, the amount of inhibiting substrate 
present would decrease as it was consumed (t = 1, 2), until it needed to be replenished to 
maintain the reaction rate at a reasonable level. In a fed-batch system this would involve 
dosing more of the substrate into the reactor through the same input, but in the microfluidic 
reactor this would require an entirely separate ‘auxiliary’ input, connected to the main channel, 
to feed a continuous supply of the substrate into the reaction mixture at the desired residence 
time (t = 3). By including multiple auxiliary inputs in the microfluidic reactor it should be 
possible to perform further gradual addition of inhibiting substrate to the reaction mixture over 
time, sustaining the reaction without allowing the concentration to reach a detrimental level, 
in the same way as a fed-batch process (t = 4, 5, 6). 
This chapter will show the development of the concept described into a microfluidic multi-
input reactor and its application to the transketolase-catalysed reaction described in chapter 4, 
in an attempt to overcome the limitations of substrate inhibition at high substrate 
concentrations and intensify the production of ERY at the microfluidic scale. 
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Figure 41: Illustration of the conceptual design of a continuous-flow microreactor (left) to mimic a fed-
batch process (right). 
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5.2 Reactor Design and Characterisation 
5.2.1 Reactor Design 
The motivation behind the design of the multi-input reactor was the desire for a device 
that could be easily reconfigured to suit different feeding strategies for biocatalytic reactions 
requiring multiple substrate inputs to avoid inhibitory effects. The design therefore needed to 
provide a large enough channel volume that long residence times could be tested, multiple 
ports that could be sealed off when not required, as well as a cross-sectional area that was 
suitable to avoid clogging by dissolved cell lysate. The design also needed to be able to operate 
leak-free over long periods of time, and ideally could be fabricated quickly. 
The chosen reactor design was a single channel with a Y-junction at the top and multiple 
side-feeding ports along its length, such that substrate could be fed into the reaction mixture 
at several points as it progressed down the channel. The design consisted of one main channel 
with a total volume of 1650 µL, fabricated in PMMA, with two primary inputs at the front end 
of the channel where the biocatalyst and substrate could be combined to start the reaction 
(Figure 42A). Ten further auxiliary inputs were spaced evenly along the channel, for the 
feeding of additional substrate, along with a priming port that was located 3 cm from the Y-
junction. The inputs and priming port were designed for standard M6 fittings, facilitating the 
easy reconfiguration of the reactor as well as the potential to integrate it into the devices shown 
in Chapters 3 and 4.  
To allow the substrate inputs to be reconfigured for the testing of different reaction 
conditions, PDMS plugs were also designed that could be inserted into the ends of standard 
interconnect plugs, allowing any unused inputs to be reliably and reversibly sealed by 
screwing the plugs into place. In this way the reactor could easily be configured to test a range 
of different feeding strategies, sealing off certain inputs where required.  
The reactor was designed with a relatively large total volume to allow the use of long 
residence times, such that conversion of large amounts of substrate would be possible. At the 
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same time, to allow it to be fabricated quickly on the available laser ablation system and make 
it more widely usable with other laser cutting systems, the maximum outer dimensions of the 
reactor were constrained at 85 x 85 mm. The reactor was therefore divided over three layers 
of PMMA, with the main reaction channel and inlets being divided over the base and middle 
layers and the top layer serving to seal the reactor and provide fluidic connections. The main 
channel was comprised of 55 individual sections, each 60 mm long with a cross section of 1 
x 0.5 mm. These sections were arranged in an alternating ‘zig-zag’ from one side of the reactor 
to the other, reducing the overall footprint of the reactor to 85 x 84 mm. A priming port was 
added to the first section of channel, 20 mm downstream from the Y-junction, which had the 
same standard fitting as the other ports and could be sealed with the use of a PDMS plug 
described above. 
The sections of channel in middle layer (labelled in yellow in Figure 42) were aligned 1° 
degree from the horizontal and channels on the base layer (labelled in red) were aligned 179° 
degrees from the horizontal. These angles were chosen such that the spacing between 
alternating ends of the channel sections were 2 mm, leaving a 1 mm radius of intact PMMA 
around each section to form a seal with the layer above it during bonding. Through-holes were 
ablated into either end of the channels in the middle layer such that, when the layers were 
bonded together, they aligned to join individual channels on the different layers into a single 
continuous channel. The alignment of the three layers for bonding was therefore very 
important, and was ensured by placing steel dowel pins into 1.6 mm though-holes fabricated 
into each layer (Figure 42B).  
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Figure 42: Design of multi-input reactor. 
(A) Design of individual layers showing size of large features (grey areas indicate ablated channels, black 
lines indicate cuts through the substrate); (B) zoomed view of mid layer showing distance between 
channels; (C) exploded view of layers of reactor; (D) zoomed view of intersection between main channel 
and auxiliary input; (E) photograph of assembled reactor with multiple dye colours. All units in mm. 
For simplicity of design, the fluidic connections for the auxiliary input ports were joined 
to the main channel laterally, with the two streams coming into contact at the point that the 
fluid ascends or descends between the layers of the reactor (Figure 42D). The interconnects 
were offset from the main channel by 7 mm to allow the physical connection of the 
interconnect blocks whilst minimising the dead volume to be cleared when equilibrating the 
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reactor, as well as the overall footprint. The offset also means that the structure of the main 
channel could be changed, for example to adjust the residence volume between individual 
ports, without the need to modify the port layout.  
Laser ablation was chosen to fabricate because of the rapidity with which it can be used 
to create features in PMMA. Using the laser, it was possible to fabricate the features of the 
middle layer in less than 6 minutes and to complete all three layers of the reactor in around 15 
minutes. Given the number of channels and other features involved, fabricating the same 
design using a micro milling machine, another commonly used tool for rapid fabrication, 
would have taken a few days. Profilometry of the surface of the channel showed the mean 
roughness RZ to be 6.8µm, a similar value to that shown in previously-published work 
describing the roughness of channels fabricated in PMMA by laser ablation (Klank et al., 
2002). 
The rapidity of fabrication combined with the low cost of PMMA made the reactors quite 
inexpensive to produce, meaning that it could easily be disposed of and replaced at the end of 
their useful life. Furthermore, the increasing availability of laser ablation technology and, in 
particular, the range of sizes of systems, means that the reactor could be reproduced easily and 
could be scaled up by simple modifications to the design and by use of a larger laser ablation 
system. This would then allow bench-top or even pilot scale production using fed-batch 
methodology in continuous-flow mode, which is of interest to the chemical and biochemical 
industries due to the opportunities for process intensification and the use of valuable but 
unstable intermediates (Roberge et al., 2008 b; Yoshida et al., 2013). 
5.2.2 Distribution of Substrate from Auxiliary Inputs  
Confocal imaging was used to analyse the rate of diffusion of substrate fed at the auxiliary 
inputs into the main reaction mixture. A microfluidic chip was designed specifically for this 
purpose, mimicking the structure of a single auxiliary input and channel section in the MIR, 
with some modification to accommodate confocal imaging (Section 2.5.2, Figure 9). The chip 
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was fabricated primarily in PMMA except for the top plate which was an adhesive-free 
microwell plate sealing film, used to facilitate the transmission of light from the interior of the 
channel. Fluorescein was used as an analogue for GA to allow the dispersion to be imaged. 
The flow regime within the main reactor channel was determined to be laminar, with a 
Reynolds number of 2.2 × 10-4 at a flow rate of 10 µl min-1 (calculated using the viscosity and 
density of water). This was confirmed experimentally by confocal imaging using the setup 
described above, determining the diffusion of fluorescein into water downstream of a junction 
between an auxiliary input and the main channel, where the dye fed though the auxiliary was 
shown to form a lamina over the bulk fluid in the channel (see Figure 43). 
 
Figure 43: Cross-sectional images of diffusion in MIR channels taken with confocal microscopy. 
Images of diffusion of fluorescein dye in channels taken at a range of residence times: (A) 1.4; (B) 2.8; (C) 
14.8; (D) 29.6; (E) 45.0 and (F) 60.0 seconds. 
The confocal images show that the solution fed into the auxiliary input was initially 
deflected to the outer edges of the main channel by the faster-flowing fluid from the primary 
inputs (Figure 43A and B). However, despite the laminar regime and the absence of mixing 
structures, the dye in the auxiliary solution began to diffuse into the bulk fluid quite rapidly, 
and the two solutions appeared to be homogenous within 45 seconds of being combined at the 
channel join (Figure 43C to F). This is in agreement with the calculation of the diffusional 
length of the tracer in the channel, which predicts that it will have propagated 0.39 mm across 
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the channel depth in one minute, where the diffusion coefficient of fluorescein in water is 0.64 
× 10-9 m2 s-1 (Galambos and Forster, 1998). 
The maximum flow rate used in any of the synthesis experiments performed with the MIR 
(see Table 5, Section 5.3) is 14.4 µl min-1, which is the combined flow rate of the primary and 
auxiliary inputs used for the conversion of 200 mM HPA. Even at this flow rate, 45 seconds 
corresponds to less than half of the residence time of a single section of the main reactor 
channel. Given that the molecular weight of fluorescein is five times as large as that of GA 
(332 g mol-1 and 60.1 g mol-1 respectively), it is expected that the GA fed will be well-
distributed into the reaction mixture within a similar amount of time. 
The distribution of substrate from the auxiliary inputs across the main channel could be 
improved by the inclusion of herringbone or similar structures on the channel floor, as in the 
microreactor shown in Chapter 4. Laser ablation would not be a suitable fabrication method 
in this case as the size of the herringbone structures would be below minimum achievable 
feature size; however hot embossing could be used instead. A positive of the existing channel 
structure with additional grooves in the base of the channels near the auxiliary inputs could be 
micromilled and used to create the channel structures in PMMA. Although the machining of 
the positives for each layer would be quite time-consuming, once they had been produced the 
time required to fabricate each device would probably not be much different to that of the 
existing laser ablation process. Herringbone grooves could also be embossed on to the 
undersides of the layers above each channel, creating a parallel set of herringbone grooves 
adjacent to each auxiliary input. This would create more lamination between the two fluids 
and reduce the time required to distribute the substrate across the channel even further. 
5.2.3 Flow of Substrate at Auxiliary Inputs 
To minimise the dilution of the product, the setup for the synthesis of ERY required that 
GA be fed into the reactor at high concentration but at a much lower flow rate compared to 
that of the reaction mixture. The feeding of substrate along the auxiliary channel itself was 
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therefore also evaluated with confocal microscopy in order to ensure there was no backflow 
of reaction mixture or GA out of the auxiliary ports. In this case the fluorescein solution was 
flowed through the primary input and water was flowed into the auxiliary input of the chip 
described in the previous section. The join between the channels was imaged across both 
layers while fluorescein solution and water were flowed into the chip in a 20:1 ratio, at 3.3 µl 
min-1 and 0.17 µl min-1 respectively. A control image was taken with static fluorescein solution 
in the main channel and the auxiliary input.  
The control images (Figure 44A and C) clearly show the structure of the channel join. A 
column of fluid is visible on the right side of the images which links the channels on the top 
and base layers. The auxiliary input channel is shown on the left side of the images. Under 
flow conditions (Figure 44B and D), no fluorescein is visible in the input channel, indicating 
that there was no backflow from the main channel. Given that the images were taken whilst 
operating at around half of the minimum flow rate used in the synthesis experiments, it can be 
assumed that there was no backflow through the auxiliary input channels during synthesis 
either. 
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Figure 44: Confocal imaging of input channel and join. 
Images captured to show absence of backflow from main to input channel. (A) and (B) show view of 
composites at 45° from normal, (C) and (D) show view from top. (A) and (C) show control images of static 
fluorescein, (B) and (D) show images taken while flowing fluorescein dye and water at rates of 3.3 µl min-1 
and 0.17 µl min-1 respectively. 
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5.3 Determining of Substrate Feeding Schedules Using Activity 
Models 
Michaelis-Menten kinetics were used to estimate when GA would need to be fed into the 
reaction mixture in order to complete the conversion of HPA to ERY without exposing TK to 
GA concentrations higher than 50 mM. A previously-published equation describing the 
kinetics of the TK-catalysed condensation of HPA and GA was used, along with reported 
kinetic and inhibitory constants (Gyamerah et al., 1997). The kinetic parameters are shown in 
Table 4. 
 
𝑉 =
𝑘𝑐𝑎𝑡𝐸𝑖[𝐴][𝐵]
𝐾𝐵[𝐴] (1 +
[𝐴]
𝐾𝑖𝐴
) + 𝐾𝐴[𝐵] (1 +
[𝐵]
𝐾𝑖𝐵
) + [𝐴][𝐵] + (
𝐾𝐴
𝐾𝑖𝑃
) [𝐵][𝑄] + (
𝐾𝐴𝐾𝑖𝐵
𝐾𝑖𝑃
) [𝑄]
 
(13) 
   
Kinetic parameter Value 
Rate constant: kcat 5076 min-1 
Michaelis constant for HPA: KA 13.2 mM 
Michaelis constant for GA: KB 16.1 mM 
Inhibition constant for HPA: KiA 42.2 mM 
Inhibition constant for GA: KiB 597.6 mM 
Inhibition constant for ERY: KiP 565.8 mM 
Table 4: Table of kinetic parameters determined by Gyamerah and Willetts (1997). 
The equation was used in an Excel spreadsheet model to make an estimation of the 
reaction's progress over time in order to estimate where GA feeding points would be required 
(see Appendix A for the full spreadsheet). The model effectively treated the reactor was as a 
series of discrete sections of constant volume, and the reaction rate and substrate and product 
concentrations were calculated for each section in sequence. In the first section the reaction 
rate was calculated using the initial concentrations of TK, HPA and GA; this was assumed to 
remain constant over the length of the section. The consumption of HPA and GA and the 
production of ERY were then calculated, and this data was used as the input to determine the 
reaction rate for the next section. 
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The feeding concentration of GA (i.e. the concentration in the reaction mixture after the 
GA input was dispersed) was set at 50 mM. To minimise the dilution of the product in 
reactions where numerous GA inputs would be required, whilst keeping the flow rate above 
the minimum that a syringe drive could reliably deliver, the GA input flow rate was limited to 
5% of the primary flow rate. From this, the dilution of the other chemical species in the 
reaction mixture upon the addition of a further GA input could be calculated. 
 
Figure 45: Calculated concentration profiles of HPA, GA and ERY over course of reaction in MIR for 
input concentrations of 500 mM HPA (A) and 400 mM HPA (B). 
The grey dotted line indicates a point at which GA feeding is simulated. 
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Figure 46: Calculated concentration profiles of HPA, GA and ERY over course of reaction in MIR for 
input concentrations of 300 mM HPA (A) and 200 mM HPA (B). 
The grey dotted line indicates a point at which GA feeding is simulated. 
The lower limit of GA concentration in the reaction mixture was set at 5 mM. If the model 
calculated that the GA concentration would drop below this threshold in a particular section, 
the addition of a further GA input would be simulated instead. The GA concentration would 
therefore be increased by 50 mM, while all other components in the reaction mixture would 
be diluted by 5%. For the purposes of calculating the reaction rate over the section in which 
the GA was fed, and subsequent sections, it was assumed that the GA and reaction mixture 
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streams would combine instantaneously, so there would be no diffusion limitation of the 
reaction rate.  
By simulating the feeding of GA every time the concentration dropped below the 5 mM 
limit, it was possible to estimate the number and timing of GA inputs that would be required 
to achieve complete conversion to ERY. The conversion of 200, 300, 400 and 500 mM input 
HPA was evaluated using this model. The reaction profiles generated by the model are shown 
in Figure 45 and Figure 46. 
From the estimated reaction profile generated for each input concentration of HPA tested, 
a mean residence time (of the reaction mixture) was established based upon the estimated time 
required to achieve a minimum of 97.5% theoretical conversion to ERY. A mean flow rate 
was then established to allow the calculated GA feeding time points to be assigned to physical 
input positions on the reactor, chosen to be closest to the required points estimated by the 
model. Finally, the actual flow rates were calculated using the overall residence time, the 
number of GA inputs required and the ratio of the primary flow rate to auxiliary flow rates 
(1:20). This was calculated using the following formula: 
 
𝑡 =∑
𝑉𝑖
𝑢𝑖
𝑖=𝑛
𝑖=0
 (14) 
   
 
𝑡 =∑
𝑉𝑖
𝑢𝑝𝑟𝑖𝑚𝑎𝑟𝑦(1 + 0.05𝑖)
𝑖=𝑛
𝑖=0
 (15) 
   
 1
𝑡
= 𝑢𝑝𝑟𝑖𝑚𝑎𝑟𝑦∑
(1+ 0.05𝑖)
𝑉𝑖
𝑖=𝑛
𝑖=0
 (16) 
   
 
∴ 𝑢𝑝𝑟𝑖𝑚𝑎𝑟𝑦 =
1
𝑡 × ∑
𝑉𝑖
(1 + 0.05𝑖)
𝑖=𝑛
𝑖=0
 
(17) 
   
Where uprimary is the primary flow rate, t is the total residence time, i denotes sections of 
the MIR for which the flow rate is constant (starting at i = 0 where the flow is determined by 
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the primary rate only), and Vi is the volume of a section i for which the flow rate is constant 
at ui. 
The feeding strategies generated from the estimation of the reaction’s progress at various 
input HPA concentrations, including the GA input positions and flow rates, is shown in Table 
5. 
 HPA input concentration (mM) 
200 300 400 500 
Residence time (mins) 120 165 264 286 
P
o
si
ti
o
n
 
Primary 1 TK/HPA TK/HPA TK/HPA TK/HPA 
Primary 2 GA GA GA GA 
Aux 1 GA GA GA GA 
Aux 2 - - GA GA 
Aux 3 - - GA GA 
Aux 4 GA GA GA GA 
Aux 5 - GA GA GA 
Aux 6 GA - GA GA 
Aux 7 - - - GA 
Aux 8 - GA - GA 
Aux 9 - - GA - 
Aux 10 - - - - 
Total GA inputs 4 6 8 9 
Flow rate 
(µl min-1) 
Primary 1 11.90 8.24 4.94 4.49 
Primary 2 & Aux 0.63 0.43 0.26 0.24 
Table 5: Input configuration and flow rates used in the feeding strategies developed for each input HPA 
concentration. 
The estimated end-point concentrations calculated for different input HPA concentrations 
using the model are shown in Table 6. 
HPA input concentration (mM) 200 300 400 500 
Residence time (mins) 120 165 264 286 
Estimated end-point 
concentrations (mM) 
HPA 4.5 3.7 0.7 3.9 
ERY 173 240 296 353 
Table 6: End-point concentrations estimated by the reactor model. 
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5.4 Continuous Multi-Input Synthesis of ERY 
5.4.1 Effect of Tris on Transketolase Activity 
The evolution of CO2 posed a potential problem in the synthesis of ERY in the MIR as 
the reaction was taking place in a sealed channel. In previous experiments (see Chapter 4) the 
target concentration of ERY, and therefore the concentration of CO2 evolved, was 50 mM, not 
high enough for any adverse effects. However, the maximum target concentration of ERY in 
the proposed feeding strategy was over seven times this amount. It was thought that the 
concomitant evolution of a higher concentration of CO2 could lower the pH of the reaction to 
a level outside of the operating pH range of the wild type TK enzyme used, pH 6.0 – 8.0, 
limiting the yield of the reaction where higher input HPA concentrations were used (Torres, 
2008).  
50 mM Tris buffer has been used in the ERY synthesis experiments performed so far. The 
concentration could have been increased to compensate for the evolution of additional CO2, 
but Tris buffer has also been shown to have an inhibitory effect on TK. Multi-variate 
experiments were therefore performed to attempt to establish whether the TK concentration 
could be increased from 50 mM without having a detrimental effect on TK activity. 
The conversion of 100 mM of HPA and GA was evaluated over the course of 120 minutes 
at Tris concentrations of 81, 143, 205, 267 and 329 mM (see Figure 47 and Figure 48). The 
results indicated a sharp decline in the amount of ERY produced in 120 minutes, from near-
complete conversion at 81 mM Tris concentrations to yields of around 50% at Tris 
concentrations of 267 mM. The drop in yield appeared to plateau at this point. The 
consumption of HPA reflected a similar trend. 
The longer-term effects of Tris concentration on storage of the enzyme were also 
evaluated. In each synthesis experiment, the crude lysate containing TK was taken from a 
frozen stock, pre-prepared from E. coli cells lysed in batches and stored in aliquots at -20°C 
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until required. These lysates were prepared and stored in 50 mM Tris, and it was these same 
lysates that were used in the range-finding experiments described above.  
 
Figure 47: Effect of Tris concentration on rate of HPA consumption. 
 
Figure 48: Effect of Tris concentration on rate of ERY production. 
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However, it was found that preparing the lysates in higher concentrations of Tris buffer 
could have a detrimental effect on the activity of TK (see Figure 49). The activity of two 
batches of TK lysate, prepared from the same harvest of cells from the same fermentation but 
lysed in 50 mM and 200 mM of Tris respectively. It was found that the TK lysed in 200 mM 
Tris was almost completely inactive, with a minimal amount of ERY being produced from 
100 mM HPA and GA. By comparison, lysate prepared in 50 mM Tris had a normal level of 
activity compared to that previously shown. It was therefore decided that the concentration of 
Tris used to buffer the synthesis reactions should not be changed. 
 
Figure 49: Effect of Tris storage concentration reaction kinetics (n = 3). 
(A) Rate of HPA consumption; (B) rate of ERY production. ♦ = 50 mM Tris, ■ = 200 mM Tris. 
5.4.2 Performance of the Multi-Input Reactor 
The conversion of four different input concentrations of HPA was carried out in the MIR 
using the four different feeding schedules shown in Table 5. As a control, the same feeding 
5 – MICROFLUIDIC MULTI-INPUT REACTOR FOR BIOCATALYTIC SYNTHESIS 
137 
 
schedules were followed in fed-batch mode using microwell plates, diluting the reaction 
mixture with the equivalent dose of GA at the equivalent time point to that of the MIR. In each 
strategy the configuration or timing of GA feeding points was altered according to the 
estimated progress of the reaction, in order to avoid inhibitory effects on the enzyme whilst 
aiming for complete conversion to ERY (see Section 5.3). The flexibility of the reactor’s input 
design was such that each of these feeding strategies could be tested with a minimal amount 
of effort in setting up, simply by changing the auxiliary connections and flow rates as required. 
Any ports which were not required in the synthesis reactions could be simply and reliably 
sealed using the PDMS plugs described in Section 5.2.1, which were held in place by standard 
M6 interconnects used in all devices presented in this thesis.  
 
Figure 50: End point concentrations from synthesis experiments performed in (A) the MIR and(B) in 
microwell plates (n = 3).  
Figure 50 shows the end-point concentrations of HPA and ERY from synthesis 
experiments performed under various input HPA concentrations in the MIR and microwell 
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plates. Compared with the microfluidic SHM reactor shown earlier, which had only a single 
substrate input microfluidic reactor (see Chapter 4), the use of multi-point feeding increased 
the yield of ERY from 50 mM to a maximum of 224 mM with the MIR. Compensating for the 
dilution caused by the nine GA inputs used in the feeding strategy, the maximum concentration 
of ERY generated is 313 mM. 
 
Figure 51: Throughput of ERY from fed-batch microwell plate and continuous MIR synthesis experiments 
(n = 3). 
Figures 32, 33 and 34 show the throughput, conversion and volumetric productivity data 
respectively, from the MIR and equivalent fed-batch microwell plate reactions. Comparing 
the output from the two systems, a very large improvement in the throughput of ERY from 
the MIR was observed, regardless of the input HPA concentration used, with the highest 
observed increase being 8-fold at the lowest input concentration (Figure 51). There was also 
see an increase in throughput from 3.6 mg h-1 to 15 mg h-1 when compared with the SHM 
reactor discussed in Chapter 4. This clearly shows the improvements in throughput and space-
time yield that are the foremost advantage of continuous flow reactors over batch or fed-batch 
reactors, which is in agreement with similar examples of such reactors for biocatalytic 
synthesis (Itabaiana et al., 2013). A continuous flow system is also of great interest for use in 
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multi-step synthesis processes, where a cascade of separate reactors can be created to perform 
a complex conversion. The MIR would be well-suited to this, having standard interconnect 
ports that would allow connection to other reactors or intermediate purification steps. 
 
Figure 52: Percentage conversion achieved in fed-batch microwell plate and continuous MIR synthesis 
experiments (n = 3). 
 
Figure 53: Volumetric productivity from fed-batch microwell plate and continuous MIR synthesis 
experiments (n = 3). 
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The volumetric productivity and conversion achieved in the MIR was higher than that of 
the fed-batch microwell plate reactions at lower input HPA concentrations, reaching a 
maximum of 9.4 (g h-1) L-1 and 86% respectively (Figure 52 and Figure 53). At higher HPA 
concentrations the conversion and productivity of the fed-batch microwell plate reactions 
surpassed that of the MIR. This may have been caused by decreasing pH as the reaction 
progressed, due to the evolution of CO2 as a by-product, which was released to the headspace 
in the microwells but remained in solution in the MIR. 
A reaction system designed for synthesis should aim to reach 100% conversion in order 
to minimise the downstream requirement for purification, or unintended side reactions when 
used as part of a multi-step process. Any change in pH could be mitigated in a manner 
analogous to that of a pH-stat reactor.  This could be accomplished by using some of the 
auxiliary inputs on the MIR to feed a base solution, thereby counteracting the pH drop and 
allowing complete conversion of substrate to product. However, to investigate this further 
would require integration of online pH monitoring into the MIR; a technology that has thus 
far only been used in cellular microreactors (Schäpper et al., 2009). 
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Figure 54: Concentration of HPA and ERY at MIR output over 12 hours of operation with 500 mM input 
HPA setup. 
HPA and ERY concentrations (left axis) were measured from samples taken hourly, the cumulative ERY 
output is an estimate calculated from the ERY concentration measured and total volume collected each 
hour. 
Figure 54 shows the output concentration profiles of HPA and ERY from a continuous 
synthesis experiment performed in the MIR 12 hours, using the feeding schedule developed 
for a 500 mM HPA input concentration. The reaction was sampled every hour with an 
automated sampling arm. The reaction equilibrated between hour 4 and 5 (as might be 
expected given that the residence time was 286 minutes), with a maximum output 
concentration of around 400 mM ERY. An estimated 90 mg of ERY was produced over the 
course of the experiment. The output concentration drops continuously between hours 5 and 
12, suggesting decay in TK activity due to exposure to room temperature conditions. This may 
provide a further explanation of the decrease in conversion observed at higher input HPA 
concentrations (Figure 52). The reactions were each sampled at 2.5 residence times, at 
between 5 and 12 hours (depending on the input HPA concentration). The data in Figure 54 
would suggest that the TK activity may have already decayed significantly by the time that 
the reactions with longer residence times, i.e. those for input concentrations of 400 and 500 
mM HPA, had reached their respective equilibration time and were sampled. 
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A modification that could be made to overcome this problem is the addition of a cooling 
system to maintain the stability of the solubilised enzyme. The enzyme could be thermo-stated 
to the desired temperature shortly before it is introduced into the reactor. A mutant of the TK 
enzyme with greater temperature stability could also be used. If the initial concentration of 
ERY observed in figure 4 could be maintained, this would allow production at a rate of 19 mg 
h-1, and thus would have led to a total of 171 mg over the 12 hours. 
5.5 Summary of Findings  
In this chapter, the design of a continuous flow multi-input reactor for biocatalytic 
synthesis has been shown, which is capable of mimicking fed-batch feeding strategies for use 
in overcoming substrate inhibition of biocatalysts. The reactor was designed to be fabricated 
rapidly with the use of laser ablation, such that entire devices can be assembled from scratch 
in a few hours. The speed with which the devices can be fabricated leaves open the possibility 
of modifying the design, for example to tailor it to specific feeding schedules or to scale up to 
achieve greater throughput. 
The MIR was applied to the synthesis of ERY using TK, with feeding strategies being 
designed for the conversion of 200 – 500 mM HPA, based on kinetic data from literature. The 
reactor was able to achieve more than a four-fold increase in yield by comparison with the 
output from the SHM reactor discussed in Chapter 4, and a five-fold increase in throughput. 
The throughput from the MIR was also shown to be 2.5 – 8 times that of the equivalent fed-
batch reactions, depending on the input concentration of HPA. Furthermore, a continuous flow 
synthesis experiment, operated using the maximum input HPA concentration, was able to 
produce a maximum of 400 mM of ERY immediately after equilibration, with the output 
concentration dropping to 120 mM over the next seven hours. The experiment produced a total 
of around 90 mg of ERY over the course of 12 hours. 
The application of the MIR to biocatalytic synthesis using an inhibiting substrate 
represents a step towards process intensification at the microfluidic scale, having been used to 
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produce concentrations of a metabolite that are rarely achieved at such scales. However, 
approaching these concentrations has created new challenges, such as the increased evolution 
of CO2 and concomitant pH drop which that could bring. Overcoming this problem would 
likely require monitoring of pH such that a basic solution could be fed to counteract the drop. 
It seems likely that other biocatalytic reactions would require similar monitoring. In addition, 
the long-term stability of the enzyme when it is exposed to room temperature appears to be a 
problem for sustained synthesis reactions. In this case a cooling system might be necessary to 
maintain the activity of the enzyme that has yet to be fed into the reactor, with a heating circuit 
to raise the temperature of the enzyme feed before it enters the reaction channel. Again, this 
would likely be required for applications involving other biocatalysts. 
Beyond this, the consistency of design of the MIR with the other devices shown in this 
thesis means that it could be integrated into a wider network of purification or reaction steps 
in order to work up to more complex products. 
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6.1 Conclusions 
6.1.1 Development of Microfluidic Tangential Flow Filter 
After several iterations, a microfluidic filter was designed which could be clamp sealed 
and could therefore be used with two commercial membranes, avoiding problems with pore 
blocking encountered when membranes were glued, or  problems with chemical compatibility 
that might be encountered in other bonding methods. The main body of the filter could be 
reused multiple times, and its fabrication in polycarbonate meant that it could sterilized by 
autoclaving for the purposes of cell handling, in particular mammalian cell recovery. 
The burst pressure of the assembled filter was shown to be dependent upon the torsion 
applied to the assembly screws. A strong seal was achieved using a torsion of 10 cN-m on all 
assembly screws, giving a burst pressure of 100 psi. The filter was tested for the purification 
of a small molecular product in a biocatalytic synthesis process (Chapter 4) and the separation 
of mammalian cells from a suspension containing trypsin (Appendix C), using two different 
commercially available membranes. 
6.1.2 Biocatalytic Synthesis Using Inline Microfluidic Filtration Device 
The filter was used in combination with a staggered herringbone mixer reactor to 
synthesize ERY using a TK enzyme as the biocatalyst, with the filter being used to retain the 
enzyme after the reaction. The two devices were first used separately to determine the best 
conditions for conversion and filtration. Full conversion of 50 mM HPA and GA to ERY was 
achieved in 120 minutes using the SHM reactor. The kinetic data in the reactor was shown to 
be comparable to equivalent experiments performed in 96-well plates, with similar 
enantiomeric excess of ERY 90% and 87% in the well plate and SHM reactor respectively. 
A commercially available 10 kDa molecular weight cut-off polysulphone membrane was 
tested in the microfluidic filter to retain the cell debris containing TK, which was capable of 
fully retaining the material. Capillaries with specified diameters were used in combination 
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with specific flow rates in order to control the pressure in the filter; a capillary diameter of 
50µm and a flow rate of 10 µl min-1 was found to give the best yield of ERY. 
Having determined the best conditions for conversion and filtration, the two devices were 
connected together into a continuous system to synthesise and purify ERY. The system was 
operated for 10 hours, giving a peak of ERY output in the permeate immediately after 
equilibration of 100%. This decreased over the next 3-4 hours, but was shown to be restored 
by backflushing with tris buffer. No HPA was present throughout the experiment, indicating 
that the conversion to ERY in the reactor was complete. The cumulative yield of ERY was 
approximately 3.2 mg. 
The successful addition of a downstream processing step to a biocatalytic synthesis 
reaction at the microfluidic scale opens up possibilities for the evaluation of whole 
bioprocesses at this scale. Furthermore, the ability to retain the product of a biocatalytic 
reaction performed with solubilised enzyme could allow the integration of several such 
reaction step into one continuous operation. Here the compartmentalisation of the reactions 
could prevent formation of side products and also allow each biocatalyst to be operated at its 
own ideal conditions. 
6.1.3 Microfluidic Multi-Input Reactor for Biocatalytic Synthesis 
A microfluidic multi-input reactor was designed for the purposes of mimicking fed-batch 
reactions in a continuous-flow system. The reactor consisted of a 3.3 meter channel with two 
main inlets and multiple additional inputs along its length, to allow additional substrate to be 
fed into the reaction mixture, analogous to the feeding of substrate at fixed time points in a 
fed-batch reactor. The reactor was designed to be fabricated by a laser with a relatively small 
operating window, with an overall footprint of 85 x 85 mm, and the complete fabrication of a 
new reactor could be completed in two hours excluding the modular interconnect blocks. 
Reported kinetic data for transketolase was used to design feeding strategies for the 
conversion of different concentrations of HPA, estimating the overall residence time, the 
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points at which GA would need to be fed and the flow rates required. Using these feeding 
strategies, the highest concentration of ERY yielded by the reactor was 224 mM (4.5 times 
that of the SHM reactor used previously), or 313 mM accounting for the dilution by additional 
GA. An 8-fold increase in throughput over equivalent fed-batch reactions was also 
determined. 
The yield of ERY from the MIR tended to decrease as the input HPA concentration used 
was increased, a trend which was not observed in the equivalent fed-batch reactions. This 
could be attributed to the build-up of CO2 in the MIR, which appeared to remain in solution 
and could have reduced the pH below the operating range of the enzyme. Further improvement 
of the reactor would be required to overcome this problem (detailed in Section 6.2) though if 
the theoretically calculated conversion could be reached it would represent a significant step 
towards the level of throughput that is commonly associated with chemical microreactors. 
This could be used as a way of intensifying synthesis reactions with biocatalysts, with 
processes developed at the microfluidic scale being scaled up or out to pilot or even industrial 
scales, in much the same way as observed with chemical microreactors in recent years. 
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6.2 Future Work 
Further experiments are envisioned which could focus on three main themes: 
1. The scaled-down (and intensified) production of chiral metabolites. 
2. Cascading of multiple reaction and purification steps to find novel routes to 
metabolites for process development. 
3. Analysis and optimisation of the operational space of individual process steps at 
the microfluidic scale. 
 
Figure 55: Critical path analysis of additional activity towards enhancing the design of the 
microfluidic filter, multi-input reactor, and combining the two devices for multi-step synthesis.  
The two streams of work on the filter and MIR could alternatively be carried out in parallel, while the 
‘Combined’ stream would require both devices. The length of the bars indicates the predicted workload 
involved in each aspect of the project. Lighter grey bars indicate activities with a lower priority. 
Initial work involving the filter could focus on further investigation of processing 
conditions for the removal of transketolase from a reaction mixture after synthesis, in order to 
maintain a higher yield than was achieved in previous experiments in Chapter 4 (bar a of the 
critical path analysis shown in Figure 55). In particular, this might include the testing of other 
membrane materials, pore sizes and a more detailed evaluation of the effects of TMP to define 
the critical pressure for the process. Given the volume of experiments required it is imagined 
that this will create a larger workload, relating to a longer bar on the critical path analysis. 
Addition of pressure transducers to the inlets and outlets of the device along with computer-
controlled micrometering valves (b), as opposed to manual valves which were found to give 
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poor control of pressure, would help to achieve more precise pressure control for this purpose 
and give a greater quantity of data on the filtration process, and should therefore be done early 
on. This should be a relatively trivial step, although identifying valves capable of delivering 
pressure control at such low flow rates may be a challenge. 
Key scaling parameters could be identified in experiments performed with the 
microfluidic device and compared with those of larger equivalent units used more routinely 
in process development, in order to better establish the value of the device as a tool for scale-
down process development (c). This could allow the device to be used in scale-down 
bioprocess development for other processes; however I believe the primary worth of the device 
is as an intermediary purification step in a network of microfluidic reactors, so this would be 
less of a priority. A higher priority would be increasing the filtration area of the device itself, 
either by elongation or by widening the filtration channel, using flow splitters to ensure an 
even flow rate over the surface of the membrane (d). This should help to reduce effects of 
fouling on flux and make the device more useful for separations at the microfluidic scale.   
The MIR could also be further developed, either after or in parallel to the experiments 
carried out with the tangential flow filter. The initial focus of work on the MIR should be to 
establish pH sensing within the reactor channel (e), in order to confirm whether the downward 
trend in conversion with higher input HPA concentrations is indeed caused by a drop in pH. 
Initial tests might require that off-the-shelf pH sensors are incorporated into the fluidic circuit 
through additional ports and tubing, with more sophisticated versions potentially using a pH 
sensing coating that can be interrogated by Fourier transform infrared spectroscopy. The 
addition of a method of chilling the reaction mixture before it enters the MIR would also be 
necessary to rule out the possible effects of enzyme inactivation at room temperature (f). The 
technical challenges involved in step (e), including the evaluation of methods for 
incorporating the necessary sensors and fibers, and the modification of the reactor to make 
detection possible, would create quite a large workload. Step (f) would be relatively trivial; 
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however both of these steps would be beneficial to intensifying the production of the chosen 
chiral metabolite. 
With the pH sensing system in place, the substrate feeding strategies previously developed 
could be modified to neutralise any changes to the pH of the reaction mixture that would 
adversely affect the activity of the enzyme, for instance feeding in a slightly basic solution of 
GA. The synthesis experiments performed in Chapter 5 could then be repeated to see if there 
was better agreement between the continuous-flow and fed-batch reactors (g), a relatively 
time-consuming process but one that shouldn’t present any technical challenges.  
Assuming that the data from the continuous-flow and fed-batch reactions were more 
closely aligned, the feeding strategy with the best conversion could be improved further. This 
could be achieved by modifying the design of the reactor to feed the substrate more closely to 
the point that it was required, either by changing the point at which each input joined the main 
channel or making slight modifications to the channel width, to change the residence time 
between sections (h). The reactor might also be scaled up to increase the throughput achieved 
(i), moving the MIR from a scaled-down tool for process development and intensification to 
a bench-top reactor, a step which is in-keeping with current trends in the use of microreactor 
designs in the chemistry industry. The speed of the laser fabrication process would allow both 
of these steps to be completed relatively quickly. Again, this scaled-up and tailored design 
could be compared with a bench-top fed-batch reactor to demonstrate its value as a method 
for generating a continuous supply of a chiral product (j).  
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Figure 56: The transketolase – transaminase pathway for the production of ABT. 
Having performed the work described above, the tangential flow filter and the MIR could 
be combined to perform a two-step synthesis process, using the transketolase – transaminase 
pathway to produce 2-amino-1,3,4-butanetriol (ABT; see Figure 56). This would serve as a 
useful proof-of-concept for pharmaceutical production, given that the molecules produced by 
the pathway can be used as precursors for protease inhibitors (Ingram et al., 2007). The same 
process that was used to create feeding strategies for the synthesis of ERY could be applied to 
transaminase using the available kinetic data, based on the conversion of the established output 
concentration of ERY and using methylbutylamine as the inhibiting substrate (Rios-Solis et 
al., 2013). These strategies could be tested in the MIR (k) and a new reactor could be fabricated 
which is tailored to the best optimised strategy (l). Using the data gathered in the earlier 
optimisation of the filtration conditions for TK, a set of conditions could be established for the 
separation of TK and TAm downstream from their respective reactors (m). Finally, the two 
reactions could be combined in a single network consisting of two MIRs and two tangential 
filters, producing a continuous stream of ABT (n). 
This work would further validate the devices presented in this thesis for the purpose of 
evaluating biocatalytic process conditions and intensifying the production of the desired chiral 
products. Not only that, but it would represent a significant step towards the use of 
microreactor designs for multi-step industrial biocatalysis, something that has to date only 
been explored for chemical synthesis. 
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Appendix A – Program Code 
Presented in this appendix is the LabVIEW program for the recording of pressure data 
from a transducer burst pressure and back pressure monitoring experiments performed in the 
tangential flow filtration device. The use of a Hagen-Poiseuille model to determine condition 
sets for achieving particular TMP values in the filtration device is also shown. 
Also presented is a comparison of the methods used to estimate TK activity, using the 
same kinetic data in an Excel spreadsheet and the MATLAB ODE solver. 
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A.1 LabVIEW Virtual Instruments for Pressure Monitoring 
LabVIEW Virtual Instruments (VIs) were used to monitor and record data from a pressure 
transducer connected to the tangential flow filter. The transducer was attached to a DAQ card 
with a 1 kHz maximum sample rate. For the recording of burst pressure, voltage measurements 
were made at the maximum sample rate of the card and written directly to an Excel 
spreadsheet, with a simple graphical output so that the user could monitor the change in 
pressure in real time (see Figure 57). 
 
Figure 57: A LabVIEW VI designed to acquire voltage data from the pressure transducer at the maximum 
sample rate of the DAQ, for burst pressure measurements. 
A separate VI was made for the recording of back pressure measurements from the filter, 
as the flow rate and therefore the pressure had to be allowed to stabilise over the period of 
several minutes to an hour. Using the maximum possible sampling rate was impractical in this 
case as it consumed too much memory and caused frequent crashes. Instead, the sampling rate 
was limited to 1 Hz with an infinite loop (see Figure 58). The data was written to an Excel file 
in the same way as before, and a live trace of recent measurements was also included for the 
purpose of troubleshooting slow leaks. 
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Figure 58: A LabVIEW VI designed to acquire voltage data from the pressure transducer at 1 Hz, for 
back pressure measurements. 
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A.2 Comparison of an Excel Spreadsheet and MATLAB ODE Solver 
for TK Reaction Estimation 
An Excel spreadsheet was used to make an iterative model of the progress of the TK 
reaction in the MIR, to estimate time points at which GA should be fed into the reaction 
mixture in order to sustain the reaction without causing substrate inhibition. As discussed in 
Section 5.3, the model was based on kinetic parameters determined by Willetts and Gyamerah 
and effectively assumed that the reaction was occurring in a single plug of fluid travelling 
down the length of the reactor (Gyamerah et al., 1997).  
The spreadsheet calculations used are shown in Figure 59A, with the flow of information 
through the spreadsheet illustrated in Figure 59B. The model divided the reaction’s progress 
into time intervals of defined length (10 sec to 5 min). The initial concentrations of HPA (a), 
GA (b) and ERY (d) were used with the equation determined by Willetts and Gyamerah 
(shown below) and the kinetic parameters (c) to determine the rate of reaction.  
 
𝑉 =
𝑘𝑐𝑎𝑡𝐸𝑖[𝐴][𝐵]
𝐾𝐵[𝐴] (1 +
[𝐴]
𝐾𝑖𝐴
) + 𝐾𝐴[𝐵] (1 +
[𝐵]
𝐾𝑖𝐵
) + [𝐴][𝐵] + (
𝐾𝐴
𝐾𝑖𝑃
) [𝐵][𝑄] + (
𝐾𝐴𝐾𝑖𝐵
𝐾𝑖𝑃
) [𝑄]
 
(13) 
   
The calculated rate (f) was used with the time interval (e) and the dilution factor (g) to 
determine the depletion and resulting concentrations of HPA, GA and ERY over the course of 
a single interval, assuming that the reaction rate was constant for that time. These updated 
concentrations were then used to recalculate the reaction rate for the next interval and the 
process was repeated. 
At the beginning of each new interval, the concentration of GA from the previous interval 
(h) was compared to the reaction rate (i). If the concentration and reaction rate were such that 
the GA would fall below 5 mM, the model automatically assumed that another 1M GA input 
was required, causing the dilution factor of the reaction mixture to increase by 1/20th (j) and 
increasing the GA concentration for the next iteration accordingly (k). This information was 
also used to update the concentrations of HPA and ERY to reflect the dilution. 
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The accuracy of iterative model created in Excel was compared to that of a model created 
using the ODE solver function in MATLAB (The Mathworks, Inc., Natick, USA), using real 
data generated in the SHM T-piece reactor (see Figure 36, Section 4.2.3). Both models used 
the same kinetic parameters and starting conditions of 50 mM HPA and GA, with a Vmax of 
5.3 mM min-1. The MATLAB ODE solver program used is shown over the page. The models 
were programmed to determine the change in concentration of HPA and GA over a 120 minute 
reaction, and the output from each was compared to the real data already acquired (Figure 60). 
There was quite a large discrepancy between the both models and the real data in the early 
stages of the reaction, with both models underestimating the rate of reaction over the first 30 
minutes (Figure 60A). The Excel-based model appeared to fit the real data closer than the 
MATLAB model, catching up to the real concentration of ERY more quickly and being closer 
to the real data overall (Figure 60B). The divergence from the real data could well have 
occurred because the mutant of TK used differed from that used to determine the kinetic 
parameters used; however this was outside the scope of the project. 
Since there was no improvement in the accuracy of the predicted data from the use of a 
MATLAB model, the Excel-based model was used, as it could more easily be adapted to 
simulate GA feeding. The data generated from the model was used to estimate where GA 
would need to be fed into the MIR in order to sustain the reaction without causing substrate 
inhibition. 
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Figure 59: The equations used in iterative Excel model of TK activity. 
(A) Shows the equations and data used in their raw form; the overlaid boxes and arrows in (B) represent 
the flow of data from one data point/formula to the next. 
 
function [ dydt ] = tkmm( t, y, kcat, E, ka, kb, kia, kib, kiq ) 
 
%A refers to HPA, B to GA and Q to ERY 
 
ERY = y(1); 
HPA = y(2); 
GA = y(3); 
 
dydt = [ (kcat*E*HPA*GA)/( (kb*HPA*(1+HPA/kia)) + 
(ka*GA*(1+GA/kib)) + (HPA*GA) + ((ka/kiq)*GA*ERY) + 
((ka*kib/kiq)*ERY) ); 
    -(kcat*E*HPA*GA)/( (kb*HPA*(1+HPA/kia)) + (ka*GA*(1+GA/kib)) 
+ (HPA*GA) + ((ka/kiq)*GA*ERY) + ((ka*kib/kiq)*ERY) ); 
    -(kcat*E*HPA*GA)/( (kb*HPA*(1+HPA/kia)) + (ka*GA*(1+GA/kib)) 
+ (HPA*GA) + ((ka/kiq)*GA*ERY) + ((ka*kib/kiq)*ERY) ); 
]; 
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Figure 60: Comparison of predicted reaction kinetics to real data generated in SHM reactor. 
(A) Reaction profile of real data compared to profiles predicted with MATLAB and Excel models (n = 6, 
error bars are standard deviation); (B) predicted versus actual concentration of ERY (n = 6, error bars 
are standard deviation). 
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A.3 Excel Spreadsheet for Prediction of TMP  
Glass capillaries of determined diameter were used to constrict flow and apply pressure 
to the fluid in the microfluidic tangential flow filter. A range of capillary diameters were 
available; the Hagen-Poiseulle equation was used in a spreadsheet to estimate the 
transmembrane pressure (TMP) in the filter when the flow from the retentate and permeate 
outlets was constricted by different capillary diameters. A TMP value was then determined by 
finding the difference in pressure between the retentate and permeate sides (Figure 61). The 
pressure generated for a range of different capillary diameters (0.32, 0.5, 0.6 and 0.8 mm) was 
evaluated at different flow rates (0.01, 0.1, 1 and 5 mL min-1). Different combinations of 
capillary diameter on the retentate and permeate were also evaluated.  
Each TMP value for calculated the various condition sets was automatically tabulated in 
a separate sheet by a macro; the program code for this is shown over the page. The calculated 
TMP values are shown in Table 7.  
 
Figure 61: Equations used in TMP calculating spreadsheet. 
Condition sets were selected from Table 7 to match three TMP values as closely as 
possible for the cell filtration experiments. These values were 0.689, 1.379 and 2.068 bar (10, 
20 and 30 psi). The condition sets used are shown in Table 8. 
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Sub Macro_fr_&_d() 
' fr_&_d_adjust Macro 
' Uses flow rate adjust macro to 
sequence through permeate diameters 
(fixed length 20cm), changes retentate 
diameter and length, tabulates in Sheet 
2 
 
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "10" 
    Range("I5").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("d20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("h20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("l20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("p20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
         
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "20" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("T20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("X20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AB20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AF20").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
     
    'Repeat for next permeate d 
value 
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "10" 
    Range("I5").Select 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("d24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
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    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("h24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("l24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("p24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
     
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "20" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("T24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("X24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AB24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AF24").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
 
    'Repeat for next permeate d 
value 
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "10" 
    Range("I5").Select 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("d28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("h28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("l28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
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    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("p28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
     
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "20" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("T28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("X28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AB28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AF28").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
     
    'Repeat for next permeate d 
value 
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "10" 
    Range("I5").Select 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("d32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("h32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("l32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("p32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
     
    Range("I4").Select 
    ActiveCell.FormulaR1C1 = "20" 
    Range("I3").Select 
    ActiveCell.FormulaR1C1 = "0.32" 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("T32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
APPENDIX A – PROGRAM CODE 
174 
 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.5" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("X32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.6" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AB32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
    Range("I3").Select 
    Application.CutCopyMode = False 
    ActiveCell.FormulaR1C1 = "0.8" 
    Range("I4").Select 
    Application.Run "'pressure drop 
expt space.xls'!flow_rate_adjust" 
    Range("H10:K13").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("Sheet2").Select 
    Range("AF32").Select 
    ActiveSheet.Paste 
    Sheets("Sheet1").Select 
End Sub 
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l (mm)     100 
  d (mm)   0.32 0.5 0.6 0.8 
    Q (ml min-1) 0.01 0.1 1 5 0.01 0.1 1 5 0.01 0.1 1 5 0.01 0.1 1 5 
100 
0.32 
0.01 0.00 0.06 0.75 6.06 -0.01 0.01 0.22 3.37 -0.01 0.00 0.16 3.08 -0.01 0.00 0.12 2.91 
0.1 -0.06 0.00 0.70 6.00 -0.06 -0.05 0.16 3.31 -0.06 -0.06 0.10 3.03 -0.06 -0.06 0.06 2.85 
1 -0.64 -0.58 0.11 5.42 -0.65 -0.64 -0.43 2.73 -0.65 -0.64 -0.48 2.44 -0.65 -0.64 -0.52 2.26 
5 -3.23 -3.17 -2.48 2.83 -3.24 -3.23 -3.02 0.13 -3.24 -3.23 -3.07 -0.15 -3.24 -3.24 -3.11 -0.33 
0.5 
0.01 0.01 0.06 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.01 0.16 3.09 0.00 0.00 0.13 2.91 
0.1 0.00 0.06 0.75 6.06 -0.01 0.00 0.21 3.36 -0.01 0.00 0.15 3.08 -0.01 -0.01 0.12 2.90 
1 -0.10 -0.04 0.65 5.96 -0.11 -0.10 0.11 3.26 -0.11 -0.10 0.06 2.98 -0.11 -0.11 0.02 2.80 
5 -0.54 -0.48 0.22 5.52 -0.54 -0.53 -0.32 2.83 -0.54 -0.54 -0.38 2.55 -0.54 -0.54 -0.41 2.37 
0.6 
0.01 0.01 0.07 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.01 0.17 3.09 0.00 0.00 0.13 2.91 
0.1 0.00 0.06 0.76 6.06 0.00 0.01 0.22 3.37 0.00 0.00 0.16 3.09 -0.01 0.00 0.12 2.91 
1 -0.05 0.01 0.71 6.02 -0.05 -0.04 0.17 3.32 -0.05 -0.05 0.11 3.04 -0.05 -0.05 0.08 2.86 
5 -0.26 -0.20 0.50 5.81 -0.26 -0.25 -0.04 3.11 -0.26 -0.26 -0.10 2.83 -0.26 -0.26 -0.13 2.65 
0.8 
0.01 0.01 0.07 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.01 0.17 3.09 0.00 0.00 0.13 2.91 
0.1 0.00 0.06 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.00 0.16 3.09 0.00 0.00 0.13 2.91 
1 -0.01 0.05 0.74 6.05 -0.02 0.00 0.21 3.36 -0.02 -0.01 0.15 3.07 -0.02 -0.01 0.11 2.90 
5 -0.08 -0.02 0.68 5.98 -0.08 -0.07 0.14 3.29 -0.08 -0.08 0.08 3.01 -0.08 -0.08 0.05 2.83 
200 
0.32 
0.01 -0.01 0.05 0.75 6.05 -0.01 0.00 0.21 3.36 -0.01 -0.01 0.15 3.08 -0.01 -0.01 0.12 2.90 
0.1 -0.12 -0.06 0.63 5.94 -0.13 -0.12 0.09 3.24 -0.13 -0.12 0.04 2.96 -0.13 -0.13 0.00 2.78 
1 -1.29 -1.23 -0.53 4.77 -1.29 -1.28 -1.07 2.08 -1.29 -1.29 -1.13 1.80 -1.30 -1.29 -1.17 1.62 
5 -6.47 -6.41 -5.72 -0.41 -6.47 -6.46 -6.25 -3.10 -6.48 -6.47 -6.31 -3.38 -6.48 -6.47 -6.35 -3.56 
0.5 
0.01 0.00 0.06 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.00 0.16 3.09 0.00 0.00 0.13 2.91 
0.1 -0.02 0.04 0.74 6.05 -0.02 -0.01 0.20 3.35 -0.02 -0.02 0.14 3.07 -0.02 -0.02 0.11 2.89 
1 -0.21 -0.15 0.54 5.85 -0.22 -0.21 0.00 3.16 -0.22 -0.21 -0.05 2.87 -0.22 -0.21 -0.09 2.70 
5 -1.08 -1.02 -0.33 4.98 -1.09 -1.07 -0.86 2.29 -1.09 -1.08 -0.92 2.00 -1.09 -1.08 -0.96 1.83 
0.6 
0.01 0.01 0.06 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.01 0.16 3.09 0.00 0.00 0.13 2.91 
0.1 0.00 0.06 0.75 6.06 -0.01 0.00 0.21 3.36 -0.01 0.00 0.16 3.08 -0.01 -0.01 0.12 2.90 
1 -0.10 -0.04 0.66 5.96 -0.10 -0.09 0.12 3.27 -0.10 -0.10 0.06 2.99 -0.10 -0.10 0.02 2.81 
5 -0.52 -0.46 0.24 5.54 -0.52 -0.51 -0.30 2.85 -0.52 -0.52 -0.36 2.57 -0.52 -0.52 -0.39 2.39 
0.8 
0.01 0.01 0.07 0.76 6.07 0.00 0.01 0.22 3.37 0.00 0.01 0.17 3.09 0.00 0.00 0.13 2.91 
0.1 0.00 0.06 0.76 6.06 0.00 0.01 0.22 3.37 0.00 0.00 0.16 3.09 0.00 0.00 0.13 2.91 
1 -0.03 0.03 0.73 6.03 -0.03 -0.02 0.19 3.34 -0.03 -0.03 0.13 3.06 -0.03 -0.03 0.10 2.88 
5 -0.16 -0.10 0.59 5.90 -0.16 -0.15 0.06 3.21 -0.17 -0.16 0.00 2.93 -0.17 -0.16 -0.04 2.75 
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l (mm)     200 
  d (mm)   0.32 0.5 0.6 0.8 
    Q (ml min-1) 0.01 0.1 1 5 0.01 0.1 1 5 0.01 0.1 1 5 0.01 0.1 1 5 
100 
0.32 
0.01 0.01 0.12 1.40 9.30 0.00 0.02 0.32 3.91 -0.01 0.01 0.21 3.35 -0.01 0.00 0.14 2.99 
0.1 -0.05 0.07 1.34 9.24 -0.06 -0.04 0.27 3.85 -0.06 -0.05 0.15 3.29 -0.06 -0.06 0.08 2.93 
1 -0.63 -0.52 0.76 8.66 -0.65 -0.62 -0.32 3.27 -0.65 -0.64 -0.43 2.71 -0.65 -0.64 -0.50 2.35 
5 -3.23 -3.11 -1.83 6.07 -3.24 -3.22 -2.91 0.68 -3.24 -3.23 -3.02 0.12 -3.24 -3.23 -3.09 -0.24 
0.5 
0.01 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.22 3.35 0.00 0.00 0.15 2.99 
0.1 0.00 0.12 1.40 9.29 -0.01 0.01 0.32 3.91 -0.01 0.00 0.21 3.34 -0.01 -0.01 0.14 2.98 
1 -0.10 0.02 1.30 9.20 -0.11 -0.09 0.22 3.81 -0.11 -0.10 0.11 3.24 -0.11 -0.10 0.04 2.89 
5 -0.53 -0.41 0.87 8.76 -0.54 -0.52 -0.21 3.37 -0.54 -0.53 -0.33 2.81 -0.54 -0.54 -0.40 2.45 
0.6 
0.01 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.92 0.00 0.01 0.22 3.35 0.00 0.00 0.15 2.99 
0.1 0.01 0.13 1.40 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.21 3.35 0.00 0.00 0.14 2.99 
1 -0.04 0.08 1.36 9.25 -0.05 -0.03 0.28 3.86 -0.05 -0.04 0.17 3.30 -0.05 -0.05 0.09 2.94 
5 -0.25 -0.13 1.15 9.04 -0.26 -0.24 0.07 3.65 -0.26 -0.25 -0.04 3.09 -0.26 -0.26 -0.12 2.73 
0.8 
0.01 0.01 0.13 1.41 9.31 0.00 0.02 0.33 3.92 0.00 0.01 0.22 3.35 0.00 0.00 0.15 3.00 
0.1 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.22 3.35 0.00 0.00 0.14 2.99 
1 0.00 0.11 1.39 9.29 -0.01 0.01 0.31 3.90 -0.02 0.00 0.20 3.34 -0.02 -0.01 0.13 2.98 
5 -0.07 0.05 1.33 9.22 -0.08 -0.06 0.25 3.83 -0.08 -0.07 0.14 3.27 -0.08 -0.08 0.06 2.91 
200 
0.32 
0.01 0.00 0.12 1.40 9.29 -0.01 0.01 0.32 3.90 -0.01 0.00 0.21 3.34 -0.01 -0.01 0.13 2.98 
0.1 -0.12 0.00 1.28 9.18 -0.13 -0.11 0.20 3.79 -0.13 -0.12 0.09 3.22 -0.13 -0.13 0.02 2.87 
1 -1.28 -1.16 0.11 8.01 -1.29 -1.27 -0.96 2.62 -1.29 -1.28 -1.08 2.06 -1.29 -1.29 -1.15 1.70 
5 -6.46 -6.35 -5.07 2.83 -6.47 -6.45 -6.15 -2.56 -6.47 -6.46 -6.26 -3.12 -6.48 -6.47 -6.33 -3.48 
0.5 
0.01 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.22 3.35 0.00 0.00 0.14 2.99 
0.1 -0.01 0.11 1.39 9.28 -0.02 0.00 0.31 3.89 -0.02 -0.01 0.20 3.33 -0.02 -0.02 0.12 2.97 
1 -0.20 -0.09 1.19 9.09 -0.22 -0.19 0.11 3.70 -0.22 -0.21 0.00 3.14 -0.22 -0.21 -0.07 2.78 
5 -1.07 -0.96 0.32 8.22 -1.08 -1.06 -0.76 2.83 -1.09 -1.07 -0.87 2.27 -1.09 -1.08 -0.94 1.91 
0.6 
0.01 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.22 3.35 0.00 0.00 0.15 2.99 
0.1 0.00 0.12 1.40 9.29 -0.01 0.01 0.32 3.91 -0.01 0.00 0.21 3.34 -0.01 -0.01 0.14 2.98 
1 -0.09 0.03 1.30 9.20 -0.10 -0.08 0.23 3.81 -0.10 -0.09 0.11 3.25 -0.10 -0.10 0.04 2.89 
5 -0.51 -0.39 0.88 8.78 -0.52 -0.50 -0.19 3.39 -0.52 -0.51 -0.31 2.83 -0.52 -0.52 -0.38 2.47 
0.8 
0.01 0.01 0.13 1.41 9.31 0.00 0.02 0.33 3.92 0.00 0.01 0.22 3.35 0.00 0.00 0.15 2.99 
0.1 0.01 0.13 1.41 9.30 0.00 0.02 0.33 3.91 0.00 0.01 0.21 3.35 0.00 0.00 0.14 2.99 
1 -0.02 0.10 1.38 9.27 -0.03 -0.01 0.30 3.88 -0.03 -0.02 0.18 3.32 -0.03 -0.03 0.11 2.96 
5 -0.15 -0.04 1.24 9.14 -0.16 -0.14 0.16 3.75 -0.16 -0.15 0.05 3.19 -0.17 -0.16 -0.02 2.83 
Table 7: Transmembrane pressure values calculated using the Hagen-Poiseuille spreadsheet.  
Parameters along the top of the table correspond to the conditions on the retentate side, parameters along the left side of the table correspond to conditions on the permeate side. l is 
capillary length, d is capillary diameter and Q is flow rate.
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TMP 
(bar/psi) 
l (capillary length, mm) d (capillary diameter, 
mm) 
Q (flow rate,  
mm min-1) 
Retentate Permeate Retentate Permeate Retentate Permeate 
0.696/10 100 100 0.32 0.32 0.1 1.0 
1.344/20 200 100 0.32 0.32 0.1 1.0 
2.078/30 100 200 0.5 0.32 1.0 5.0 
Table 8: Condition sets used to achieve specific TMP in cell filtration experiments. 
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Appendix B – Mechanical Drawings 
This appendix contains the mechanical drawings for the individual PC or PMMA parts 
that made up the microfluidic tangential flow filtration device and multi-input reactor used in 
this thesis, as well as PMMA moulds used for the casting of PDMS parts. Unless otherwise 
indicated, all dimensions are shown in mm. 
 
APPENDIX B – MECHANICAL DRAWINGS 
179 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
180 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
181 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
182 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
183 
 
 
  
APPENDIX B – MECHANICAL DRAWINGS 
184 
 
 
  
APPENDIX B – MECHANICAL DRAWINGS 
185 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
186 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
187 
 
 
 
APPENDIX B – MECHANICAL DRAWINGS 
188 
 
 
 
  
APPENDIX C – PUBLICATIONS 
189 
 
 
 
Appendix C – Publications 
Selected results from Chapters 3 and 4 have been published as a journal article in 
‘Modular Microfluidic Reactor and Inline Filtration System for the Biocatalytic Synthesis of 
Chiral Metabolites’ (J. Mol. Cat. B, 2012, 77: 1-8). The results of Chapter 5 were also 
published as a journal article in ‘Microfluidic Multi-Input Reactor for Biocatalytic Synthesis 
Using Transketolase’ (J Mol. Cat. B, 2013, 95: 111-117). Reproductions of these publications 
have been removed the electronic version of this thesis for copyright reasons, but are available 
in the printed version. 
 
